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Neutrophil apoptosis represents a major mechanism involved in the resolution of
inflammation. When neutrophils die by apoptosis they retain their granule contents, but
lose chemotactic and secretory responsiveness, and are phagocytosed intact by
macrophages via a mechanism that does not incite an inflammatory response. While the
processes involved in regulating neutrophil survival are poorly understood, there is now
considerable evidence to indicate that this process is not immutable since many pro¬
inflammatory mediators can modulate neutrophil apoptosis. For example, under in vitro
conditions, LPS, GM-CSF and IL-1 and IL-6 all inhibit neutrophil apoptosis, while
TNFa is able to induce apoptosis in these cells. Thus it appears that such agents act not
only in a priming/secretory capacity, but also affect neutrophil functional longevity by
regulating apoptosis. I was interested to examine whether other physiochemical insults,
in particular hypoxia, which is highly relevant to the inflamed site, could also affect this
cells life span.
It was shown that incubating neutrophils under hypoxic conditions greatly enhances
neutrophil survival, as assessed by morphological criteria. The inhibition of apoptosis
by hypoxia was concentration-dependent and confirmed by propidium iodide-staining
and annexin V binding. While neutrophils had to be hypoxic from time 0 in order for
hypoxia to achieve its full protective effect, a delayed hypoxic challenge was still able to
provide some inhibitory effect, even at a late stage in the apoptotic program. Hypoxic
neutrophils (3-18 hours) returned to a normoxic environment underwent apoptosis at the
same rate as control cells.
The anti-apoptotic effects ofGM-CSF and hypoxia in neutrophils were additive,
indicating these effects are discrete and act via independent mechanisms. In addition,
neither of these protective effects were associated with an upregulation of the proto-
oncoprotein Bcl-2. Antioxidants, glucose deprivation, heat shock or mitochondrial
inhibitors were not able to mimic the protective effect of hypoxia. These results indicate
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the enhanced survival of neutrophils under hypoxic conditions is specific for hypoxia,
and is not sensitive to other cellular stresses such as cellular ATP depletion or inhibition
of the mitochondrial respiratory chain. The hypoxic-mediated inhibition of neutrophil
apoptosis was found to be sensitive to the protein synthesis inhibitor, cycloheximide,
even at very low concentrations that did not influence the rate of constitutive apoptosis,
suggesting that de novo protein synthesis is required for the inhibition and that hypoxia
may be inducing upregulation of a survival protein(s).
To investigate the potential mechanisms underlying the anti-apoptotic effect of hypoxia
the effect of iron chelators was investigated and found to mimic the response observed
with hypoxia. This effect was concentration-dependent and, at higher concentrations,
iron chelators inhibited neutrophil apoptosis to a similar extent as hypoxia. These data
may implicate a role for chelatable iron in the oxygen-sensing mechanism underlying
the inhibition of neutrophil apoptosis by hypoxia. A putative role of several redox
sensitive transcription factors in the hypoxia-induced survival of neutrophils was also
investigated. A constitutive form ofNF-kB binding was found to be upregulated in
response to hypoxia; however, this effect was extremely donor specific and the iron
chelator, desferrioxamine, did not cause a similar enhancement. AP-1 DNA binding
activity was found to be present constitutively in neutrophils and the presence of
desferrioxamine or hypoxia failed to further modulate binding of this transcription
factor. The transcription factor hypoxia-inducible factor-1 (HIF-1) was identified in
neutrophils incubated under hypoxic conditions and in the presence of desferrioxamine
but was not expressed in normoxic cells.
Finally, the role of oxidant pathways in TNFa-stimulated apoptosis in neutrophils was
also investigated. It was discovered that TNFa-cytotoxicity could be abrogated by
anaerobic conditions and mitochondrial inhibitors could modulate the rate of TNFa-
induced apoptosis, although antioxidants and iron chelators did not exert any protective
effects. Inhibition of the pro-apoptotic enzyme CPP32 (caspase 3) also protected
neutrophils from TNFa-induced apoptosis. These findings implicate an oxygen-
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dependent step in TNFa-mediated apoptosis and also imply that the mitochondria and
caspase family of proteases may play important roles in this phenomenon.
These data suggest that hypoxia, which characterises many inflammatory sites in vivo,
may extend the neutrophils life span by inhibiting both spontaneous apoptosis and
TNFa-induced apoptosis, and this may be a contributory factor in neutrophil-mediated
tissue damage. The mechanism underlying the inhibition of constitutive neutrophil
apoptosis may involve the transcription factor HIF-1, although further work will be
required to confirm this. The mechanism underlying TNFa-induced apoptosis appears
to be largely unrelated to that controlling basal apoptosis and the data presented suggest
the involvement of mitochondria and the caspase family of death-inducing proteases.
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Neutrophils are derived from pluripotent stem cells located in the bone marrow.
These stem cells are also the origin of all mature white cells, red cells and platelets.
Pluripotent uncommitted stem cells differentiate into unipotent committed stem cells
and neutrophils are then further differentiated from these cells via several
recognisable morphological stages. These stages in neutrophil development are
represented by the myeloblasts, promyelocytes and band cells, with the major
increase in neutrophil number occurring at the myelocyte level. Three major
haemopoietic growth factors: G-CSF, GM-CSF and IL-3 regulate neutrophil
development (Metcalf and Nicola, 1983; Metcalf et al., 1986; Bot et al., 1988).
During development neutrophils acquire their characteristic granules and nuclear
morphology and, finally, mature polymorphonuclear neutrophils are stored in a pool
in the bone marrow from which they are then released into the peripheral blood at a
rate of 1011 cells per day (Cannistra and Griffin, 1988). The neutrophils in the
vascular compartment can be further divided into a circulating pool and the so-called
marginated pool of cells which exists in the spleen, liver and possibly lung (Peters,
1997) and is in dynamic equilibrium with the circulating pool.
1.1.2 Structure and contents
On electron microscopy neutrophils have a mean diameter of 7 pm and are
characterised by a multilobed chromatin-dense nucleus. Like the other members of
the polymorphonuclear leukocyte family, neutrophils contain a large number of
intracellular granules. Variations in granule composition distinguish neutrophils
from other granulocytes, namely eosinophils and basophils. Initially, neutrophil
granules were classified as either peroxide-positive (azurophil or primary granules)
or peroxide-negative (specific or secondary granules). More recently, differential
exocytosis of granule proteins and incorporation of granule membrane receptors into
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the plasma membrane suggested the presence of additional granule sub-groups,
namely gelatinase/tertiary granules and secretory vesicles (Borregaard et ah, 1993).
Azurophil granules are defined as peroxidase-positive granules (Bainton, 1975).
They are round or oval and vary in size and electron density. Although CD63 and
CD68 have been shown to reside in the azurophil granule membrane, no receptors or
other functional proteins are present. The azurophil granule matrix contains the
stores ofmost proteolytic and bactericidal proteins and the presence of
myeloperoxidase (which acts on H2O2 generated by the NADPH oxidase to produce
oxyhalides) is of prime importance for full function of the oxygen-dependent
bactericidal system.
Specific granules appear as round, oval or elongated granules and are slightly larger
than gelatinase granules. They are defined by their matrix content of lactoferrin.
The specific granule membrane is an important source of cytochrome bssg, the flavo-
cytochrome membrane-bound component of the NADPH oxidase (Borregaard and
Tauber, 1984; Rostrosen et ah, 1992). Other important protein constituents are
laminin-receptors, fMLP-receptors and TNF-receptors, although, it is not yet known
whether these receptors are fully functional when translocated to the plasma
membrane. The number of integral membrane proteins present in the specific
granules is much lower than that in the plasma and secretory vesicle membrane (see
below). This may indicate that the membrane of specific granules serves a very
specific function when translocated to the plasma membrane.
The existence of a separate subset of neutrophil peroxidase-negative granules, termed
gelatinase or tertiary granules, has been proposed on the basis of differences in
sedimentation by rate zonal centrifugation (Murphy et ah, 1980; Dewald et ah,
1982). These granules are characterised by the presence of gelatinase, cytochrome
b558 and ubiquinone but not lactoferrin. While their existence as a separate entity has
been questioned (Hibbs and Bainton, 1989), experiments showing that gelatinase in
specific granules is complexed with another protein (neutrophil gelatinase associated
lipocalin, NGAL), a feature not observed in gelatinase granules, has strengthened the
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argument in favour of a distinct granule population (Kjeldson et al., 1992). Although
the precise membrane composition of these granules is not known, the amount of
gelatinase granule membrane that is incorporated into the plasma membrane appears
to be only a fraction of that derived from peroxidase-negative granules. Thus, the
significance of mobilising gelatinase granules following stimulation by inflammatory
mediators appears to relate to the release of gelatinase rather than their contribution
ofmembrane proteins.
Secretory granules were initially characterised by the presence of alkaline
phosphatase, which is present on the luminal side of these vesicles (Borregaard et al.,
1987; Sengelov et al., 1992b). It is now established that the secretory granule
membrane also contains the adhesion molecule MAC-1 (CD1 lb/CD18) (Calafat et
al., 1993), the chemotactic fMLP receptor (Sengelov et al., 1994), the receptor for
urokinase-type plasminogen activator (uPAR) (Plesner et al., 1994) and cytochrome
bssg (Calafat et al., 1993). In addition, from experiments on the kinetics of granule
mobilisation, it also seems likely that the secretory vesicles contain Fey receptor III
(CD16) (Tosi and Zakem, 1992), C3bi (Berger et al., 1984) and decay accelerating
factor (Berger and Medof, 1987), although direct evidence to support this is still
lacking. The exocytosis of secretory vesicles results in upregulation of adhesion
proteins in the plasma membrane, suggesting that these vesicles play a primary role
in regulating the interaction of neutrophils with endothelium (Borregaard et al., 1987;
Borregard et al., 1990; Senglelov et al., 1993). The primary function of uPAR
appears to be potentiation of the uPA-catalysed plasminogen activation system (Ellis
et al., 1989). Thus, it is likely that concurrent translocation of uPAR may ease
subsequent diapedesis, while upregulation of fMLP receptors will augment the
chemotactic responsiveness of the neutrophil during its subsequent migration.
1.1.3 Role in inflammation
Inflammation is normally a highly complex and physiological protective response to
tissue injury (e.g., due to bacterial infection or trauma). This process serves to
destroy, dilute and partition off or remove the injurious agent and injured tissue,
thereby promoting tissue repair. It has been proposed, however, that when this
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crucial and normally beneficial response occurs in an uncontrolled or exaggerated
manner the result is inappropriate or excessive tissue damage, which itselfmay result
in chronic inflammation. The neutrophil is a key player in several aspects of the
evolving inflammatory response and is essential for host defence. This role is
epitomised by the often life threatening infections acquired by patients with
neutropaenia, leukaemia or congenital diseases affecting neutrophil structure and/or
f
function.
Circulating neutrophils are largely quiescent cells, serving a physiological
monitoring role, and expressing only a limited number of low affinity receptors on
their surface. During inflammation their responses are orchestrated by a variety of
cytokines and chemotactic factors so that they attach to vascular endothelium, move
through the vessel wall and migrate into the tissue. Once at the site of tissue
infection or injury, the fully activated neutrophils are able to defend against
pathogens by their ability to generate toxic oxygen metabolites and to release and
synthesise several degradative enzymes and lipid-derived products. The oxidative
burst and degranulation response are stimulated by a variety of organism-derived
peptide agonists and cytokines produced by other inflammatory cells may act
synergistically with such agonists to potentiate or 'prime' the oxidative burst.
However, under certain circumstances, the excessive or inappropriate release of such
histotoxic agents can also result in undesirable tissue damage and accentuate the
inflammatory response. The main events and processes involved in the neutrophil's
role in inflammation are discussed below.
1.1.4 Migration ofneutrophils into tissues
Bi-directional interactions between endothelial cells and leukocytes are essential for
the emigration of circulating neutrophils, from the blood, into inflamed tissues. The
paradigm for leukocyte emigration in the systemic circulation is based on data
obtained from in vitro studies and in vivo videomicroscopy of the mesenteric and
other systemic microvessels (Abbassi et ah, 1991; Butcher, 1992; Harlan et al., 1992;
Lawrence and Springer, 1991; Ley et al., 1991; Smith et al., 1989; Von Andrian et























Figure 1.1.3 The role of the neutrophil in inflammation.
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neutrophil transit through the injured site by reversible loose adhesion between
neutrophils and endothelial cells that results in transient contacts and rolling of the
neutrophil along the endothelium. This step is mediated through selectins and the
details of the involvement of each of the main selectins (L-, P-, and E-selectin) has
now been described. The normal distribution of L-selectin on the microvilli of
neutrophils places this molecule in an ideal position for initial interactions with the
endothelium (Picker et al., 1991). In the systemic circulation such interactions
normally take place in the post-capillary venules but in the lung neutrophil-
endothelial interactions take place largely in the capillary and, hence, alterations in
neutrophil deformability may also play an important role in determining the duration
of neutrophil 'hold up' in the lung.
The second step follows further activation of the neutrophils by chemotaxins, which
include IL-8, platelet activating factor (PAF) and complement protein fragments
(C5a). Binding of these molecules to receptors on the surface of the rolling
neutrophil results in the upregulation ofMac-1 (CD1 lb/CD 18) and the shedding of
L-selectin. In the third step, leukocytes bind firmly to the endothelium through
CD 11 /CD 18-ICAM-1 - or VLA-4/VCAM-1 -mediated adhesion. This stable binding
is required for neutrophil emigration. Finally, transmigration of neutrophils across
the endothelial barrier involves an interaction between leukocyte integrins and
endothelial ICAM, and between glycosylated aminoglycans on the neutrophil plasma
membrane and PECAM-1, which is localised in the intercellular junctions of
endothelial cells (Muller et al., 1993).
After the endothelial cell, the next 'barrier' to neutrophil emigration is the basement
membrane. Although neutrophils contain an extensive repertoire of enzymes capable
of degrading ECM constituents, it has been proposed that endothelial cells may
themselves play the lead role of local degradation and reformation of the capillary
basement membrane during neutrophil transmigration (Huber and Weiss, 1989).
Similarly, neutrophils can migrate through the tight junctions of intact monolayers of
epithelial cells in vitro without injuring the monolayer or altering its electrical
resistance. During migration to the inflammatory focus, neutrophils adopt a
6
particular morphology, with a blunt leading front and more elongated body
containing the nucleus and cytoplasmic structures including granules. The release of
granules appears to occur at the blunt front end of the cell, resulting in the highest
concentration of receptors at the leading edge and a gradient of receptors across the
surface of the cell that are able to interact with the gradient of chemoattractant
resulting in directed movement toward the site of inflammation (Nunoi et ah, 1985).
1.1.5 Phagocytosis
Once a neutrophil has migrated into the tissue, its primary purpose is to recognise
and destroy pathogens. Phagocytosis is a process utilised by neutrophils to ingest
and clear large particles (> 0.5 pM), including infectious agents and cellular debris.
Phagocytosis is initiated by the interaction of specific receptors on the surface of the
neutrophil with ligands on the surface of the particle. This leads to the
polymerisation of actin at the site of ingestion and the internalisation of the particle
via an actin based mechanism. The receptors that participate in the ingestion and
killing of microbes can be divided into those that require the target particle to be
coated by serum opsonins and those that do not (Ofek et ah, 1992). Non-opsonic
phagocytosis allows ingestion and killing ofmicrobes as a result of the presence of
neutrophil surface receptors that recognise microbial sugar molecules. However,
many microbes are most effectively killed in the presence of serum opsonins
(immunoglobulin and complement fragments). Once the microbe has been
internalised, the phagosome fuses with other intracellular granules to form a
phagolysosome. Under normal conditions, specific granule products are released
into the phagosome first and the azurophil granule products second (Bainton et ah,
1971), while some specific granule products (e.g., lactoferrin; Wang-Iverson et ah,
1978) and secretory vesicle (Borregard et ah, 1990) products are preferentially
secreted into the extracellular milieu. The formation of a phagolysosome creates a
highly toxic, but confined and controlled, microenvironment capable of killing the
engulfed pathogen and also prevents release of the granules microbicidal armoury
into surrounding tissues.
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Figure 1.1.5 Schematic representation of neutrophil phagocytosis and microbial
killing. (1) The recognition of opsonized agents by neutrophils at the inflammatory
site initiates the process of phagocytosis. (2) Fusion and release of the granule
contents into the phagosome generates a highly microbicidal environment
(phagolysosome). (3) This results in the killing and degradation of the ingested agent
by a combination of oxidative and non-oxidative processes. SOD = superoxide
dismutase, MPO = myeloperoxidase (modified from Smith, 1994).
1.1.6 Respiratory burst
The respiratory burst, so called because of the 50- to 100- fold increase in oxygen
consumption that occurs during this process, is activated concomitantly with
phagocytosis and the resultant cytotoxic reactive oxygen species (ROS) work in
concert with the microbicidal proteins to kill and eliminate pathogens. Activation of
the respiratory burst activity occurs upon the translocation and assembly of the
cytosolic components of the NADPH oxidase enzyme system (p45p/!OX, p61phox,
p21rac) with the membrane-bound flavocytochrome, cytochrome bss8. The active
enzyme complex then generates superoxide anions by the transfer of an electron
from NADPH to molecular oxygen in the following reaction:
NADPH + H+ + 202 -> NADP+ +2H+ +202"
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Although O2" may contribute to microbial killing, other more potent and effective
ROS are generated from this precursor. H2O2 is formed by spontaneous dismutation
and/or the catalytic action of superoxide dismutase (SOD). Following this, in the
presence of a halide ion (usually chloride in the case of neutrophils),
myeloperoxidase released from azurophil granules catalyses the conversion of H2O2
to oxyhalides such as hypochlorous acid (HOC1):
H202 + HC1 -> HOC1 + H20
Various groups have claimed that the hydroxyl radical (OH*), formed by the Fe2"-
catalyzed decomposition of H2O2 and singlet oxygen are also generated by
neutrophils. There is considerable debate, however, as to whether these additional
ROS are produced under physiological conditions. Lactoferrin may prevent FeJ+
being used as a Fenton catalyst, and hence the bulk of the H2O2 generated in these
cells appears to be converted to HOC1 (Weiss, 1989). Perhaps not surprisingly,
neutrophils contain large reserves of antioxidants such as glutathione and ascorbate
(Eaton, 1993; Voetman et al., 1980) and their ability to maintain these antioxidants in
the reduced state during phagocytosis (Voetman et al., 1980) appears to prevent
'auto-oxidative' stress-mediated cell damage. However, recent reports have implied
that upregulation of ROS production may play a role in the increased rate of
neutrophil apoptosis following phagocytosis of opsonized particles (Coxon et al.,
1996) and E. coli (Watson et al., 1996).
1.1.7 Priming
Neutrophils exist in various states of 'activation', which vary from dormant to
primed to fully activated. While activation triggers the immediate expression of
neutrophil microbicidal activity, the extent and nature of this response is greatly
magnified if the neutrophil has initially been exposed to a (non-activating) priming
agent. Indeed, the respiratory burst that occurs in response to a secretagogue agonist
may be enhanced up to 20 fold by prior exposure of cells to a priming agent (Guthrie
et al., 1984). Other functions upregulated by priming agents include agonist-induced
degranulation (Fittschen et al., 1988) and the generation of lipid mediators (Doerfler
et al., 1989; Doerfler et al., 1994). Priming agents consist of a variety of stimuli
including LPS, TNFa, GM-CSF, G-CSF and a number of other cytokines (Guthrie et
9
al., 1984) and, except at very high concentrations, these agents are not able to elicit
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Figure 1.1.7 Schematic representation of neutrophil priming. Several pro¬
inflammatory mediators are able to prime neutrophils for an amplified respiratory
burst to secretagogue agonists. Priming is also associated with other increased
functional responses, including neutrophil shape change, adhesiveness and release of
inflammatory mediators.
1.1.8 Cytokineproduction
It has been a long held belief that neutrophils are terminally differentiated
phagocytes that arrive at the inflammatory focus pre-possessing all the weapons
required to perform their primary role, i.e. that of phagocytosis and destruction of
invading organisms and cellular debris. However, it is now recognised that
neutrophils have a far greater synthetic capacity than originally believed and are in
fact capable ofproducing a large number of additional proteins when appropriately
stimulated. These include Interleukin (IL)-l (Tiku et al., 1986; Lindemann et al.,
1988), IL-6 (Cicco et al., 1990), IL-8 (Bazzoni et al., 1991), TNFa (Dubravek et al.,
1990; Djeu et al., 1990), interferon a (Bronchud et al., 1988), C-CSF (Lindemann et
al., 1989), and transforming growth factor-(3 (TGF-P) (Carrington et al., 1988).
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Thus, it would appear that neutrophils are not solely 'pre-programmed' effector cells,
but are also able to respond to environmental signals to further refine and orchestrate
other aspects of the immune response at inflammatory sites.
1.1.9 Neutrophils and disease
Although neutrophils are essential to host defence, they have also been implicated in
the pathogenesis of a wide variety of diseases. These include some forms of
glomerulonephritis, rheumatoid arthritis, ischaemia-reperfusion injury and
myocardial infarction and, in the lung, chronic bronchitis and emphysema, asthma,
acute respiratory distress syndrome (ARDS) and a variety of types of interstitial lung
disease. Host tissue damage may occur through several independent mechanisms.
These include (i) premature neutrophil activation occurring in the intravascular space
or during migration, (ii) extracellular release of neutrophil microbicidal products
during 'frustrated phagocytosis' where micro-organisms are too large for full
phagocytosis to occur, (iii) saturation of the normal controls preventing generalised
or excessive activation or (iv) failure to terminate or resolve the acute inflammatory
response. As well as playing a causative role in extending myocardial injury by
releasing its histotoxic contents into areas of both necrotic and adjacent viable tissues
during myocardial infarction, the neutrophil may also limit reperfusion by physically
obstructing the myocardial microvasculture (Engler et ah, 1986). Plugging of
capillaries by aggregates of activated neutrophils may also be a relevant factor in
other sites of ischaemia-reperfusion injury where neutrophil influx is thought to be
triggered by substances released from damaged host cells or as a consequence of
superoxide anion generation through xanthine oxidase (the superoxide radical
appears to activate a latent neutrophil chemotactic factor present in the extracellular
fluid) (Ricevetti et al., 1991; McCord et al., 1987). Activation of neutrophils by
immune complexes in synovial fluid is also thought to contribute to the pathology of
rheumatoid arthritis (Robinson et al., 1992). In addition, released ROS and granule
enzymes from neutrophils have been shown to depolymerize long chain hyaluronan
into smaller molecules and hence decrease its lucrative properties (Grootveld et al.,




Death of nucleated cells can be divided into two distinct types, necrosis (accidental
death) or apoptosis (programmed cell death). Necrosis is usually a consequence of
environmental insult and follows a relatively well-documented pathway (Trump et
ah, 1981a, b). Briefly, the cell undergoes swelling and blebbing, which rapidly
becomes irreversible, and leads to the disintegration of the cell. Necrosis is
characterised by damage to the plasma membrane, which leads to abnormal
permeability of the cells to water and ions, and, thus, necrotic cells can be detected
by their inability to exclude vital dyes such as trypan blue. In contrast, apoptosis
represents a physiological form of cell death under the control of a 'cell specific'
genetic program. It is widely accepted that apoptosis is crucial for the development
and homeostasis ofmetazoan animals. For example, apoptosis serves as a prominent
force in sculpting the developing organism (Granerus et ah, 1995), as a major
mechanism for regulating cell numbers in organs where there is rapid turnover (e.g.
gut epithelium and haematopoietic system) (Raff, 1992) and as a defence mechanism
to remove unwanted and potentially dangerous cells (Cohen, 1991), in particular
cells that have been infected by viruses (Vaux et al., 1994) or undergone malignant
transformation (Williams, 1991).
Apoptotic cells were initially described with respect to their morphological criteria
(Wylie et al., 1980). Cells undergoing apoptosis shrink and lose up to one third of
their cytoplasmic and nuclear volume; electron micrographs show an extremely
condensed cytoplasm with some organelle swelling. The plasma membrane becomes
ruffled and blebbed in a way more pronounced than that seen in necrosis. The most
distinct changes, however, are seen at the nuclear level, although the exact pattern
varies from cell to cell. In general, the nucleus condenses and its chromatin becomes
very dense, collapsing into patches, then into crescents around the nuclear envelope
and, finally, into one or several dense 'pyknotic' spheres. These changes are
accompanied by the process of chromatolysis, which involves the activation of
endonuclease activity (Wylie, 1981). Indeed, the orchestrated fragmentation of the
DNA into a 'ladder' of regular sized subunits, the result of apparently random
double-stranded DNA breaks in the linker regions between nucleosomal cores, has
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become a classical hallmark of apoptosis. While, larger apoptotic cells may break
into fragments, termed apoptotic bodies, these remain sealed with intact osmotic
gradients; smaller cells do not usually fragment. Apoptotic bodies and cells are
phagocytosed rapidly by macrophages or neighbouring phagocytic cells and, indeed,
the removal of the cells without the release of cellular contents is very important in
the prevention of inflammation and consequent damage to healthy cells.
1.2.1 Neutrophil apoptosis
Among the leukocytes, mature human neutrophils have the shortest life span (their
half life in the circulation has been estimated at 6-7 hours). It is generally accepted
that neutrophils are either removed from the circulation by the reticuloendothelial
system of the liver and spleen or meet their fate, under pathophysiological
conditions, at the inflamed site. There is little evidence that extravasated neutrophils
return to the blood stream, or that the lymphatic drainage system provides an
important disposal route (Haslett and Henson, 1988). It was originally assumed that
neutrophil death occurred by necrosis (Hurley, 1983). However, if acute
inflammatory lesions are to be resolved and not progress to chronicity, then
neutrophils must be effectively disposed of in a manner that prevents the
disgorgement of granule contents, which would otherwise lead to further tissue
injury and a perpetuation of the inflammatory response. Death by necrosis, with its
associated cell disintegration, would not be expected to fulfill such a role and,
although subsequently ignored for many years, pioneer observations by Metchnikoff
(1891), suggesting that intact neutrophils were engulfed by macrophages, implied
that an alternative mechanism indeed existed.
Initial studies in vitro demonstrated that neutrophils died rapidly in a constitutive
fashion, with changes characteristic of cells undergoing apoptosis (Lopez et ah,
1986). More vigorous analysis of these cells have confirmed that this process is
indeed apoptosis (Savill et ah, 1989a); and it has been shown that during this event
neutrophils also lose CD 16 (FcyRIII) expression and demonstrate a reduced ability to
degranulate, generate a respiratory burst or undergo chemotaxis in response to
external stimuli (Whyte et ah, 1993a). Thus, apoptosis may serve to limit tissue
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injury and promote resolution of inflammation. Furthermore, it is now recognised
that apoptosis is the triggering event that determines the recognition and
phagocytosis of intact senescent neutrophils by macrophages (Savill et ah, 1989a and
b) and there is now clear evidence to support a role in vivo for apoptosis in the
clearance of neutrophils from tissues in a variety of acute inflammatory disorders and
their experimental models (Grigg et al., 1991; Cox et al., 1995). It is also noteworthy
that macrophages phagocytose apoptotic neutrophils using a mechanism involving a
novel recognition system that does not trigger macrophage release of pro¬
inflammatory mediators. This system utilises the integrin avP3 (the vitronectin
receptor) and CD36 (thrombosondin receptor) (Savill et al., 1990; Savill et al.,
1992b). Finally, it is apparent that semi-professional phagocytes, such as fibroblasts
and mesangial cells, also have the capacity to recognise and ingest apoptotic
neutrophils in vitro although to a lesser extent than macrophages (Savill et al., 1992a;
Hall et al., 1994). Thus, it is now evident that neutrophil apoptosis is a major
process, essential for the successful resolution of granulocyte inflammation in vivo.
Although neutrophils appear to be 'pre-programmed' or committed to death via
apoptosis, it is clear that the life span and functional longevity of these cells can be
modulated significantly by a number of exogenous agents. These include pro¬
inflammatory cytokines, such as G-CSF, GM-CSF, IFN-y, IL-8 and IL-2, bacterial
products LPS and fMLP, chemotactic peptides e.g. C5a, anti-inflammatory
glucocorticoids and calcium ionophores, all ofwhich have been shown to inhibit
neutrophil apoptosis (Cox et al., 1992; Colotta et al., 1992a; Lee et al., 1993;
Leuenroth et al., 1998; Cox, 1996; Whyte et al., 1993b). TNFa has been reported to
have a bi-phasic effect, inducing apoptosis at early times while inhibiting neutrophil
death at late time points (Murray et al., 1997).
1.2.2 Molecular and genetic regulation ofapoptosis
Apoptosis is widely regarded as a suicidal response since the dying cell appears to be
an active participant in this process. Earlier studies in non-haemotopoeitic cells
showing that chemical inhibition of protein or RNA synthesis delay or abrogate
apoptosis (Wyllie et al., 1984; Cohen and Duke, 1984; Sellins and Cohen, 1987)
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provided early evidence to support this view and led to the proposal that transcription
and translation of specific genes is a requirement for death via apoptosis. However,
later studies found that inhibitors of macromolecular synthesis had no effect and
could even induce apoptosis in other systems, including constitutive apoptosis in
neutrophils (Waring, 1990; Martin et al., 1990; Whyte et ah, 1997). These latter
observations may be explained by the presence of constitutive inhibitors of execution
pathways in these cells. However, it was the recent identification and investigation
of the molecular components of the apoptotic machinery that has provided the
strongest support for the widespread involvement of an active, genetically
determined cell death program.
Genetic analysis of the nematode Caenorhabditis elegans revealed three gene
products essential for selective apoptotic cell deletion during worm development.
These are CED-3 and CED-4, which promote apoptosis, with a third gene, CED-9,
able to prevent their action (Ellis and Horvitz, 1986; Hengartner et al., 1992). This
mechanism of apoptosis has proven to be remarkably conserved, albeit with greater
complexity, in mammals. Bcl-2, the gene activated by chromosome translocation in
human follicular lymphoma, was the first mammalian 'anti-apoptotic' regulator
discovered (Tsujimoto et al., 1984). To date, at least 15 Bcl-2 family members have
been identified in mammalian cells (Adams and Cory, 1998). The products of the
mammalian Bcl-2 gene family are related to CED-9 but include two subgroups of
proteins that either inhibit or promote apoptosis (Adams and Cory, 1998). The
nematode CED-3 gene product was found to be homologous to a new family of
mammalian proteases, the caspases (Yuan et al., 1993). These are a family of
cysteine proteases, which cleave certain proteins after specific aspartic acid residues.
They are synthesised as zymogens and are activated through cleavage that can be
auto-catalytic or catalysed by other 'ICE-like' proteases (Kumar and Harvey, 1995).
Indeed, there is in vivo evidence of a caspase catalytic cascade (Enari et al., 1996).
Members of this family of proteases are thought to play a major role in mammalian
cell apoptosis and certain viral proteins or synthetic peptides have been shown to
block apoptosis by acting as caspase inhibitors (Nicholson et al., 1995; Tewari and
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Dixit, 1995; Xue and Horvitz, 1995; Fearnhead et al., 1995). CED-4 and its
mammalian homologue, Apaf-1, have recently been recognised as adapters for
facilitating the auto-catalysis, which can initiate activation of the caspase cascade
(Zou et al., 1997). In addition, the caspase cascade can be activated by external
stimuli via so called death receptors. These belong to the tumour necrosis
factor/nerve growth factor (TNF/NGF) receptor gene superfamily, which is defined
by the presence of a number of similar, cysteine-rich extracellular domains linked
through a single transmembrane domain to a cytoplasmic death effector domain
(Smith et al., 1994; Gruss and Dower, 1995; Tartaglia et al., 1993). Although the
death domains can enable death receptors to engage the cell's apoptotic machinery,
in some instances they also trigger a set of signals that serve distinct and even anti-
apoptotic functions. One of the best characterised death receptors is the TNFR1
(also called p55 or CD120a), which is activated by its corresponding ligand TNFa.
Upon binding TNFa the TNFR1 trimerizes, inducing association of the receptors'
intracellular death domains. Subsequently, an adapter termed TRADD (TNFR-
associated death domain) binds to the receptor death domain (Hsu et al., 1995) and
functions as a platform adapter that recruits several additional signalling molecules to
the activated receptor. Of these, FADD (Fas-associated death domain) couples the
TNF1-TRADD complex to activation of caspase-8, thereby initiating apoptosis
(Chinnaiyan et ah, 1996; Varfolomeev et al., 1996).
1.2.3 Reactive oxygen species and apoptosis
A central role for reactive oxygen species (ROS) in apoptosis has been proposed
based on a number of observations in different cell types: (1) the addition of ROS or
the depletion of endogenous antioxidants has been shown to induce apoptosis
(Lennon et al., 1991; Sandstrom et al., 1994b; Hockenbery et al., 1993), (2) apoptosis
can sometimes be inhibited by the addition of endogenous or exogenous antioxidants
(Wolfe et al., 1994; Ramakrishnan et al., 1993; Sandstrom et al., 1994a), (3)
apoptosis has been demonstrated to be associated with increases in intracellular ROS
levels (Heller and Kronke, 1994), (4) the nematode gene ced-9 is part of a bi-
cistronic gene co-encoding a protein similar to cytochrome bs6o of complex II of the
mitochondrial respiratory chain, indicating that ced-9 might have redox or ROS-
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regulatory functions (Hengartner and Horvitz, 1994), (5) Bcl-2 is located to
organelles known to participate in redox reactions (Nakai et al., 1993) and, finally,
(6) increased synthesis of Bcl-2 was shown to block the increased ROS levels
associated with apoptosis (Hockenbery et al., 1993; Kane et al., 1993).
However, findings demonstrating that cells incubated in near-anaerobic conditions
(where ROS production would be negligible) can still undergo apoptosis has argued
against a ubiquitous and critical need for ROS generation during apoptosis (Jacobson
and Raff, 1995). In addition, hypoxia itself has been shown to induce apoptosis in
certain cells, an effect that can be inhibited by Bcl-2 and Bcl-XL (Shimisu et al.,
1995). Thus, Bcl-2 can inhibit apoptosis in the absence ofROS suggesting that
whatever antioxidant or ROS inhibiting properties Bcl-2 may possess, they are not
crucial for the anti-apoptotic effect of this protein. Additional evidence arguing
against a universal role for ROS in driving apoptosis came from experimental
systems where antioxidants were clearly not capable of blocking all modes of
apoptosis (Jacobson and Raff, 1995; Schulze-Osthoff et al., 1994). Furthermore,
antioxidants and ROS scavengers undoubtedly serve many other functions that may
interfere indirectly with the molecules required for apoptosis. For example, many
antioxidants are reducing agents and, as such, might modify sulphydryl groups of
proteins. An example of one such protein is the transcription factor AP-1 where
DNA-binding activity is regulated by a redox mechanism. Metal ion chelators were
also commonly used as antioxidants in these studies; however, various additional
cellular enzymes require these ions to function and, thus, can be inhibited by such
compounds.
This evidence argues strongly against a central role for ROS in mediating apoptosis;
however, it would seem that ROS are capable of activating apoptosis, at least in
certain cell types. Hence, apoptosis can be induced by treating cells either (i)
directly with ROS, such as H2O2 or lipid peroxides (Lennon et al., 1991; Sandstrom
et al., 1994b); (ii) with agents that promote intracellular ROS formation by inhibiting
endogenous antioxidant functions (for example inhibition of catalase or depletion of
intracellular glutathione) or (iii) with compounds that enhance ROS production (e.g.
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transition metals or excess glucose) (Hockenbery et al., 1993; Ratan et al., 1994;
Donnini et al., 1996). ROS have also been implicated in several physiological forms
of cell death. For example, ROS have been proposed to play a role in TNFa-induced
cytotoxicity. TNFa can kill by either apoptosis or necrosis depending on the
concentration ofTNFa, the cell environment and the cell type. TNFa-induced cell
death can be inhibited by antioxidants, mitochondrial inhibitors and anaerobic culture
conditions (Laster et al., 1988; Chang et al., 1992; Schulze-Osthoff et al., 1992).
However, at least some of these effects appear to be due to an effect on cell necrosis
rather than apoptosis.
1.2.4 The role ofmitochondria in apoptosis
Several investigators have hypothesised that the origins of mitochondria and aerobic
metabolism in eukaryotes formed the basis for the evolution of'active' cell death and
that apoptosis was developed as a mechanism to remove ROS-overproducing or ROS
damaged cells (Frade and Michaelidis, 1997). Although such a hypothesis is
virtually impossible to verify, a central role for mitochondria as mediators of
apoptosis has been established in many systems. Not only are mitochondria a major
source ofROS, they are also the site of electron transport, oxidative phosphorylation
and adenosine triphosphate production and it is now recognised that these organelles
contain a number of pro-apoptotic proteins. It is likely that each of these properties
interrelate and together play a role in resulting cellular apoptosis. Disruption of
electron transport has long been recognised as an early feature of cell death (Scaife,
1966; Garcia-Ruiz et al., 1997). One predicted consequence of electron transport
failure would be a drop in ATP production; this has been observed during apoptosis,
but often occurs quite late in the process (Bossy-Wetzel et al., 1998). Thus, although
loss ofmitochondrial ATP production may contribute towards apoptotic killing in
some cells, it is unlikely that this is a general mechanism for the induction of
apoptosis.
The collapse of the mitochondrial inner transmembrane potential (Ai|/m) has been
proposed to play a key role in apoptosis (see Kroemer et al., 1998 for recent review).
Dissipation of the Ai[/m is mediated through the opening of a large conductance
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channel known as the mitochondrial permeability transition (PT) pore. A series of
drugs known for their PT-inhibitory potential, such as cyclosporin A or bongkrekic
acid, inhibit the pre-apoptotic collapse and, in many systems, are effective inhibitors
of receptor or stress-induced apoptosis. A further argument in favour of the
implication of PT in apoptosis regulation is the finding that Bcl-2 functions as an
endogenous PT inhibitor. This PT-protective effect by Bcl-2 has been observed in
whole cells as well as in isolated mitochondria.
A critical role of the mitochondria in mediating apoptosis has been implied further by
studies using a cell-free system in which the presence ofmitochondria was essential
for constitutive, Bcl-2 inhibitable nuclear morphological changes and DNA
fragmentation (Newmeyer et al., 1994). Following this, studies in a second cell-free
system found cytochrome c (released from the mitochondria during cytosol
preparation) was required for activation of the caspase cascade by deoxyadenosine
triphosphate (Liu et al., 1996). There is now evidence to suggest that cytochrome c
(also termed Apaf-2) is released from the mitochondria during apoptosis both in vitro
and in vivo and this release may be blocked by the presence of Bcl-2 located on these
organelles (Yang et al., 1997; Kluck et al., 1997). Cytosolic cytochrome c forms an
essential part of the vertebrate apoptosome, which is composed of cytochrome c,
dATP, Apaf-1 and pro-caspase 9 (Li et al., 1997). This results in activation of
caspase 9, which in turn is able to activate a cascade of lower 'effector' caspases and
thus induce apoptosis. A second factor, apoptosis inducing factor (AIF)-l, is also
released from mitochondria and this can also stimulate the proteolytic activation of
caspase 3 (CPP32) (Susin et al., 1996; Susin et al., 1997).
1.3 Oxygen levels in the body
1.3.1 The oxygen cascade
The p02 of dry air at sea level is 21.2 kPa. However, this partial pressure is in no
way physiological when compared to the p02 present at the cellular level. Oxygen
moves down a partial pressure gradient from air, through the respiratory tract, the
alveolus, pulmonary circulation, the systemic capillaries and the cell. While the p02
differs significantly within different parts of the body and even within particular
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organs, it reaches the lowest level within the mitochondria where it is consumed.
The steps by which the pC>2 decreases from air to the mitochondria are known as the
oxygen cascade (see figure 1.3.1) and are of great practical importance. Any one
step in the cascade may be increased under pathological conditions and this can lead
to tissue hypoxia. The highest pC>2 value in the body is that in the alveoli and,
although this PaC>2 (Alveolar pCb) may vary depending on the subject, the mean
value for alveolar pC>2 in healthy adults is 13.6 kPa. The next highest pC>2 value is
the PaC>2 (arterial pCb). This value is dependent upon the alveolar pC>2 and shows a
modest but progressive decrease with age. Marshall and Whyche (1972) have
suggested the following relationship in subjects breathing air: Mean arterial pC>2 =
13.6 - 0.044 (age in years) kPa. While the standard pC>2 value for mixed venous
blood in the pulmonary artery is 5.3 kPa, this is again subject to variation.
Figure 1.3.1 The oxygen cascade. The pC>2 falls from the level in ambient air down
to the level in mitochondria, which is the site of utilisation. However, cellular oxygen
tension varies depending on the cell's position relative to the capillaries (Adapted
fromNunn, 1993).
1.3.2 Regulation ofnormal oxygen tensions in the tissues
The primary site of O2 utilisation is at the tissue level, where cells require O2 for the
generation of the high energy phosphate bonds (ATP), which support cellular aerobic
biochemical function. Thus, it would seem that the most meaningful pC>2 value
would be that within the tissues. The overall extraction ratio of O2 from capillary
0
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blood is about 25% in healthy adults at rest but may increase to 70-80% during
maximal exercise in well trained athletes. The relationship between pC>2 and %
saturation of haemoglobin (the oxygen-haemoglobin dissociation curve) is non¬
linear. This sigmoidal curve is defined by the O2 concentration at which 50% of the
haemoglobin is saturated (P50) - normally 3.5 kPa. However, various physiochemical
factors (increased temperature, increased pCC>2, decreased pH and increased 2,3
diphosphoglycerate concentration) shift the capillary oxygen-haemoglobin
dissociation curve to the right and, thus, cause enhanced release of O2 to tissues and
improved O2 availability. Chemical release from haemoglobin is followed by
diffusion through the endothelium and subsequently through the tissues to its site of
utilisation in the mitochondria, although diffusion may be potentially aided by
protoplasmic streaming. Diffusion paths are much longer in the tissues than in the
lung. In well vascularized tissue, such as the brain, each capillary serves a cellular
zone with a radius of about 20 pm; this contrasts to distances of approximately 200
pm in skeletal muscle and greater still in fat and cartilage. Krogh and Erlangen
(1959) outlined the determinants of tissue oxygen tension by suggesting a cylindrical
model to represent the volume of tissue served by a single capillary: the oxygen
concentration (px) at the point x within a tissue depends upon the distance (x) from
the point to the nearest capillary and also on the intercapillary distance (2R). The
oxygen tension also depends on the radius of the capillary (r), the rate of oxygen
consumption by the tissue (m) and the diffusion coefficient of oxygen in the tissue
(d). The mathematical formulation based on these factors is as follows:
Px = Po - m/d(R2/2 logx/r-x2-r2/4)
In which Px is the oxygen tension in question and Po is the oxygen tension in the
capillary directly opposite point x. Although this focuses on oxygen transport
mediated by single capillaries, oxygenation of tissues as a whole is extrapolated from
findings on oxygen exchange in these vessels. This analysis is clearly simplistic for
complex organs and is under review (Intaglietta et al., 1996), not least because
capillaries are not the sole source of oxygen and it is becoming increasingly apparent
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that arterioles are a significant equivalent source, with venules serving as sinks for
capillary and arteriolar oxygen.
1.3.3 Measurement oftissue pC>2
A number of methods can be used to estimate tissue pC>2 directly. (1) One of the
most frequently employed methods utilises polarographic electrodes. The electrodes
consist of a cell formed by a silver anode and a platinum cathode, both in contact
with an electrolyte in dilute solution. When a potential difference is applied to the
cell, a current is passed which is directly proportional to the p02 of the electrolyte in
the region of the cathode. At the end of the electrode is a thin membrane, which
separates the electrolyte from the sample and is gas permeable. Hence, the
electrolyte is able to equilibrate rapidly with the sample and, thus, the current passed
by the cell is proportional to the pC>2 of the sample. Electrodes may be inserted
directly into tissue or placed or attached on or to the surface of an organ to indicate
the pC>2. (2) A different approach is to implant a silastic tonometer (gas permeable
silastic tubing) within the tissue by means of a wide bore needle. The tube is then
perfused with deoxygenated saline solution and the pC>2 of the fluid inside the
tonometer is then measured after a suitable equilibration period. (3) The oxygenation
status of the tissue may be determined biochemically by the use of transmission
spectroscopy in the near infrared (700-1000nm), where tissues are relatively
translucent. At present, however, the path length is limited, although successful
measurements of cardiac and cerebral tissue pC>2 values have been obtained. (4) An
indication of tissue pC>2 may also be obtained by measuring the venous pC>2 of blood
draining a particular tissue. However, the significance of this index is lost when
there are shunts that enable arterial blood to mix with blood draining the tissue. (5)
Finally, polarographic estimation of skin pC>2 has been advocated as a non-invasive
method of determination of pC>2. A polargraphic electrode is applied to the skin,
which must be heated to at least 44°C to maximise cutaneous blood flow
(Severinghaus, 1981). The resultant pC>2 does not equal arterial pC>2 in all
circumstances, but maybe used as an indirect determination of the overall
oxygenation state of a patient.
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From such methods it is evident that tissue pC>2 varies from one organ to another,
with the tissue pC>2 being dependent, not only on arterial pC>2, but also on the ratio of
tissue oxygen consumption to perfusion. However, as predicted by the Krogh model
(see section 1.3.2), even greater difficulties arise where variations in tissue pC>2 exist
in different parts of the same organ. These are mainly due to regional variations in
tissue perfusion and oxygen consumption. Within an organ there are invariably some
areas occupying more favourable sites towards the arterial ends of capillaries, while
others must accept oxygen from the more distal ends of these blood vessels. Thus,
unlike arterial and mixed venous pC>2, tissue pC>2 is not a uniform or fixed entity and,
consequently, there is variation in reported pC>2 values for the same tissue. For
example, reported skeletal muscle pC>2 values range from 0 - 13.1 kPa, with mean
values varying from 2.13 ± 0.53 kPa to 5.87 kPa ± 0.27 (Kunze, 1969). Likewise, in
the liver steep intercellular gradients exist along the sinuoids from the portal to the
central regions of the liver lobules (Sies, 1977; Ji et ah, 1982). As demonstrated by
the use ofmicro-needle electrodes, the actual pC>2 around an individual hepatocyte in
the liver ranges between 0.13 and 8 kPa, with mean values around 2.9 kPa (De Groot
and Noll, 1987).
Tissue 60 pm diameter electrode 330 pm diameter electrode
p02 (kPa) p02 (kPa)
Liver 1.73 ±0.27 2.27 ±0.4
Kidney 2.67± 0.27 3.73 ±0.53
Intraperitoneal 6.13 ±0.8 6.53 ±0.53
Subcutaneous 3.07 ±0.4 4.13 ±0.27
Brain 4.93 ±0.8 4.4 ±0.27
CSF subarachnoid space 4.67 ± 0.93 4.67 ±0.27
Spleen 2.27 ± 0.27 3.07 ±0.27
Table 1.3.3 Effect of electrode size on pC>2 measurements in rat tissue. Results
from Jamieson and Van Den Brenk (1964) showing that electrodes with larger
diameters tend to give higher tissue pC>2 values. These differences have been
attributed to tissue damage caused during electrode insertion. See text for more
detail.
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Further variation has also been attributed to the method used to measure tissue pC>2.
Jamieson and Van Den Brenk (1964) demonstrated that the physical trauma
produced by electrode insertion causes quantitative estimations of pC>2 that outweigh
errors of calibration (see table 1.3.3). When electrodes were inserted into the liver,
kidney cortex or spleen, macroscopic bruising was immediately apparent. As smaller
electrodes tend to give somewhat lower values of tissue pC>2, it appears that any
bleeding that occurs paradoxically gives rise to a higher value of pC>2 than initially
present in the tissue. Alteration of O2 consumption in surrounding damaged cells
will also contribute to tissue pC>2 changes.
1.3.4 Causes and consequences of tissue hypoxia
Significant hypoxia is best regarded as a deficiency of O2 at the tissue level, and
approximately 8 decades ago Barcroft (1920) introduced a classification of the forms
of hypoxia that, with modifications and minor name changes, remains in use today
(West, 1990). Hypoxia has been divided into 4 types: (1) hypoxic hypoxia, in which
the pC>2 of the arterial blood is reduced; (2) anaemic hypoxia, in which the arterial
p02 is normal but the amount of haemoglobin available to carry O2 is reduced; (3)
stagnant or ischaemic hypoxia, in which the blood flow to a tissue is so low that
adequate O2 is not delivered, despite a normal pC>2 and haemoglobin concentration;
and (4) histotoxic hypoxia, in which the amount of O2 delivered to a tissue is
adequate but, because of the action of a toxic agent, the tissue can not make use of
the O2 supplied. Tissue hypoxia features prominently in a number of pathological
conditions including tissue injury, lung disease, myocardial infarction, rheumatoid
arthritis, sepsis and hypovolaemic shock.
The impositions of the effects of injury on most of the determinants shown in the
Krogh model equation predict a decrease in tissue oxygenation. The intercapillary
distance is increased, as is the rate of O2 utilisation by accumulation of O2-
consuming leukocytes and the formation of granulation tissue. The blood flow is
also reduced in the centre of the wound because of thrombosis of the
microcirculation in that area. Wound p02 levels have been measured by Niinikoski
et al (1972) and Hunt et ah, (1967). These groups reported values of 0.8 and 1.5 kPa
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respectively when measuring wound 'dead space' using an implanted tonometer.
Since the dead space is generally the area farthest removed from the capillary, this
tension probably represents the lowest average extracellular oxygen tension within
the wound. Niinikoski and co-workers (1972) also investigated the oxygen gradients
around damaged tissue using microelectrodes. Using this method, the pC>2 of the
fluid filling the dead space was very low and persistently showed tensions between 0
and 0.4 kPa. At the point the electrode moved from the dead space to the new tissue,
the pC>2 varied between 0.7 and 2 kPa. This region was occupied predominantly by
cells resembling macrophages. In the area occupied by fibroblasts, i.e. closer to the
distal capillaries, the pC>2 was 2.7 to 4 kPa. The oxygen gradient of this area was
extremely steep, from 10 to 12 kPa directly over the capillary to a mean of 2.7 kPa in
the fibroblast region 50 pm from the vessel.
Tissue hypoxia is an essential feature of hypovolaemic shock. In traumatised
patients gross injury can induce irreversible changes and inhibit wound healing and
increase susceptibility to infection. Correction of cardiac index and arterial pC>2 does
not necessarily ensure a normal tissue pC>2 and, therefore, arterial pC>2 tension
provides an inadequate index of peripheral tissue oxygenation. In patients with
multiple injury and hypovolaemic shock the tissue pC>2 remains depressed for several
days. Niinikoski (1977) investigated the effect of hypovolaemic shock on
myocardial and skeletal muscle tissue oxygenation. They found that profound
decreases ofmyocardial oxygenation occurred, even in moderate hypovolemia
(control myocardial pC>2 = 4 kPa vs hypovolaemic pC>2 = 2 kPa); they also found that
occlusion of the left anterior descending coronary artery lowered myocardial tissue
pC>2 even further to 1.3 kPa. Similarly, in skeletal muscle, control pC>2 values of 4.1
± 0.7 dropped to 0.3 - 0.7 kPa following haemorrhage. Hypovolaemia also resulted
in a complete cessation of blood flow in distal capillaries and a fully anoxic
environment at the wound edge (Silver, 1973).
Multiple organ failure appears to be a major factor determining the poor outcome of
patients with acute respiratory distress syndrome (ARDS). One mechanism that has
been proposed to contribute to multiple organ failure is regional hypoxia in tissues
25
rendered particularly vulnerable by the high metabolic demands ofARDS. Profound
arterial hypoxaemia is a diagnostic criterion ofARDS, and is largely caused by
ventilation-perfusion mismatch and right to left shunting (Petty and Fowler, 1982;
Wallace and Spence, 1983; Dantzker et al., 1979), which presumably results from
blood flow through under- or non- ventilated areas of lung. Furthermore, ARDS also
appears to be associated with peripheral gas exchange abnormalities manifested as an
abnormal relationship between systemic oxygen uptake and systemic oxygen
delivery. This may be explained by a combination of a greater basal metabolic
requirement and a decreased ability of the tissues to extract oxygen from the blood.
Due to the impracticalities of directly measuring tissue pC>2 in patients with ARDS
metabolic markers of anaerobic metabolism have been monitored instead and, in
several studies, have shown elevated blood lactate concentrations in conditions such
as sepsis and ARDS (Gilbert et al., 1986; Vincent et al., 1990). The products of
adenosine monophosphate (AMP) degradation, namely inosine, hypoxanthine,
xanthine and uric acid have also been proposed as metabolic markers of tissue
hypoxia and Grum et al. (1985) noted an increase of these metabolites in the venous
blood of critically ill patients with ARDS.
As in ARDS, tissue oxygen requirements rise above normal in patients with sepsis.
However, it is not known whether the tissue dysfunction observed in sepsis results
from cellular hypoxia or deranged intracellular oxygen metabolism. The tissue
hypoxia associated with sepsis may result from inadequate oxygen delivery to 'at
risk' areas, consequent upon disturbed microvascular control or from abnormal
extraction of oxygen, despite adequate perfusion. Sepsis is believed to disrupt
microcirculatory flow and nutrient exchange and, in addition, cause intravascular
leukocyte aggregation, abnormal red cell deformability, increased microvascular
permeability, interstitial protein loss and tissue oedema. These changes are promoted
by proinflammatory mediators and modulated by the function and integrity of the
endothelium (Curzen et al., 1994). Indeed, Sair et al. (1996), measuring skeletal
muscle p02 in a rat model of endotoxaemia using implantable tissue electrodes,
found a significantly lower tissue p02 in endotoxaemic rats compared to control
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animals (3.2 kPa vs 6.7 kPa) when the arterial blood pC>2 in sham and endotoxin
treated animals was not significantly different.
The rheumatoid synovium has been widely studied as an example of a pathological
hypoxic environment. This occurs due to a combination of increased O2 utilisation
by metabolically active tissue (oxygen consumption by rheumatoid synovial
membrane has been reported to be twenty times that of normal synovium (Dingle and
Page-Thomas, 1956)) and an inadequate, or impaired, supply of oxygen to the tissue.
When Falchuk and co-workers (1970) analysed synovial fluid samples from 30
patients with a variety of conditions, the lowest pC>2 values were found in those with
the most active and severe rheumatoid disease. Similarly, Lund-Oleson (1970)
measured the oxygen tension in 103 joint aspirates obtained from patients with
rheumatoid arthritis (RA) (n =85) and a variety of other conditions (n=l 8). The
lowest oxygen tensions were found in the rheumatoid group (mean 3.5 kPa).
Treuhaft and McCarty (1971) analysed 55 synovial fluid samples and, in general,
found lower pC>2 values in fluids obtained from patients with inflammatory arthritis
and this has been confirmed subsequently by other workers (Goetzl et al., 1971).
While the measurement of oxygen tension in aspirated synovial fluid does not
necessarily reflect the situation in the synovium, when O2 tensions were measured
directly in the knee synovium and peri-articular tissues of patients with RA and
osteoarthritis, as well as normal subjects, the results confirmed that the lowest pC>2
tensions were found in the rheumatoid group (mean control value = 6.7 kPa vs mean
RA patients = 3.8 kPa) (Ellis et al., 1994).
When flow through a coronary artery is reduced the part of the myocardium that it
supplies becomes hypoxic; if the myocardial ischaemia is severe and prolonged,
irreversible changes occur in the muscle and the result is myocardial infarction.
Several groups have investigated myocardial pC>2 using animal models ofmyocardial
infarction. Feola and colleagues (1979) reported that occlusion of the left anterior
descending coronary (LAD) artery in dogs produced a rapid and significant drop in
myocardial pC>2 to 0.33 ±0.13 kPa compared to control values of 1.9 + 0.4 kPa.
Likewise, in a second study using pigs, Walfridsson and co-workers (1985) found
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that myocardial pC>2 dropped rapidly following LAD occlusion; in the representative
experiment shown, tissue pCL levels dropped from 6-8 kPa to 0 kPa in most
myocardial regions measured. Finally, a study by Faithful et al. (1996) using pigs
ventilated with 100% oxygen gave mean control myocardial oxygen tensions of 15 ±
1.1 kPa with a reduction following LAD occlusion to 8 kPa and 10 kPa in the
ischaemic area and ischaemic border respectively.
The measurement of absolute tissue pC>2 values in such disease states is invaluable in
furthering understanding of these conditions. Moreover, these values would
contribute in the design of suitable in vitro systems in which to study individual cell
responses to similar levels of hypoxia. At present, the measurement of the extent of
tissue hypoxia in these pathological conditions is hampered, not only by natural
variations in tissue pC>2 within individual organs and limitations in methodology as
discussed in section 1.3.3, but also by the impracticalities of studying critically ill
patients and the need for invasive monitoring. Thus, studies are predominantly
restricted to those using animal models. However, such experiments demonstrate
that pathological conditions can result in profound tissue hypoxia and suggest that
tissue pC>2 values can be reduced to levels only slightly above zero.
1.4 Hypoxia and signalling
The primary role of oxygen in most eukaryotic cells is to insure an adequate energy
supply via aerobic metabolism. Therefore, the ability to detect a reduced oxygen
tension in the environment and adapt to O2 deprivation is an essential requirement of
most complex cells and organisms. Mammals respond to a drop in environmental O2
(hypoxic hypoxia) with both short and long term adaptive mechanisms that are
designed to maintain CL-delivery to the tissues at a near-normal or stably reduced
level. The immediate response of the body to hypoxic hypoxia is usually a
compensatory increase in respiratory rate. This is initiated by the activation of
arterial O2 chemoreceptors, which are located strategically near the carotid arteries.
In these organs, a decrease in arterial pC>2 is translated into afferent nerve discharges,
stimulating the brain stem respiratory centres to produce hyperventilation
(McDonald, 1981). A second short term response is initiated by acute local hypoxia
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and involves vasodilatation ofmost systemic arteries in order to increase blood flow
and, thus, O2 delivery to hypoxic tissues. In contrast, hypoxia causes constriction of
pulmonary resistance arteries, thereby diverting blood towards better ventilated
alveoli (Wadsworth, 1994). Longer term responses to hypoxia include an increase in
the production of red blood cells and the growth of new blood vessels. Red blood
cell production is under the control of the glycoprotein hormone erythropoietin, and
expression and secretion of erythropoietin by the kidney and liver is enhanced
dramatically by chronic hypoxia. By this mechanism, the production of red blood
cells is increased and the O2 carrying capacity of the blood enhanced accordingly. A
second response to chronic hypoxia is angiogenesis, or the growth of new
vasculature. This process plays a critical role during development and wound
healing and provides increased blood flow to previously poorly vascularized or
hypoxic areas. This process appears to be mediated by vascular endothelial growth
factor (VEGF), a mitogenic growth factor highly specific for endothelial cells
(Shweiki et al., 1992).
Characterisation of the cellular mechanisms whereby such 02-sensitive cells
modulate gene expression in response to hypoxia has been greatly facilitated by the
development of suitable cell lines. These include the pheochromocytoma (PC-12)
cell line, which serves as an in vitro model for the carotid body type I cells (Czyzk-
Krzeska et al., 1992; Czyzk-Krzeska et al., 1994), and the fetal hepatoma cell lines
Hep3B and HepG2, which have provided an important system for the detailed
molecular study of EPO gene regulation by hypoxia (Fandrey and Bunn, 1993).
Recently, however, it has become clear that the concept of '02-sensing' is not limited
to a few highly specialised O2 sensitive cells. All aerobic cells are capable of
detecting O2 deprivation and responding by adapting certain cellular functions that,
in many cases, involves changes in gene expression. The molecular mechanisms
underpinning these effects of hypoxia have many similarities but vary depending on
the cell type and function, as well as the degree and duration of O2 deprivation.
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1.4.1 Hypoxic regulation ofgene expression
In general, cells reduce their total RNA synthesis by 50-70% under hypoxic
conditions. However, an increasing number of genes are being identified whose
transcription is markedly augmented when cells lack oxygen. Hyperventilation,
caused by stimulation of the carotid body by hypoxia, is associated with an increase
in the activity of tyrosine hydroxylase (TH), the rate limiting enzyme in dopamine
biosynthesis in glomus cells. This augmented TH activity is regulated at the mRNA
level in carotid body type I cells (Czyzk-Krzeska et al., 1992). This finding agrees
with subsequent studies, which have shown that hypoxia increases TH expression in
the PC-12 cell line by increasing transcription and stabilising the mRNA transcript of
TH (Czyzk-Krzeska et al., 1994). Likewise, erythropoietin (EPO) production in
Hep3B cells has been shown to be induced directly by hypoxia and, again, this effect
is due to increased transcription, as well as increased stability of EPO mRNA
(Goldberg et al., 1991).
In addition to EPO and TH, several other gene products are now recognised to be
positively regulated by hypoxia. Perhaps unsurprisingly, this group of genes
includes a number of enzymes involved in anaerobic metabolism; these consist of
several glycolytic enzymes (e.g. phosphoglycate kinase-1, lactate dehydrogenase A,
aldolase A and C, phosphofructase L and C, pyruvate kinase M and enolase A) and a
number of glucose transporters (GLUT-1, GLUT-2 and GLUT-3) (Wood and
Ratcliffe, 1997). In contrast, hypoxia has been reported to decrease expression of the
mitochondrial respiratory enzymes (Murphy et al., 1984). Other hypoxia-regulated
genes are involved in inflammation, tumourogenesis, coagulation and cell growth.
Of the hypoxia-induced growth factors vascular endothelial growth factor (VEGF)
has been studied in most detail, but this group also includes platelet derived growth
factor B chain (PDGF-B) (Kourembanas et al., 1990), placental growth factor and
transforming growth factor P-l (TGFp-1) (Wood and Ratcliffe, 1997). Hypoxic
regulation ofVEGF expression occurs in many tissues and cell lines and this growth
factor has become widely recognised as a major angiogenic factor stimulating
endothelial cell mitogenesis and capillary proliferation (Shweiki et ah, 1992).
Hypoxia has been shown to increase transforming growth factor (TGF)-pi
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expression in human dermal fibroblasts and it has been proposed that this response
may contribute to enhanced collagen synthesis and the process ofwound healing
(Falanga et ah, 1991; Falanga et al., 1993; Falanga and Kirsner, 1993). Human
umbilical vein endothelial cells (HUVEC) have been shown to increase expression of
interleukin (IL)-la after hypoxic exposure and thereby enhance adherence of
leukocytes during subsequent re-oxygenation owing to IL-la dependent up-
regulation of endothelial cell-leukocyte adhesion molecule and intercellular adhesion
molecule (ICAM-1) (Schreeniwas et al., 1992). Release of IL-8 from hypoxic
HUVEC (Karakurum et al., 1994) and induction of procoagulative and 'oedemogenic
factors' in cultured bovine endothelial cells (Ogawa et al., 1990; Ogawa et al., 1991)
has also been reported. It is also noteworthy that several candidate vasoconstrictors
and growth factors (e.g. endothelin (ET)-l, PDGF) are increased in the lungs of
hypoxic animals (Cai et al., 1996; Muramatsu et al., 1997). Finally, macrophages
have been reported to produce enhanced levels of inflammatory mediators in
response to hypoxia; these include TNFa, IL-6 (Albina et al., 1995), macrophage
inflammatory protein-1 (MIP-a) (VanOtteren et al., 1995) and IL-1 (Hempel et al.,
1996). Collectively, these results support the direct regulation of several gene
products in vascular tissue by hypoxia that may contribute to the vascular
pathologies and coagulative disorders associated with ischaemia-reperfusion injury
and other cardiovascular pathophysiologies.
1.4.2 Stress proteins
A generalised response to many cellular stresses is the induction of a prescribed set
of proteins, the so-called stress proteins. These are classically sub-divided into two
families, the heat shock proteins (HSPs) and the glucose-regulated proteins (GRPs).
Their names are derived from the stimuli traditionally known to induce them. HSPs
were first described following exposure of cells to increased environmental
temperatures and GRPs are classically induced following glucose deprivation.
However, most cell types studied to date, including Chinese hamster ovary cells,
mouse mammary tumour cells, rat embryo cells, rat fibroblasts, myogenic cells and
cardiac and brain tissue, also induce HSP and/or GRP synthesis in response to
hypoxia (Sciandra et al., 1984; Heacock and Sutherland, 1986; Roll et al., 1991;
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Dwyer et al., 1989; Knowlton et al., 1991). Although their precise function is, as yet,
unclear, these proteins appear to play a role in maturation and/or repair of nascent or
damaged proteins (Becker and Craig, 1994; Hightower, 1991) and it is thought that
induction of these proteins may help cells survive otherwise lethal stress. GRP and
HSP expression has also been linked to certain forms of drug resistance. For
example, chronic anoxia, 2-deoxyglucose (both known GRPs inducers) and heat
shock can all lead to a cellular resistance to adriamycin and these findings may be
relevant to the increased resistance of hypoxic tumour regions to chemotherapy
(Shen et al., 1987).
More recently, a third group of stress proteins termed hypoxia-associated proteins
(HAPs) have been identified (Zimmerman et al., 1991; Graven et al., 1993). As their
name suggests, these proteins are specifically induced by hypoxia. They appear
distinct from HSPs and GRPs and cannot be induced by heat shock or glucose
deprivation. To date, HAP expression appears to be restricted to endothelial cells
where it is thought to contribute to endothelial cell hypoxic tolerance (Graven et al.,
1995). However, direct evidence for this is still required.
1.4.3 Oxygen sensing
The mechanism(s) by which mammalian cells sense hypoxia remains obscure.
However, several models have been proposed and these are discussed in this section.
There are two main pathways by which oxygen may interact with biological systems.
Firstly, oxygen may act as an electron acceptor in redox reactions, for example its
role as the terminal electron acceptor in the mitochondrial respiratory chain.
Secondly, oxygen may react with specific Tigands'. However, because of oxygen's
unique chemical properties, there are a limited repertoire ofmolecules to which it
can combine. Probably the best known oxygen ligands are the haem proteins
exemplified by the oxygen carrying protein haemoglobin. Thus, it is not surprising
that a similar haem protein based mechanism has been sought in order to explain
mammalian oxygen sensing. The main evidence supporting a role for such a protein
comes from experiments utilising carbon monoxide (CO). CO reacts specifically
with the O2 binding site of haem-proteins, substituting for O2, and has been shown to
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inhibit hypoxia-induced expression of erythropoietin (EPO) and vascular endothelial
growth factor (VEGF) and has a parallel effect on 02-sensing in the carotid body
(Goldberg et ah, 1988; Goldberg and Schneider, 1994). Further evidence comes
from studies showing that the haem synthesis inhibitor, 4,6-dioxoheptanoic acid,
produced a reduction in EPO production in response to hypoxia (Goldberg et ah,
1988). Goldberg and co-workers (1988) proposed that the putative haem-protein
sensor might switch from an oxygenated to a deoxygenated state like haemoglobin
allowing close control of gene expression depending upon the cellular oxygen
tension. A haem-based O2 sensor system has been found in Rhizobium meliloti, a
bacterium whose nitrogen-fixation genes are regulated by the ambient O2 tension
(Gilles-Gonzalez et ah, 1991). In this system the CE-sensor FIXL is an integral
membrane haem containing kinase whose activity is modulated by O2 binding. In its
deoxy-conformation the kinase phosphorylates the transcription factor FIXJ, which
turns on a cascade of transcriptionally controlled events leading to the expression of
gene products engaged in nitrogen fixation. However, no such molecule has been
identified in mammals and subsequent observations that EPO gene regulation can
also be upregulated by iron chelators (Wang and Semenza, 1993) are hard to
accommodate using this model as haem iron is non chelatable.
Other lines of evidence are also inconsistent with a haem-protein based 02-sensing
model and have suggested an alternative mechanism based on intracellular ROS
levels. The sequence of the oxygen sensor in Rhizobium meliloti was found to share
some homology with a human cytochrome P450, a member of the h-type haem protein
family (Lois et ah, 1993), and Fandrey and co-workers have suggested that such a
molecule may be important to mammalian oxygen sensing. This group found that
inhibitors of cytochrome P450 reduced, and enhancers of this enzyme increased, EPO-
production (Fandrey et al., 1990). More recently, spectrophotometric analysis
demonstrated the presence of a h-type cytochrome in hepatoma (Gorlach et al., 1993)
and type I carotid body cells (Cross et al., 1990). Further work showing that
iodonium compounds exert powerful inhibitory effects on the hypoxic induction of
gene expression suggest the involvement of a flavoprotein oxidoreductase (Gleadle
et al., 1995b) and haem proteins in the group of b-cytochromes include such
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enzymes, for example, NADPH-oxidase. This enzyme catalyses the production of
H2O2 from molecular O2. Experiments showing that EPO induction by hypoxia
could be aborted by the addition of H2O2 or by an inhibitor of catalase suggested that
H2O2 may play a role in the regulation of hypoxia-responsive genes (Fandrey et ah,
1994). The effect of iron chelators in this model can be explained by a decrease in
iron-catalysed production of ROS. Elowever, the failure ofmany other antioxidants
agents to mimic the effects of hypoxia on gene expression is not consistent with this
theory. In addition, the ability of certain transition metals to induce EPO, and other
hypoxia-induced gene expression (Goldberg et ah, 1988) is also hard to explain
given that these ions are more likely to have pro-oxidant actions. It is also very
unlikely that NADPH oxidase itself is involved as patients with genetic subtypes of
chronic granulomatous disease, characterised by the absence or abnormality of one
of the subunits of this enzyme, have no evidence of disordered oxygen sensing
(Wenger et ah, 1995).
1.4.4 Redox sensitive transcription factors
The mechanisms by which cells may sense changes in oxygen concentration remain
unclear. However, oxygen-dependent induction of hypoxic-sensitive genes depends,
to a large extent, on an increase in their transcriptional rate and a number of
transcriptional activators involved in the up-regulation of genes by hypoxia have now
been identified. The most widespread mechanism identified in regulating
mammalian hypoxic gene expression involves interaction of, the recently identified,
hypoxia-inducible factor-1 (HIF-1) with specific cis-acting elements within
promoters and enhancers of target genes (for recent review see Ratcliffe et ah, 1998).
This transcription factor was initially described in relation to its role in EPO gene
expression in hepatoma cell lines. In response to hypoxia HIF-1 was shown to bind
to an enhancer element containing the sequence 5' TACGTGCT-3' (Semenza and
Wang, 1992), which lies 3' to the EPO gene. HIF-1 is a heterodimer consisting of
the subunits HIF-1 a and HIF-1 P; both these proteins have now been purified, and
details of their characterisation and regulation are discussed in Chapter 5. Because
of the highly tissue specific expression ofEPO, it was initially thought that the O2-
sensitive mechanism regulating its transcriptional control would be restricted to the
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cells in the kidney and liver which produce EPO. However, expression of reporter
genes containing the hypoxic-responsive cis-acting sequence from the EPO gene has
subsequently been identified in a wide variety of cell types (Maxwell et ah, 1993).
Thus, it appears that HIF-1 may represent part of a universal oxygen sensing
mechanism. In accordance with this, the binding sequence for HIF-1 has been
identified in a number of other hypoxia-induced genes. Such genes include those
encoding the glycolytic enzymes aldolase phosphoglycerate kinase,
phosphofructokinase and lactate dehydrogenase (Semenza et ah, 1994; Firth et ah,
1994), VEGF (Forthsythe et ah, 1996), tyrosine hydroxylase (TH) (Norris and
Millhorn, 1995), GLUT-1 (Ebert et ah, 1995), iNOS (Melillo et ah, 1995) and HO-1
(Lee et ah, 1997). In all these cases, binding ofHIF-1 to its consensus sequence
appears to be necessary, if not sufficient, for hypoxic regulation of transcription.
Indeed, further analysis has suggested that other transcription factors beside HIF-1
may also be required, or at least have the potential, to enhance the hypoxic induction
of some genes. For example, the transcriptional activator p300 has been reported to
increase the response of the EPO enhancer to hypoxia, in a HIF-1 dependent manner
(Arany et ah, 1996). The TH enhancer region, as well as containing HIF-1 binding
sites, also includes AP-1 and AP-2 binding sites. Indeed, binding of AP-1 to its
respective sites appears to be critical for hypoxic induction of the TH gene. Hypoxia
has also been demonstrated to induce binding of a c-fos and JunB dimer to the AP-1
element in PC-12 cells and mutation of the AP-1 site in a TH reporter gene construct
was sufficient to prevent hypoxic stimulation of TH gene activity (Norris and
Milhorn, 1995). A second hypoxia-regulated gene known to contain the AP-1 site in
its promoter region is TGF-(3 and preliminary experiments using a TGF-(3 promoter-
CAT reporter construct suggest that the AP-1 binding site is involved in hypoxic
induction (Helfman and Falanga, 1993). AP-1 binding has also been proposed to
play a role in the hypoxic upregulation of IL-8 by human macrophages (N. Hirani,
unpublished data). A further candidate for gene redox regulation is NF-kB: nuclear
extracts from hypoxic HUVEC have been shown to contain proteins, which bind to a
NF-kB site on the IL-8 promoter (Karakurum et al., 1994). However, the role ofNF-
kB binding in hypoxia has been questioned as it is also activated by pro-oxidant
conditions and is down regulated by antioxidants (Meyer et al., 1993).
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1.5 Aims
The principal aim of this thesis was to determine the potential for hypoxia to regulate
human neutrophil apoptosis in vitro.
(1) Preliminary studies focused on assessing the rate of spontaneous neutrophil
apoptosis under varying oxygen tensions. Having established that hypoxia
caused a marked enhancement of neutrophil longevity by inhibiting apoptosis,
subsequent experiments were designed to investigate the kinetics of this
inhibition.
(2) A study of the intracellular signalling pathway(s) underlying the inhibition of
neutrophil apoptosis by hypoxia was undertaken and the potential involvement of
several redox sensitive transcription factors explored.
(3) The putative involvement of an oxidant based pathway in mediating TNFa-
induced apoptosis in neutrophils was investigated and the role of the caspase





The following reagents were obtained from R&D Systems Europe Ltd (Oxon, UK):
TNFa was dissolved in PBS at 10 pg/ml and stored at -80°C; mouse IgGi anti-
human TNFR55 mAb was dissolved in PBS at 500 pg/ml and stored at -20°C.
The following reagents were obtained from Genzyme Diagnostics (Kent, UK): rat
IgG2b anti-human TNFR75 mAb (1 mg/ml in PBS) was stored at 4°C; GM-CSF
(1000 U/rnl in PBS) was stored at -70°C.
The following reagents were obtained from Gibco Life Technologies (Paisley,
Scotland, UK): Iscove's Dulbecco's modified Eagles medium, without supplements
with L-glutamine (Iscove's MDM); culture supplements penicillin (50
U/ml)/streptomysin (50 U/ml); TRIZOL® reagent; trypsin-EDTA (lx) in HBSS
without calcium and magnesium; L-glutamine (200 mM); 10% SDS; Hepes buffer
solution (1M); Iscove's MDM without D-glucose or sodium pyruvate (made to
order); dialysed fetal calf serum and 30% (w/v) acrylamide/bis solution.
The following reagents were purchased from Promega (Southampton, UK): HeLa
nuclear extract (approximately 5 mg/ml protein); T4 polynucleotide kinase; T4
polynucleotide kinase lOx buffer; gel shift binding 5x buffer and AP-1 and NF-kB
consensus oligonucleotides.
Sodium citrate solution (3.8%) was purchased from Phoenix Pharmaceuticals Ltd.
(Glouster, UK). Calcium chloride was obtained from Martindale Pharmaceuticals
Ltd. (Essex, UK). Desferrioxamine mesylate was purchased from CIBA
Pharmaceutical Company (New Jersey, USA). Hsp70 mouse monoclonal IgG was
obtained from StressGen Biotechnology's Corporation (Canada). Z-DEVD-FMK
was purchased from Calbiochen-Novabiochem Corporation (Nottingham, UK) and
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Hybond C nitrocellulose membrane from Amersham Life Science Ltd. (Cheshire,
UK). Horse radish peroxidase-conjugated, goat polyclonal, anti-mouse, secondary
antibody, MAC387 monoclonal antibody, anti-human Bcl-2 IGGi (clone 124) mouse
monoclonal antibody and FITC-conjugated goat anti-mouse Ig polyclonal antibodies
were obtained from DAKO (Bucks, UK). MOPC21 IGGi antibody was a gift from
Dr I Dransfield (Respiratory Medicine Unit, University of Edinburgh). Consensus
oligonucleotides for HIF-1 were gifts from Professor P. Ratcliffe (Institute of
Molecular Medicine, Oxford, UK). CP94 was a gift from Professor R.C. Hider
(King's College, London, UK).
All other reagents were purchased from Sigma Chemical Company (Poole, Dorset,
UK) and stored according to the manufacturer's instructions. Dextran-500 (MW
500,000) was dissolved in sterile 0.9% saline (6% w/v) and stored at 4°C. Rotenone
was dissolved (100 pg/ml) in chloroform prior to dilution (1 pg/ml) in Iscove's
MDM and stored at -20°C. Antimycin A and dinitrophenol were initially dissolved





Human neutrophils were purified from the peripheral blood of healthy human
volunteers according to the method of Haslett et al., (1985). Neutrophil isolation was
performed at room temperature, under sterile conditions and using endotoxin-free
reagents and plasticware (Falcon, Oxford, UK). Freshly drawn venous blood was
collected into 50 ml polypropylene tubes, anticoagulated (4 ml 3.8% sodium
citrate/36 ml blood) and centrifuged (300g, 20 min). The platelet-rich plasma
supernatant was aspirated and centrifuged (2500g, 20 min) for production of platelet-
poor plasma (PPP) or used to prepare autologous serum in glass tubes by the addition
ofCaCf (final concentration 20 pM) at 37°C. 5 ml of 6% dextran (MW 500,000,
37°C) was added to pelleted cells from the initial centrifugation and 0.9% saline (pre-
warmed to 37°C) added to increase the volume to 50 ml per tube. The tubes were
mixed gently and allowed to stand for 30-40 min at room temperature until the
majority of erythrocytes had sedimented. The leukocyte-rich plasma was aspirated,
centrifuged (300g, 6 min) and the supernatant discarded. The resulting leukocyte
pellet was resuspended in 2 ml PPP and underlayered with 2 ml 42% and 2 ml 51%
plasma-Percoll (freshly prepared from 90% Percoll in 0.9% saline, and PPP). The
gradients were centrifuged (275g, 10 min) and polymorphonuclear cells harvested
from the 42%/51% Percoll interface. Mononuclear cells sedimented at the PPP/42%
Percoll interface. Purified cells were washed sequentially in 40 ml PPP, 40 ml
Dulbecco's phosphate buffered saline (PBS) without added cations, and 40 ml PBS
with CaCl2 and MgCl2 and the cell concentration adjusted following haemocytometer
counts. Cell purity was assessed using May-Griinwald-Giemsa staining ofmethanol
fixed cytocentrifuge preparations; mononuclear cell contamination was routinely
<0.1 %. The above density gradient centrifugation method does not separate
neutrophilic from eosinophilic or basophilic granulocytes, however harvested
polymorphonuclear cells generally consisted of <3% eosinophils, and basophils were
rarely seen. Preparations containing >5% eosinophils were discarded. Cell viability
was assessed by trypan blue exclusion and was routinely >99%. The typical yield for
this isolation method was 300-600 x 106 polymorphonuclear cells/240 ml whole
blood.
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Figure 2.2.1 May/Griinwald/Giemsa-stained cytospin preparation of human
neutrophils isolated on plasma/Percoll gradients. Freshly drawn, anticoagulated
human blood was subjected to sedimentation with 6% dextran prior to centrifugation
through discontinuous 42%/51% plasma/Percoll gradients as described in section
2.2.1. Polymorphonuclear cells were harvested from the 42%/52% Percoll interface
and washed sequentially in PPP, calcium and magnesium free PBS and PBS with
calcium and magnesium. 100 pi of the resulting cell suspension was spun (300g, 3





Freshly isolated neutrophils were routinely suspended at a density of 5 x 106/ml in
Iscove's modified Dulbecco's medium (MDM) supplemented with 10% autologous
PRP derived serum, 50 U/ml penicillin, and 50 U/ml streptomycin ('monofeed'). In
certain experiments where pre-incubation ofmonofeed was required, i.e. when the
medium needed to be fully deoxygenated prior to incubation with cells, heat
inactivated (56°C, 1 hour) human AB serum was used in place of autologous serum.
Unless otherwise stated, 6.75 x 105 neutrophils were cultured in a final volume of
150 pi in flat-bottomed 96-well Falcon flexiwell plates (Becton-Dickinson, UK) (at
37°C in a humidified, 5% CO2 atmosphere) for the time periods indicated. Reagents
to be examined in this assay system were diluted to 1 Ox the final concentration
required in Iscove's MDM.
2.2.2.2 HeLa cell culture
HeLa cells (European Tissue Culture Collection, Portan Down, UK) were grown in
Dulbecco's modified Eagles medium (DMEM) supplemented with 10% fetal calf
serum, 1% glutamine, 50 U/ml penicillin, and 50 U/ml streptomycin. Cells were
used when 90-100% confluent and serially passaged when confluent. Prior to
passaging, cells were washed with PBS without calcium and magnesium and
harvested by incubating with lx trypsin/EDTA (3 min, 37°C). Residual trypsin was
inactivated by the addition ofDMEM supplemented with 10% fetal calf serum and
the cells pelleted (300g, 5 min), resuspended in fresh medium and subdivided into
fresh cell culture flasks (162 cm2, Costar, NY, USA).
2.2.2.3 Hypoxic incubation
In initial experiments, the flexiwell plates containing neutrophils were placed in air¬
tight plastic boxes and sealed with sleek (Smith and Nephew, UK). The boxes were
flushed through (15 min) with either a gas mixture containing 2.5% O2, to provide a
hypoxic environment, or a gas mixture containing 21% O2, to provide a normoxic
(control) environment. Both gas mixtures contained 5% carbon dioxide, with the
balance made up with nitrogen. The boxes containing the neutrophils were then
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incubated at 37°C for the time periods detailed. More severe hypoxic conditions
were achieved by placing neutrophils in an MK3 anaerobic incubator (0% O2, 10%
CO2) (Don Whitley Scientific Ltd., UK) or aNAPCO hypoxic incubator (0.1% O2,
5% CO2) (Precision Scientific, Inc., USA). In order to ascertain the exact pC^/pCCL
of the cell culture medium and to ensure that these levels remained constant through
out the experiments, the pC>2, PCO2 and [H+] of the culture medium was measured
using an automated blood-gas analyser (model ABL-330, Radiometer Copenhagen)
and/or an oxygen electrode (World Precision Instruments Inc., USA). Equilibration
of the oxygen concentration in the medium with the prescribed atmospheric oxygen
levels took approximately 30 min with the boxes and < 1 hour with the anaerobic
incubators.
2.2.3 Assessment of neutrophil apoptosis
2.2.3.1 Assessment ofneutrophil apoptosis by morphological criteria
Neutrophil apoptosis was assessed morphologically according to the method of
Savill et ah, (1989a). Cells were gently resuspended and 100 pi of cell suspension
(approximately 5 x 105 neutrophils) harvested from each well, cytocentrifuged (300g,
3 min) and the resulting slide preparations air dried, fixed and stained with May-
Griinwald-Giemsa. Cell recovery was measured in parallel using a haemocytometer
and cell viability assessed by trypan blue exclusion. Cell morphology was examined
by oil immersion light microscopy using a xlOO objective, and apoptotic neutrophils
defined as cells containing one or more darkly stained pyknotic nuclei (see figure
2.2.3). For each condition examined, slides were prepared from triplicate
incubations and, after coding, a total of > 500 neutrophils counted over a minimum
of five randomly selected high power fields, with the observer blinded to the assay
conditions.
2.2.3.2 Assessment ofneutrophil apoptosis by annexin Vbinding
To substantiate the data obtained using the above morphological criteria, apoptosis
was also assessed by flow cytometry using FITC-labelled recombinant human
annexin V that binds to phosphatidylserine exposed on the surface of apoptotic cells.
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Figure 2.2.3.1 Assessment of neutrophil apoptosis by morphological criteria.
Human neutrophils were cultured in serum-supplemented Iscove's MDM for the
time period of interest; cells were resuspended and 100 pi (approximately 5 x 105)
neutrophils harvested from each well, cytocentrifuged (300g, 3 min) and the resulting
slide preparations air dried, fixed and stained with May-Griinwald-Giemsa. Cell
morphology was assessed by xlOO oil immersion light microscopy and apoptotic
neutrophils defined as cells containing one or more darkly stained pyknotic nuclei
(arrowed).
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Vienna, Austria) and then added (25 ja.1) to 75 jal of the recovered cell samples.
Following a 10 min incubation at 4°C, these samples were fixed by the addition of
100 pi of 3% paraformaldehyde, prior to analysis using an EPICS Profile II flow
cytometer (Coulter Electronics, Luton, UK). Mean fluorescence values were
determined from a minimum of 5000 cells.
2.2.3.3 Assessment ofneutrophil apoptosis by propidium iodide staining
DNA fragmentation occurring during apoptosis was quantified by flow cytometric
analysis of permeabilized cells stained with the intercalating fluorescent dye,
propidium iodide, using a modification of the method ofNicoletti et al. (1991). Cells
(6.75 x 105) were fixed in 100 pi ice-cold 70% ethanol at 4°C for 10 min, washed 3x
(220g, 1 min) in PBS (4°C) and resuspended in 30 pi PBS and 30 pi RNase (1
mg/ml). After gentle mixing, 60 pi of propidium iodide (100 pg/ml) was added and
the samples incubated in the dark (25°C, 15 min). Cells were then analysed
immediately using an EPICS Profile II (Coulter Electronics, Luton, UK). Mean
fluorescence values from a minimum of 5000 cells were determined.
2.2.4 Immunoblotting of Hsp 70 in human neutrophils
2.2.4.1 Heat shock protocol
Aliquots of 107 freshly isolated neutrophils were suspended in 2 ml monofeed and
transferred to sterile 6 well plates (Costar, USA). The cells were then heat or cold
shocked by incubation at 42°C or 4°C respectively for 1-2 hours as indicated, before
being returned to a control (37°C) environment. Hypoxic (0% O2, 37°C) and
normoxic (21% O2, 37°C) cells were incubated in parallel. At the appropriate times
neutrophils were harvested into 2 ml Eppendorfs, pelleted (7,500g, 1 min) and
washed twice in PBS without calcium and magnesium.
A number of lysis methods were employed to extract neutrophil proteins as
inconsistent results and Hsp 70 proteolysis were found when standard lysis methods
were utilised (figures 2.2.4.2, 3 and 4). These problems occurred despite inclusion of
a broad spectrum of protease inhibitors and may reflect the major protease content of
neutrophils.
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2.2.4.2 Extraction ofproteinsfrom neutrophils using Triton X-100 lysis buffer
200 pi of lysis buffer (10 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 0.1% Triton
X-100, pH 7.4) containing protease inhibitors (500 mM e-amino-n-caproic acid, 50
pg/ml antipain, 50 pg/ml chymostatin, 50 pg/ml leupeptin, 50 pg/ml pepstatin A, 50
mM AEBSF) was added to the PBS washed, pelleted neutrophils (see 2.2.4.1) and
the cells thoroughly resuspended by repeat pipetting. The samples were then
incubated on ice for 10 min before being centrifuged (10,000g, 4°C, 10 min). The
resulting supernatants were stored at -80°C prior to analysis. Protein concentration
was ascertained using the BCA protein assay (section 2.2.4.6) and protein
concentrations standardised. Prior to electrophoresis, 5 pi of 4x sample buffer (50
mM Tris base, 10% glycerol, 2% SDS, 0.1% and 100 mM dithiothreitol, pH 6.8) was
added to 15 pi of lysate and samples boiled for 5 min, 95°C.
2.2.4.3 Extraction ofproteinsfrom neutrophils using boiling SDS
Washed cell pellets were resuspended in 20 mM Tris (pH 7.4, 200 pi) and an equal
volume of boiling SDS (2%) added. Samples were then vortexed and incubated at
95°C for 5 min before being placed on ice to cool and centrifuged (10,000g, 4°C, 10
min). The resulting supernatants were stored and subsequently treated as in section
2.2.4.2.
2.2.4.4 Extraction ofproteinsfrom neutrophils using TCA
After the treatments described in section 2.2.4.1 neutrophils were harvested into 12
ml of ice-cold HEPES (20 mM, pH 7.5)-buffered saline containing protease
inhibitors (50 pg/ml leupeptin, 20 pg/ml aprotinin and 1 mM AEBSF) ('HBSI'), and
neutrophils collected by centrifugation (7,500g, 1 min, 4°C). Cell pellets were then
immediately resuspended in 0.5 ml HBSI plus 0.5 ml 20% TCA, vortex mixed, and
incubated for 10 min at 4°C. TCA precipitated material was sedimented (10,000g,
10 min, 4°C) and lipids extracted by washing the resulting pellet twice in 1 ml ice-
cold ethanol. Following sedimentation (10,000g, 10 min, 4°C), protein extracts were
taken up in 10 pi dH20, resuspended in 190 pi boiling (2x) Laemmli sample buffer
(LSB: 0.125 M Tris-HCl, 4% SDS, 20% glycerol, 2.5 mM dithiothreitol, 0.01%
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bromophenol blue, 50 pg/ml leupeptin, 20 pg/ml aprotinin and 1 mM AEBSF, pH
6.8) and boiled for 5 min in a heated water bath (Grant, UK). Cooled samples were
then incubated with 10 mM iodoacetamide for 20 min (25°C), centrifuged (14,000g,
5 min, 25°C) and supernatants stored at 4°C prior to analysis.
2.2.4.5 Extraction ofproteins from neutrophils using Laemmli sample buffer
The neutrophil pellets (107 cells) (obtained after harvesting cells into ice-cold HBSI
and centrifugation; see 2.2.4.4) were taken up in 25 pi HBSI, immediately
resuspended in 175 pi boiling LSB and boiled for 20 min. Following centrifugation
(14,000g, 5 min, 25°C), supernatants were again stored at 4°C prior to
electrophoresis.
2.2.4.6 Assessment ofprotein concentrations
Protein concentrations were quantified using a BCA protein assay (Pierce, IL, USA).
This assay is based on the ability of protein present in the test samples to cause a
reduction of Cu2+ to Cu+ and bicinchoninic acid (BCA) to chelate Cu+ forming a
purple compound which can be measured using spectrophotometry (562 nm) (Smith
et al., 1985). Samples were diluted 1 in 10 in dHiO and 10 pi incubated with 200 pi
of test solution (30 min, 37°C) in 96 well plates prior to analysis using an automated
plate reader (MR5000, Dynatech, UK). Samples were assayed in triplicate and
standard curves formed using pre-made BSA standards.
2.2.4.7 Separation ofprotein extracts by polyacrylamide gel electrophoresis
(PAGE) and electroblotting onto nitrocellulose membranes
20 pi of each sample and 10 pi of pre-boiled (5 min, 100°C) molecular weight
markers (Rainbow markers, Biorad, CA) were loaded into individual lanes of a 10%
Tris-glycine polyacrylamide gel. PAGE was then conducted (Mini Protean II
apparatus, Biorad, CA) in running buffer (50 mM Tris base, 0.1% SDS, 250 mM
glycine) at a current of 30 mA for approximately 2 hours. Gels run under identical,
parallel conditions were either (i) stained for total protein content with Coomassie
brilliant blue (0.25% plus 10% glacial acetic acid-v/v) for 4 hours followed by 4 x 4
hour washes in 40% methanol/10% glacial acetic acid; or (ii) used for protein
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transfer onto nitrocellulose membranes (Hybond C, Amersham, UK) (400 mA, 4
hours) using Protein II transfer apparatus, (Biorad, CA) filled with transfer buffer (25
mM Tris base, 210 mM glycine, 20% v/v methanol).
2.2.4.8 Detection ofHsp 70 in neutrophils
Following protein transfer to nitrocellulose membranes, non-specific binding sites
were blocked overnight in 50 ml blocking buffer (150 mM NaCl, 20 mM Tris-HCl,
0.02% Tween-20, 5% powdered fat-free milk (Marvel), pH 7.4) on a rocking
platform at 4°C. Membranes were then incubated at 25°C for 2 hours in 50 ml
blocking buffer containing mouse monoclonal anti-Hsp 70 antibody (Stressgen,
Canada). This was followed by 3 sequential washes (30 min, 25°C) in TBS Tween
(150 mM NaCl, 20 mM Tris-HCl, 0.02% Tween 20, pH 7.4) and incubation with a
horse radish peroxidase-conjugated, goat polyclonal, anti-mouse, secondary antibody
(diluted 1:10,000) (DAKO, Bucks, UK) in blocking buffer, and three further washes
in TBS Tween. Immuno-labelled proteins were then detected by enhanced
chemiluminescence (ECL, Amersham, UK) and exposure to photographic film (20 s,
Kodak XAR).
When neutrophil lysates, prepared using a standard triton-XlOO based lysis buffer
(section 2.2.4.2), were separated with SDS-PAGE and the western blots developed
using an anti-Hsp 70 antibody, two bands, both with molecular weights < 34 kDa,
were observed (figure 2.2.4.2) suggesting that severe protein degradation had
occurred during the neutrophil lysis. Two bands were also observed when
neutrophils were lysed in boiling SDS (figure 2.2.4.3). The slower migrating band
had a molecular weight of 72 kDa and probably represented the full sized Hsp 70
protein, while the faster moving band was again thought to represent a proteolytic
cleavage product ofHsp 70. When neutrophils were lysed using either TCA (section
2.2.4.4) or Laemmli sample buffer (section 2.2.4.5) only a single band (72 kDa) was
observed when the western blots were developed with anti-Hsp 70 antibody;
however, in subsequent experiments (n = 3) the Laemmli sample buffer method gave
inconsistent results (see figure 4.2.6B). In accordance with these findings, analysis
of the Coomassie stained gels (figure 2.2.4.4) showed that TCA-extracted samples
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Figure 2.2.4.2 Neutrophil lysates (30 \ig total protein per lane), prepared using
a standard triton-XlOO lysis buffer supplemented with protease inhibitors, and
separated by 10% SDS-PAGE. The western blot was developed with an antibody
to Hsp 70 (see section 2.2.4.8). No protein band of 72 kDa was observed, however,
two protein bands were identified with molecular weights of approximately 30 and
33 kDa. These results suggest that proteolytic cleavage of Hsp 70 occurred during
cell lysis. Lane 1 contains untreated neutrophils lysed at time 0. Lanes 2, 4, and 6
show control cells incubated at 37°C for 1, 4, and 20 hours respectively, while lanes
3, 5 and 7 show parallel cells which were heat shocked for 1 hour at 42°C before
being returned to control (37°C) incubation conditions.
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Figure 2.2.4.3 Neutrophil lysates (30 pg total protein per lane) prepared using
boiling SDS and separated by 10% SDS-PAGE. The western blot was developed
with an antibody to Hsp 70 (see section 2.2.4.8). Two protein bands were identified;
the slower migrating band had a molecular weight of 72 kDa and probably represents
Hsp 70 protein, while the faster migrating band (MW 70 kDa) was thought to be a
proteolytic cleavage product of this protein. Lane 1 contains control cells (37°C, 4
hours). Parallel cells were either heat shocked (42°C, 60 min, lane 2) or cold shocked
(4°C, 60 min, lane 3) prior to incubation at 37°C for a further 3 hours and lane 4
contains hypoxic cells (0% oxygen, 37°C, 4 hours).
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Figure 2.2.4.4 Comparison of TCA and Laemmli sample buffer methods of
neutrophil protein extraction. After isolation neutrophils were either lysed
immediately (time 0; lanes 1, 2, 3 and 4) or cultured for 4 hours at 37°C (control;
lanes 5, 6, 7 and 8). Parallel cells were heat shocked for 1 hour at 42°C before being
returned to 37°C for 3 hours prior to lysing (lanes 9, 10, 11 and 12). Neutrophil
lysates were prepared by either direct lysis in boiling Laemmli sample buffer (odd
numbered lanes) or a TCA based lysis method (even numbered lanes) and separated
by 10% SDS-PAGE. Gels were stained for total protein content with Coomassie
brilliant blue. Improved protein extraction was noted with the TCA based extraction
method; in particular the preservation of high molecular weight proteins. Identical
data was obtained in 2 additional experiments.
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contained greater numbers of prominent protein bands than samples extracted by the
Laemmli sample buffer method. Therefore, the TCA extraction protocol was
selected for all further studies.
2.2.5 IMMUNOCYTOCHEMISTRY
To substantiate the data obtained using the above western blot method, Hsp 70
expression in human neutrophils was also assessed by immunocytochemistry. This
method was also used to investigate the presence of the Bcl-2 oncoprotein in human
neutrophils. After appropriate times in culture, cells (1-2 x 105) were transferred into
round bottomed 96-well polypropylene plates and permeabilized and fixed with
0.01% (w/v) L-a-lysophosphatidylcholine in PBS containing 3.7% (v/v)
formaldehyde (50 pi) for 15 min at 37°C. The cells were then washed twice with
PBS containing 0.5% (w/v) BSA and labelled with pre-determined saturating
concentrations of primary antibody (see below) for 1 hour at 4°C. Samples were
subsequently washed with PBS/0.5% (w/v) BSA before the addition of FITC-
conjugated secondary antibody (1 hour, 4°C). The cells were then analysed using an
EPICS Profile II flow cytometer (Coulter Electronics, Luton, U.K.). A minimum of
3000 events were collected and analysed per sample. Appropriate negative and
positive controls were prepared with each sample, and the data presented as mean
fluorescence relative to the negative control.
Saturating concentrations of antibody was determined by titration: the mouse anti-
human Hsp 70 monoclonal antibody was titrated against HL-60 cells. Controls
included MAC 387 (DAKO, Bucks, UK), a monoclonal antibody, which recognises
the myeloid cell antigen p8,14 present in neutrophils (positive control to ensure
efficient permeabilization; mean fluorescence 25.1 ± 8, n=7) and MOPC21 control
antibody (kindly donated by Dr I. Dransfield, University ofEdinburgh) as a negative
control.
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2.2.6 Identification of HIF-la in neutrophils
2.2.6.1 RNA analysis
2.2.6.1a Isolation of total cell RNA
Freshly isolated neutrophils (30 x 106) were washed twice in PBS without calcium
(r)
and magnesium and the resulting cell pellet immediately lysed in 6 ml of TRIZOL
reagent (5 min, 25°C). After the addition of 1.2 ml of chloroform, samples were
vortex mixed until they took on a cloudy appearance and then incubated at room
temperature for 2-3 min. On centrifugation (12,000g, 4°C, 15 min), the mixture
separated into 3 phases, with the RNA present in the upper aqueous phase. This
aqueous phase was transferred into sterile tubes and RNA precipitated by the
addition of 3 ml of isopropanol. The samples were subsequently incubated for 10
minutes at room temperature or, alternatively overnight at -20°C, and the RNA
pelleted by centrifugation (12,000g, 4°C, 10 min). The supernatant was discarded, 6
ml of ethanol (75%) added, and the samples vortexed mixed. Following this,
samples were centrifuged (7,500g, 4°C) for 5 minutes and the supernatant removed
taking care not to disturb the pellet. The pellet was then allowed to air dry for 20-30
minutes prior to being redissolved in a minimum amount of 0.5% SDS. Samples
were stored at -80°C prior to analysis. The RNA content of samples was quantified
using a RNA/DNA calculator (Pharmacia Biotech, Flerts., UK); 4 pi of sample was
diluted with 996 pi dH20 prior to measurement of the 260/280 ratio from which the
RNA concentration was ascertained.
2.2.6.1b RNase protection assay
RNase protection assays were performed by Dr M. Wiesener (Wellcome Trust
Centre for Human Genetics, Oxford, UK). 40 pg of total neutrophil RNA was
subjected to hybridisation with P-labelled riboprobes for HIF-la and EPAS-1.
These were generated using an SP6 or T7 RNA polymerase; the templates used
yielded riboprobes of distinct sizes: 221 bases for EPAS-1 (nucleotides 2542 to 2762,
Genbank accession no. U81984) and 268 bases for HIF-la (nucleotides 760 to 1028,
Genbank accession no.U22431). Hybridisation was performed at 60°C in 80%
formamide, 40 mM Pipes, (pH 6.4), 400 mM NaCl and 1 mM EDTA, and RNase
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digestion performed at 20°C for 30 minutes. The protected fragments were then
subjected to denaturing PAGE using 8% gels.
2.2.6.2 Protein analysis
2.2.6.2a Extraction ofproteinsfrom neutrophils using TRIZOL® reagent
Neutrophils (10 x 106) were resuspended at a density of 5 x 106/ml in mono feed,
which had been previously incubated overnight in either normoxic (21% O2) or
hypoxic (0% O2) conditions. A third condition consisted of normoxic cells treated
with desferrioxamine (final concentration 1 mM). Cells were cultured at a final
volume of 2 ml in 6 well plates and were then incubated for 3-4 hours in either
hypoxic or normoxic environments. After incubation, neutrophils were harvested
rapidly into a large volume of ice cold PBS (in order to minimise degradation of
HIF-1) and collected by centrifugation (7,500g, 1 min, 4°C). The resulting pellet
was washed twice in ice cold PBS before being lysed in 2 ml of TRIZOL® reagent
and subsequently treated as described in section 2.2.6.1a up to the point when
samples were phase partitioned using chloroform. At this stage the upper aqueous
phase was removed leaving an upper interphase containing DNA and lipid soluble
proteins and a lower organic phase containing the remaining protein. To this, 100%
ethanol (0.3 ml per 1 ml TRIZOL used initially) was added and the samples mixed
by inverting the tubes. The samples were subsequently incubated for 2-3 min at
room temperature and then centrifuged (2,000g, 4°C) for 5 min. The resulting pellet,
which contained the DNA was discarded, while the protein containing supernatant
was transferred to clean tubes. To these, isopropanol (1.5 ml per 1 ml TRIZOL used
for the initial lysis) was added, and the samples incubated for 10 min at room
temperature before being centrifuged (12,000g, 4°C) for a further 10 min. The
resulting protein pellets were then washed 3x in 0.3 M guanidine hydrochloride in
95% ethanol (2 ml per 1 ml TRIZOL used for the initial lysis), centrifuging at 7,500g
(4°C) for 5 min between each wash. After the final wash the pellets were
resuspended in 100% ethanol, incubated (20 min, 25°C), and the protein collected by
centrifugation (7,500g, 5 min, 4°C). The protein pellets were then vacuum dried for
10 min and dissolved in 50 pi 1% SDS (50°C, 30 min). Finally, samples were
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centrifuged (10,000g, 10 min, 4°C) and the resulting supernatants stored at -80°C.
Protein concentrations were assessed as described in section 2.2.4.6.
2.2.6.2b lmmunoblot analysis
Western blots for HIF-loc were performed by Dr M. Wiesener (Wellcome Trust
Centre for Human Genetics, Oxford, UK). Protein extracts (80 pg) were separated
using SDS/6% polyacrylamide gels and transferred to Immobilon P (Millipore)
overnight in 10 mmol/L Tris, 100 mmol/L glycine, 10% methanol and 0.05% SDS.
Membranes were blocked with PBS containing 5% fat-free dried milk and 0.1%
Tween 20. For HIF-la detection, mAb 28b was used at 4 pg/ml. This antibody was
from a fusion following immunisation with a GST fusion protein including amino
acids 329 to 530 of human HIF-la. For EPAS-1, 190b supernatant was diluted 1:4
(for characterisation of these antibodies see Wiesener et al., 1998). Antibody binding
was detected using horse radish peroxidase (HRP)-conjugated goat anti-mouse Igs
(DAKO, Glostrup, Denmark) at 1:2,000 and enhanced chemiluminescence
(SuperSignal Ultra; Pierce, Rockford, IL). After analysis, membranes were stained
with Ponceau S to verify equal protein loading and transfer.
2.2.6.3 Electrophoretic mobility shift assayfor HIF-1
2.2.6.3a Preparation ofnuclear extracts
Neutrophils were prepared, cultured under normoxic or hypoxic conditions for 4
hours and harvested into pre-weighed 15 ml conical polyproplylene tubes as
described in section 2.2.6.2a. HeLa cells were used as a positive control, and treated
in an identical fashion to the neutrophils. At the beginning of the experiment, the
HeLa medium was replaced by 25 ml of medium which had either been incubated
overnight in a 0% O2 (hypoxic), 21% O2 (normoxic) or normoxic medium containing
desferrioxamine (100 pM). The HeLa cells were then incubated under these
conditions for 4 hours and the incubations terminated by the addition of a large
volume of ice cold PBS and placing the flasks on ice. The cells were then washed
again with ice cold PBS before being harvested into 5 ml of PBS using a cell scraper
and transferred into pre-weighed 15 ml conical tubes. Both HeLa cells and
neutrophils were then pelleted (l,000g, 5 min, 4°C) and the supernatants carefully
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removed using a pulled Pasteur pipette. The pellet was then washed briefly in ice
cold buffer A (see table 2.2.6.3a) before being weighed, resuspended in 4 packed cell
volumes of buffer A (4°C) and incubated for 10 min on ice. The cells were then
lysed using a dounce homogenizer (30 strokes on ice), and cell lysis verified by
microscopy using trypan blue. The lysed cells were then transferred to a second
weighed 15 ml conical tube, the nuclei pelleted (3,000g, 5 min, 4°C) and the
supernatant again carefully removed with the aid of a pulled Pasteur pipette. The
nuclear pellets were weighed and resuspended in 3 packed cell volumes of buffer C
before being transferred to 2 ml Eppendorfs and mixed on a rotator (4°C) for 30 min.
The nuclear debris was then pelleted (13,000g, 30 min, 4°C) and the resulting
supernatant dialysed against 500 ml of buffer D (4°C) for 2 hours with one change of
dialysis buffer. The dialysed extracts were aliquoted, snap frozen (liquid nitrogen)
and stored at -80°C. Protein concentrations were ascertained using the method
described in section 2.2.4.6.
Buffer A (Hypotonic)*













Table 2.2.6.3a Buffers used for isolation of nuclear proteins. ^Buffers A and C
were additionally supplemented, immediately prior to use, with the following
protease inhibitors (final concentration): ABSEF (0.5 mM); aprotinin (1 pg/ml);
leupeptin (1 pg/ml); pepstatin A (1 pg/ml); sodium vandate (1 mM); benzamidine
(0.5 mM); levamisole (2 mM); P-glycerophosphate (10 mM) and DTT (0.5 mM).
"Buffer D was supplemented immediately prior to use with (final concentration):
sodium vandate (1 mM); P-glycerophosphate (10 mM) and DTT (0.5 mM).
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2.2.6.3b Labelling ofHIF-1 probe with polynucleotide kinase
Oligonucleotides derived from the mouse erythropoietin 3' enhancer were used as
probes or competitors in the EMSAs. These were kindly donated by Prof. P. J.
Ratcliffe (Institute ofMolecular Medicine, Oxford, UK) and their sequences are
shown in figure 2.2.6.2b. The wild type probe contained the HIF-1 binding site,
while the binding site in the mutated probe was modified to abolish HIF-1 binding.
Probes were purified by polyacrylamide gel electrophoresis prior to labelling.
Single-stranded oligonucleotide (100 ng/pl) was incubated with 2 pi lOx kinase
buffer, 11 pi dH20, 4 pi [y-32P] ATP (3,000Ci/mmol at 10 rnCi/ml) and 2 pi
polynucleotide kinase for 2-3 hours at 37°C. The reaction was stopped by the
addition of 5 pi 500 mM EDTA, and 75 pi dH20 added. Labelled oligonucleotides
were then loaded onto prespun Sephadex G25-containing spin columns and
centrifuged at 13,000g for 1 min. The probe was then eluted with 100 pi of TE
buffer (10 mM Tris, pH 8.0, 1 mM EDTA) by centrifugation (1 min, 13,000g).
Following this, 10 pi NaAc (pH 8.0) and 330 pi of ethanol were added to precipitate
the probe and the oligonucleotide pelleted (10,000g, 4°C, 40 min). The
oligonucleotide pellet was then washed in 85% ethanol before being resuspended in
40 pi TE buffer (pH 8.0) and annealed with a four fold excess of the unlabelled
complementary strand (30 min, 37°C). Unlabelled oligonucleotides were annealed in
molar equivalent quantities. Finally, the double stranded probe was diluted 1 in 20 in
TE buffer to give a final concentration of 0.1 ng/pl and stored at -20°C prior to use.
EPO WT 24mer
EPO 108 5' GCC, CTA, CGT, GCT, GCC, TCG, CAT, GGC 3'
EPO 109 3' CGG, GAT, GCA, CGA, CGG, AGC, GTA, CCG 5'
EPO Mut3 24mer
EPO 110 5' GCC, CTA, ATG, TCT, GCC, TCG, CAT, GGC 3'
EPO 111 3' CGG, GAT, TAC, AGA, CGG, AGC, GTA, CCG 5'
Figure 2.2.6.2b Sequences of probes used for HIF-1 gel shift assays. All probes
were kindly donated by Prof. P. J. Ratcliffe, Institute of Molecular Medicine, Oxford,
UK.
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2.2.6.3c Binding reactions and electrophoresis conditionsfor HIF-1 EMSAs
Binding reaction mixtures (final volume 20 jj.1) contained 10 mM Tris-HCl (pH 7.5),
50 mM KC1, 1 mM MgCl2, 1 mM EDTA, 5 mM DTT, 5% glycerol, 0.03% NP40, 1
mM sodium vanadate, 150-300 ng sonnicated poly dldC and 0.1 pg labelled probe
(see 2.2.6.2b). The binding reactions were performed as follows in Eppendorf tubes
at room temperature: 5 pi of 5x binding buffer (25 mM Tris-EICl (pH 7.5), 125 mM
KC1, 5 mM MgCl2, 4.75 mM EDTA, 25 mM DTT and 0.15% NP40) and poly dldC
were initially placed in the tubes followed by the nuclear extract (5 pg total protein).
The samples were then mixed and incubated at room temperature for 5 min before
the addition of 1 pi labelled probe and (if required) unlabelled competitor. After a
further 10 min incubation, reaction products were loaded on to a pre-run and pre-
cooled 5% polyacrylamide gel. Gels were run on a Biorad Protean II system at 280
V for approximately 3 hours at 4-10°C. The running buffer used consisted of 0.3x
TBE (final concentrations, 27 mM Tris base, 27 mM boric acid, 0.06 mM EDTA, pH
7.3) at room temperature and was supplemented with 0.03% NP40. Finally, the run
gels were transferred to Whatman paper and dried under a vacuum (80°C, 30 min)
before being exposed to film (Biomax MR, Kodak) overnight at -80°C.
2.2.7 Electrophoretic Mobility Shift Assay forNF-kB and AP-1
2.2.7.1 Preparation ofnuclear extracts
Neutrophils (20-30 x 106) were cultured at a density of 107cells/ml in either hypoxic
monofeed (pre-incubated overnight in 0% 02), normoxic monofeed, or normoxic
monofeed containing desferrioxamine (1 mM). Cells were then incubated in either
21% 02 or 0% 02, as appropriate, for 0.5 to 6 hours. At the stated time points cells
were harvested immediately into ice cold PBS and pelleted by centrifugation (3000g,
3 min) at 4°C. The supernatants were discarded and the cell pellets resuspended in
0.4 ml ice cold solution A (see table 2.2.7.1), transferred to Eppendorf tubes and
incubated on ice for 15 min. Following the incubation, 15 pi of solution B was
added and the samples vortex mixed for 30 s prior to centrifugation (13,000g, 4°C, 1
min). The resulting supernatant was removed, 50 pi of ice cold solution C added to
the nuclear pellet and the samples mixed by pipetting. The samples were then placed
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on a rotating table at 4°C for 20 min prior to centrifugation (13,000g, 5 min, 4°C).
The supernatant containing the nuclear protein was removed, aliquoted and stored at
-80°C. Protein concentrations were determined as described previously in section
2.2.4.6.
Solution A (Hypotonic)






10% Nonident p40 in dH2Q
Solution C (Hypertonic)






Table 2.2.7.1 Solutions used for isolation of nuclear proteins. Solutions A and C
were made up at 2x concentration and stored at -20°C. Immediately prior to use
these solutions were additionally supplemented with the following protease inhibitors
(final concentration): ABSEF (0.5 mM); aprotinin (1 pg/ml); leupeptin (1 pg/ml);
pepstatin A (1 pg/ml); sodium vandate (1 mM); benzamidine (0.5 mM); levamisole
(2 mM) and p-glycerophosphate (10 mM).
2.2.7.2 Labelling ofconsensus NF-kB andAP-1 oligonucleotide probes
The double stranded oligonucleotides (see figure 2.2.7.2 for sequences) were labelled
with y- P in the following reaction: 2 pi consensus oligonucleotide (1.75 pmol/pl), 1
pi T4 polynucleotide kinase lOx buffer (Promega), lpl T4 polynucleotide kinase (5-
10 U/pl), 5 pi dH20 and 1 pi [y-32P] ATP (3,000 Ci/mmol at 10 mCi/ml) were added
in a sterile Eppendorf tube and incubated together for 10 min at 37°C. The reaction
was terminated by the addition of 1 pi of 0.5 M EDTA and the volume increased to
100 pi with TE buffer. The labelled probe was then stored at -20°C prior to use.
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AP-1
5' -CGC TTG ATG AGT CAG CCG GAA- 3'
3' -GCG AAC TAC TCA GTC GGC CTT- 5'
NF-kB
5' -AGT TGA GGG GAC TTT CCC AGG C 3'
3' -TCA ACT CCC CTG AAA GGG TCC G 5'
Figure 2.2.7.2 Sequences of probes for the transcription factors AP-1 and NF-
kB used in gel shift assays. Both probes were purchased from Promega
(Southampton, UK).
2.2.7.3 Binding reactions and electrophoresis conditionsfor NF-kB andAP-1
EMSAs
The following binding reactions were performed in sterile Eppendorf tubes: (1)
positive control, 5 pi dH20, 2 pi 5x gel shift buffer (Promega, Southampton, UK), 2
pi HeLa nuclear extract (Promega, Southampton, UK); (2) negative control, 7 pi
dH20, 2 pi 5x gel shift buffer; (3) sample tubes, 4 pi dH20, 2 pi gel shift buffer and
3 pi of nuclear extract (4 pg total protein). All tubes were then incubated for 5-10
min at room temperature prior to the addition of 1 pi of labelled target consensus
oligonucleotide. The binding reactions were then incubated for a further 20 min at
room temperature before termination of the reactions with 1 pi 1 Ox gel-loading
buffer (20% glycerol, 0.01% bromophenol blue, 5 mM EDTA). The reaction
products were immediately loaded onto pre-run 8% polyacrylamide gels and run in
0.5% TBE at 150 V for 2-3 hours. The gels were then transferred to Whatman paper
and dried under a vacuum for 30 minutes at 80°C. Finally, the dried gels were
exposed to film (BIO-MAX MR, Kodak) overnight at -80°C.
2.2.8 Flow cytometric analysis of TNFR55 and TNFR75 expression in
human neutrophils
Expression of TNFR55 and TNFR75 in human neutrophils was studied by indirect
immunofluorescence with primary antibody directed against TNFR55 or TNFR75
and FITC-conjugated secondary antibody detected using an EPICs Profile II.
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At the appropriate times neutrophils were harvested and transferred to pre-chilled U-
bottomed flexiwell plates (Becton-Dickinson, UK), washed (220g, 1.5 min, 4°C) in
100 pi ice-cold wash buffer (PBS containing 0.2% BSA and 0.1% sodium azide) and
resuspended in 40 pi of a saturating concentration ofmouse anti-human TNFR55,
TNFR75 (R&D Systems, UK), or CD2 mAb as a negative control (UCFIT-1 clone
IgGl; SAPU, Carluke, UK). After a 30 min incubation on ice, the cells were washed
twice and incubated with 40 pi FITC-conjugated goat anti-mouse immunoglobin
(Dako, Buckinghamshire, UK diluted 1 in 40 with PBS/BSA azide buffer). After
washing, samples were analysed using an EPICS Profile II (Coulter Electronics,
Luton, UK) and mean fluorescence from a minimum of 3000 cells determined.
Samples were processed with the help ofDr J. Murray (University of Edinburgh).
2.2.9 Data analysis
Results are reported either as pooled data from a series of n separate experiments
(mean ± SEM) or as individual representative experiments (mean ± SD, 3
replicates/condition). Statistical significance was assessed by the students t-test or,




REGULATION OF NEUTROPHIL APOPTOSIS BY HYPOXIA
3.1 Introduction
Neutrophils are the most abundant and shortest lived of all the leukocytes. Their
primary role is to defend the host against infection. However, as phagocytic cells,
neutrophils contain powerful degradative granule enzymes and toxic catonic
proteins, and inappropriate release of these histotoxic contents has been shown to
cause host tissue damage (Weiss, 1989). It is thus imperative that neutrophil
function is tightly regulated and this is achieved predominantly through two distinct
processes, namely priming and apoptosis. Priming upregulates the secretagogue
capacity of the neutrophil resulting in a hyperresponsive cell, which has the potential
to cause tissue damage if inappropriately stimulated. On the other hand apoptosis, a
process associated with maintenance of membrane integrity, results in a functionally
downregulated cell, which can be phagocytosed intact by macrophages and certain
other phagocytes (Savill et ah, 1989a and b, 1990b, 1992a; Haslett et ah, 1989;
Whyte et ah, 1993a). The observation that engulfment of apoptotic neutrophils by
macrophages does not trigger a pro-inflammatory macrophage response (Meagher et
ah, 1992) predicts that this process plays an important role in the safe disposal of
neutrophils from an inflamed focus and will thus promote the resolution of
inflammation. This view is supported by experiments showing the occurrence of this
process in vivo, for example, in endotoxin-induced lung injury (Cox et ah, 1995) and
the neonatal respiratory distress syndrome (Grigg et ah, 1991).
However, although these regulatory processes exist they are not infallible. It is now
recognised that neutrophils play a role in the pathogenesis ofmany inflammatory
diseases that, in the lung, include chronic bronchitis, emphysema (Janoff, 1985),
asthma and adult respiratory distress syndrome (Stevens and Raffin, 1984), and, in
other tissues, glomerulonephritis (Holdsworth and Bellomo, 1984), rheumatoid
arthritis and reperfusion injury following myocardial infarction (Allan et ah, 1985).
In these conditions neutrophil accumulation correlates, and is associated, with the
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tissue destruction and fibrosis, which can severely compromise organ function. It is
noteworthy that in the majority of these diseases the site of inflammation, and hence
neutrophil accumulation, will be relatively hypoxic. This is due to many factors
including reduced blood flow to the site of inflammation, increased local oxygen
requirements, and, in the case of pulmonary disease, reduced gas exchange due to
lung damage. Furthermore, tissue hypoxia following haemorrhage and trauma is
thought to be a possible initiating factor of the generalised inflammatory response
seen after shock.
The neutrophil has a circulating half life of 6-8 hours in vivo (Fliedner et ah, 1964)
and undergoes constitutive apoptosis in vitro with a half-time of 12-18 hours (Savill
et ah, 1989a and 1992; Grigg et ah, 1991; Whyte et ah, 1993a). Flowever, a number
of agents are capable of extending the neutrophil's life-span (Colotta et ah, 1992; Lee
et ah, 1993) including the proinflammatory mediators, bacterial lipopolysaccharide
(LPS), granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage-
colony stimulating factor (GM-CSF) and the interleukins 1 and 6. These agents all
promote neutrophil survival by delaying neutrophil apoptosis, whereas tumour
necrosis factor-a (TNFa) has been shown to accelerate neutrophil apoptosis at early
time points (Takeda et ah, 1992; Murray et ah, 1997). Several of these agents also
act to prime the functional responsiveness of neutrophils. Thus, it appears that the
balance of inflammatory mediators present at an inflamed site may potentially
regulate both neutrophil function and longevity. We became interested in the
possibility that other changes in the neutrophil's environment may also hold the
potential to regulate the functional life-span of these cells and, since under many
physiological and pathological conditions the site of inflammation is deprived of
oxygen, we proceeded to investigate the effect of hypoxia on neutrophil apoptosis.
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3.2 Results
3.2.1 Effect ofhypoxia on neutrophil apoptosis
To evaluate whether hypoxia could influence the rate of neutrophil apoptosis the
effects of incubating purified human peripheral blood neutrophils in an atmosphere
with a reduced oxygen content (2.5% opposed to 21% oxygen) were examined at 6
and 20 hour time points. These oxygen concentrations were achieved by placing
cultured neutrophils in sealed plastic boxes, flushed through with a gas mixture
containing either 2.5% (hypoxic conditions) or 21% oxygen (normoxic conditions).
This method has previously been validated and used to examine the effect of hypoxia
on macrophage TNFa release (Scannell et al., 1993). Figure 3.2.1.IB shows the
mean results from 5 different experiments. After 6 hours in culture the percentage of
neutrophils exhibiting morphological features of apoptosis in 21% and 2.5% oxygen
environments was not significantly different (p<0.05). After 20 hours incubation the
mean percentage apoptosis of neutrophils incubated in 2.5% oxygen was less than
that of neutrophils incubated in 21% oxygen (46.2 ± 5.3 versus 56.3 ± 5.3), however,
this difference was again not significant. When the pC>2 of the medium under these
two conditions was quantified using a blood-gas analyser (figure 3.2.1.1A) it was
found that the pC>2 of the medium only decreased to approximately 9 kPa under the
'hypoxic' condition. Although this value was significantly lower than control, it is
only slightly lower than the pC>2 of normal arterial blood and very similar to the
oxygen tension in normal tissues, even at rest. In addition, these levels were not
maintained for the duration of the experiments, suggesting that the containers used
were partially oxygen permeable.
Thus, a second set of experiments was performed in which different containers were
used. These containers maintained the required atmosphere (and medium pCh) for
the 20 hour duration of the experiment (figure 3.2.1.2A). In addition, a third
condition was introduced where neutrophils were incubated in an MK3 anaerobic
incubator. Under this condition the pC>2 of the medium was reduced to less than 3.5
kPa (figure 3.2.1.2A). Figure 3.2.1,2B shows the effect of these levels of hypoxia on
the rate of neutrophil apoptosis. After 6 hours, when the index of apoptosis is low,
there was no noticeable effect of hypoxia. However, after 20 hours incubation
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A
15 minutes 6 hours 20 hours
21% Oxygen p02 26.3 ±0.1 22.1 ±2.2 19.9 ±2.3
21% Oxygen pC02 7.5 ±0.8 4.3 ±0.6 4.2 ±0.6
2.5% Oxygen p02 8.3 ± 1.9 15.1 ± 1.6 20.2 ±0.5




Figure 3.2.1.1 The effect of hypoxia on the rate of neutrophil apoptosis using
existing methology. (A) Changes in the p02 and the pC02 of the culture medium
over the time course of the experiments shown in B. The results are expressed in kPa
as the mean ± SD from 2 separate experiments. (B) Neutrophils (5 x 106) were
incubated in atmospheres containing either 21% or 2.5% oxygen. After 6 and 20
hours cytocentrifuge preparations were made in triplicate and the percentage of
apoptosis assessed by examining cell morphology under oil immersion light
microscopy. When the pC>2 of the culture medium was monitored (A) the initial pC>2
of the culture medium was found not to remain constant for the duration of the
experiment. Data are expressed as the mean ± SEM of 5 separate experiments. The
difference in the percentage apoptosis between the conditions was not significant at 6
or 20 hours (p<0.05).
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A
15 minutes 6 hours 20 hours
21% Oxygen p02 26.9 ±0.6 22.8 ±0.8 22.4 ±0.2
21% Oxygen pC02 8.8 ±0.8 4.7 ±0.2 4.1 ±0.5
2.5% Oxygen p02 8.7 ±0.7 8.6 ±0.4 9.5 ± 1.7
2.5% Oxygen pC02 8.9 ±0.2 4.7 ±0.4 3.9 ±0.2
0 % Oxygen p02 12.7 ±0.8 3.3 ±0.3 3.3 ±0.3









Figure 3.2.1.2 Hypoxia inhibits neutrophil apoptosis in a concentration
dependent manner. (A) Changes in the pC>2 and the pCC>2 of the culture medium
over the time course of the experiments shown in B. The results are expressed in kPa
as the mean ± SD from 2 separate experiments. (B) Neutrophils were incubated and
evaluated as described in figure 3.2.1 except the pC>2 of the culture medium was
maintained for the duration of the experiment (A). Cells were also incubated in an
anaerobic environment (0% oxygen) to further reduce the pC>2 of the medium. Data
are expressed as the mean ± SEM from n = 5 separate experiments each performed in
triplicate. The difference in the percentage of apoptosis between all three conditions
is significant at 20 hours but not at 6 hours (*p< 0.05 compared to values obtained in
21% 02).
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hypoxia caused a significant and concentration-dependent inhibition of neutrophil
apoptosis.
3.2.2 Time-coursefor the effect ofhypoxia on neutrophil apoptosis
Due to the dramatic inhibition of neutrophil apoptosis found under hypoxic
conditions, an extended time-course experiment was undertaken in order to
determine at which point between 6 and 20 hours hypoxia began to inhibit neutrophil
apoptosis and to evaluate the duration of this protective effect. Neutrophils were
incubated in atmospheres containing either 21 % or 0% oxygen and the percentage of
apoptotic cells was assessed using morphological criteria at time points up to and
including 44 hours (figure 3.2.2.1). At 44 hours neutrophils incubated in 21%
oxygen showed a large increase in the percentage of necrotic cells (i.e. trypan blue
positive). Therefore, at this time point the resulting cytospins showed considerable
cell debris and it was not possible to assess the percentage of apoptotic neutrophils.
In contrast, neutrophils incubated in 0% oxygen were all viable (trypan blue
negative) and the percentage of neutrophil apoptosis was still only 21.5 ± 4.4%
(figure 3.2.2.2). The difference in the percentage of apoptotic neutrophils under
hypoxic and normoxic conditions was significant at 10, 20, 30 and 44 hours but not
at 6 hours (p < 0.05).
3.2.3 Confirmation of the hypoxic inhibition ofneutrophil apoptosis by annexin V
binding
One of the earliest events in programmed cell death is the externalisation of
phosphatidylserine, a membrane phospholipid normally restricted to the inner leaflet
of the lipid bilayer. Annexin V is an endogenous human protein with a high affinity
for membrane bound phosphatidylserine. Hence, this protein can be used as a
sensitive probe for phosphatidylserine exposure on the cell membrane and as an
index of apoptosis (Pepper et ah, 1998; Vermes et al., 1995). Neutrophils were
incubated for 6 and 20 hours in atmospheres containing 21 % and 0% oxygen and
FITC-labelled annexin V binding was assessed by flow cytometry. Figure 3.2.3A
shows representative histograms demonstrating less annexin V binding in hypoxic
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Time (hours)
Figure 3.2.2.1 Time course for the inhibition of neutrophil apoptosis by
hypoxia. Neutrophils (5 x 106/ml) were incubated in atmospheres containing either
21% or 0% oxygen. At time points up to and including 44 hours the percentage of
apoptosis was evaluated as described in figure 3.2.1. At 44 hours neutrophils
incubated in 21 % oxygen showed an increase in necrotic cells to 26% (as assessed by
trypan blue exclusion), thus it was not possible to assess the percentage of apoptotic
cells at this time point. Results are from a representative experiment of 2 and data are
expressed as mean ± SEM of triplicate determinations.
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A
Figure 3.2.2.2 Cytological appearance of human neutrophils aged in culture for
44 hours in 21% oxygen (A) or 0% oxygen (B). (magnification xlOOO).
Neutrophils were isolated by methods that cause minimal cell activation and cultured
at 5 x 106 /ml in Iscove's MDM. Cytocentrifuge preparations were fixed and stained
with May Grunwald/Geimsa. The cells cultured in 21% oxygen showed a significant
increase in the number of necrotic cells (assessed by trypan blue exclusion prior to
cell fixation). There was no such increase observed in the neutrophils incubated in
0% oxygen. (A) Due to the increase in cell necrosis it was not possible to assess the
percentage of apoptotic neutrophils. (B) In 0% oxygen the proportion of cells
exhibiting the morphological features of apoptosis was still only 21.4%.
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A
6 hours 21% oxygen 6 hours 0% oxygen
Method 6hr 21% 6hr 0% 20hr 21% 20hr 0%
Annexin V 7.6 ± 1.4 5.9 ± 1.4 59.6 ±4.4 32.1 ±2.7*






20 hours 21% oxygen
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Figure 3.2.3 Effect of hypoxia on annexin V binding in human neutrophils.
Neutrophils (5 x 106/ml) were incubated in atmospheres containing 21 or 0% oxygen.
At 6 and 20 hours neutrophils were harvested and incubated with FITC-labelled
annexin V and fixed in 3% paraformaldehyde prior to analysis using an Epics Profile
II. (A) Shows representative flow-cytometry histogram (cell count vs log
fluorescence) profiles. (B) Cytospins were also prepared in parallel and %
morphological apoptosis compared with % apoptosis as assessed by annexin V
labelling. Data is expressed as mean ± SEM from 4 separate experiments (* p < 0.05
compared to cells cultured for 20 hours in 21% O2).
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cells as compared to control cells. This difference is most striking at 20 hours. The
mean percentage apoptosis, as assessed by annexin V binding, correlated well with
values obtained using morphological criteria (figure 3.2.3B). Apoptosis values at 6
hours were slightly higher for both conditions using annexin V binding compared to
values obtained by morphology, but as the translocation of phosphatidylserine
proceeds morphological changes, this was not unexpected. Although the
externalisation of phosphatidylserine also occurs during necrosis, this possibility was
eliminated in these experiments using trypan blue exclusion (data not shown).
3.2.4 Effect ofhypoxia on propidium iodide staining in neutrophils
The inhibitory effect of hypoxia on neutrophil apoptosis was further confirmed using
propidium iodide DNA staining and flow cytometry. The DNA fragmentation that
occurs during apoptosis results in reduced binding of propidium iodide and, hence, as
a cell undergoes apoptosis there is decreased binding of the fluorescent dye
propidium iodide to DNA, which can be analysed by flow cytometry (Nicoletti et ah,
1991). Figure 3.2.4A shows the decrease in the percentage of cells with hypodiploid
DNA content following hypoxic (0% O2) incubation compared to cells incubated
under normoxic conditions (21% O2) at 20 hours. The percentage apoptosis obtained
using propidium iodide and flow cytometry closely match the extent of apoptosis
assessed by morphological criteria in parallel incubations (figure 3.2.4B). Hence,
this data confirms that the above morphological and annexin V data reflect genuine
apoptosis.
3.2.5 Kinetics of the inhibition ofneutrophil apoptosis by hypoxia
In order to characterise the hypoxic inhibition of neutrophil apoptosis in greater
detail we investigated whether hypoxia could inhibit apoptosis at any stage of the
apoptotic program, or whether neutrophils must be hypoxic from time 0. This was
achieved by incubating neutrophils for progressively longer times (3, 6, 9, 12, 15, 18
and 21 hours) in 21% oxygen before transferring them to a hypoxic environment for
the rest of the 24 hour experiment. The effect of the length of the normoxic
incubation time on the rate of apoptosis was assessed and compared to control values
(figure 3.2.5A, B and C). These data demonstrate that hypoxia can delay the rate of
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Method 6 hrs 21% 6 hrs 0% 20 hrs 21% 20 hrs 0%
Propidium Iodide Staining 1.1 ±0.1 0.9 ±0.1 65.2 ±2.0 33.9 ±4.3*
Morphology 1.4 ±0.3 0.9 ±0.2 69.3 ± 1.3 33.0 ± 1.3*
Figure 3.2.4 Effect of hypoxia on propidium iodide staining in human
neutrophils. Neutrophils (5 x 106/ml) were incubated in atmospheres containing
21% or 0% oxygen. Following a 6 or 20 hour incubation period cells were
resuspended in ice-cold 70% ethanol, washed in PBS and incubated with propidium
iodide in the presence of RNase prior to analysis using an EPICS Profile II. (A)
Shows representative flow-cytometry histogram (cell count vs log fluorescence)
profiles. (B) Cytospins were prepared in parallel and % morphological apoptosis
compared with % apoptosis assessed with propidium iodide staining. Data is
expressed as mean ± SEM from 3 separate experiments (* p < 0.05 compared to cells
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Figure 3.2.5 The kinetics of the hypoxic inhibition of neutrophil apoptosis.
Neutrophils (5 x 106/ml) were incubated in 21% oxygen for increasing amounts of
time before being transferred to an anoxic incubator and the rate of apoptosis
assessed over a 24 hour period. Control cells were incubated in either 21% or 0%
oxygen for the entire duration of the experiment. Data are expressed as the mean ±
SEM from n=4 separate experiments each performed in triplicate and is shown on 3
graphs for reasons of clarity.
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constitutive cell death even when introduced relatively late (e.g. After 3-15 hours of
normoxic incubation) and at a time when an exponential increase in apoptosis is
occurring. By 18 hours, however, the rate of constitutive apoptosis begins to plateau
in the 21% O2 control cells and, thus, it was not possible to see any effect on the rate
of apoptosis in cells that were made hypoxic at 18 hours or more into the experiment.
These results suggest that hypoxia can provide some protection against apoptosis in
neutrophils even after prolonged incubation in 21% O2.
3.2.6 Effect of re-oxygenation on neutrophil apoptosis
We also examined the effect of returning hypoxia-treated neutrophils to a normoxic
environment. As an initial experiment neutrophils were incubated under anoxic
conditions for 20 hours, at which point they were transferred to an atmosphere
containing 21% oxygen. The rate of apoptosis of these cells was then assessed for
the following 13 hours in parallel with control cells that remained under normoxic
and hypoxic conditions throughout the experiment. Over this subsequent time
period, the rate of apoptosis of the 0% —>21% (re-oxygenated) neutrophils was very
similar to that seen in the cells maintained at 0% O2 throughout the experiment
(figure 3.2.6.1). These data indicate that after a prolonged hypoxic incubation period
(20 hours) neutrophils remain resistant to spontaneous apoptosis for a significant
period of time. To clarify further this observation and define the minimum initial
hypoxic period required to delay or inhibit neutrophil apoptosis, we investigated
whether shorter periods of hypoxia could generate a similar effect. These
experiments are essentially the reverse of those described in section 3.2.5.
Neutrophils were incubated for 3, 6, 9, 12, 15, 18 or 21 hours in 0% oxygen prior to
transfer to normoxic conditions for the remainder of the 24 hour experiment and the
corresponding rates of apoptosis assessed (figure 3.2.6.2). These data demonstrated
that cells returned to a normoxic environment after an initial hypoxic incubation of 3-
15 hours entered a normal rapid sigmoid increase in apoptosis, identical to that
observed at earlier times in normoxic treated cells. Hence cells incubated for up to
15 hours under anoxic conditions did not lose their apoptotic potential or undergo
apoptosis at an increased rate when returned to a normoxic environment. Thus, it
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Figure 3.2.6.1 The effect of re-oxygenation on neutrophil apoptosis.
Neutrophils (5 x 106/ml) were incubated in 0% oxygen for 20 hours and then
transferred to an atmosphere containing 21% oxygen. The rate of apoptosis of these
cells was assessed over a subsequent 13 hour time period using the method described
in figure 3.2.1. Control cells were kept in 21% or 0% oxygen for the duration of the
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Figure 3.2.6.2 The effect of re-oxygenation on neutrophil apoptosis.
This experiment is the reverse of that shown in figure 3.2.5. Neutrophils (5 x 106/ml)
were incubated in 0% oxygen for increasing amounts of time before being
transferred to a normoxic environment and the rate of apoptosis assessed over a 24
hour period. Control cells were incubated in 21% and 0% oxygen for the entire
duration of the experiment. Data are expressed as the mean ± SEM from n=4
separate experiments each performed in triplicate and is shown on 3 graphs for
reasons of clarity.
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In the above experiments we have shown by several well established methods that
hypoxia profoundly inhibits the rate of constitutive neutrophil apoptosis in vitro.
These findings are in complete contrast to those of Jacobson and Raff (1995) and
Shimizu et al (1995) who have demonstrated that hypoxia induces apoptosis in SV-
40 transformed human fibroblasts (that lacked mitochondria) and a rat
pheochromocytoma cell line, respectively. A similar induction of apoptosis by
hypoxia has now been reported in WEHI 7.1 T-lymphoma cells (Muschel et al.,
1995), thymocytes (Steffanelli et al., 1995), neonatal rat cardiomyocytes (Tanaka et
al., 1994), the human breast cancer cell line MCF-7 (Amellem et al., 1997), human
adenocarcinoma HT29 cells (Yao et al., 1995), PC-12 cells (Yoshimura et al., 1998),
sympathetic neurons (Rosenbaum et al., 1994) and cultured hepatocytes (Shimizu et
al., 1996).
Despite such observations, there are clearly a number of instances in vivo where a
hypoxic environment appears to play a role in protecting cells against PCD. For
example, hypoxic regions are a common feature of solid tumours (Moulder and
Rowckwell, 1984; Vaupel et al., 1991); this is due to certain features of tumour
physiology including limited arteriolar supply causing arteriolar deoxygenation
(Dewhirst et al., 1996), relatively low vascular density and disorderly vascular
architecture (Secomb et al., 1993), oxygen consumption rates that are mis-matched
with oxygen supply (Secomb et ah, 1995) and an unstable blood supply (Kimura et
al., 1996). Although hypoxia has been shown to induce apoptosis in a number of
tumour cells when studied in monolayer culture (Yao et al., 1995; Shimizu et al.,
1995), cells in hypoxic regions of tumours appear to be more resistant than their
normoxic counterparts to the effects of radiotherapy and conventional
chemotherapeutic agents (for review see Teicher, 1994) and this factor is thought to
contribute importantly to disease relapse.
Hypoxia has also been shown to protect against dexamethasone and calcium
ionophore (A23187) induced apoptosis in thymocytes, although over longer periods
hypoxia itself induces apoptosis in this cell type (Stefanelli et al., 1995). These
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experiments are in agreement with the findings of Matthews et al. (1987) and Shen et
al. (1987) who found hypoxia inhibited both TNFa cytolysis of L929 cells and
doxorubicin mediated cytotoxicity in Chinese hamster ovary cells respectively.
Thus, two seemingly opposing effects of hypoxia exist, one protective and the other
inducing cell death.
An interesting anomaly of the experiments shown above was that the pC>2 of the
medium failed to reflect the atmospheric oxygen content. When an atmosphere
containing 2.5% oxygen was used the corresponding pC>2 of the medium was
approximately 9 kPa, while an anaerobic atmosphere only reduced the medium pC>2
to 3.3 kPa. The anaerobic incubator used (MK3, Don Whitley Scientific Ltd., UK)
incorporates a nickel catalyst to ensure a constant oxygen content of 0-0.1 kPa and
this is monitored constantly by assessing the growth of organisms within the
incubator that are strict facultative anaerobes. It is possible that the blood-gas
analyser used to measure the medium pC>2 was inaccurate or poorly calibrated at such
low pC>2 values, however, similar results were obtained using an independent oxygen
electrode (World Precision Instruments Inc., USA; data not shown) making these
unlikely explanations. Thus it would appear that even under protracted anaerobic
conditions the medium does not equilibrate fully with the atmosphere.
In order to assess the relevance of these findings to in vivo situations it is necessary
to compare these pC>2 values with both physiological and pathophysiological values.
Cells are routinely cultured in atmospheric oxygen (the pCf of dry air at sea level is
21.2 kPa), however, this level of oxygen is clearly 'supra' physiological with
reference to tissue levels. Maximum arterial pC>2 levels found in the body are
approximately 13 kPa. These values are found in the lung and large arteries.
However, as the majority of inflammatory sites are extrapulmonary, it is ofmore
relevance to look at tissue pCU As discussed in section 1.3.3, there are several ways
ofmeasuring tissue pC>2, however, these are all open to criticism, mainly that tissue
pC>2 is not uniform. In general, tissue pC>2 lies in the range of 1.3-6.7 kPa, although
in certain physiological and pathological states tissue pC>2 will be further reduced.
For example, a significant proportion of any injured tissue exists in conditions of
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very low O2 tension as the injury has, by definition, destroyed or interrupted the local
circulation. Attempts at measuring wound deadspace pC>2 have given values of 0.8
and 1.5 kPa (Niikinski et al., 1972; Hunt et al., 1967). Other pathologic conditions
that produce localised regions of hypoxia include myocardial infarction and
rheumatoid arthritis. In a dog model ofmyocardial infarction, occlusion of the left
anterior descending artery caused a rapid drop of myocardial tissue p02 to a mean
level of 0.3 ± 0.1 kPa (Feola et al., 1979). The pC>2 of synovial fluid taken from
rheumatoid arthritis patients has also been quantified and shown to be significantly
lower than that of control (non-rheumatoid) synovial fluid values (3.8 kPa versus 6.7
kPa) (Ellis et al., 1994). Diseases which are associated with more generalised
hypoxaemia and tissue hypoxia include lung disease such as ARDS and
endotoxaemia. Indeed multiple organ failure (MOF), which often occurs
concomitantly with ARDS and sepsis, and is at least partially responsible for the
poor prognosis associated with these diseases, has been proposed to be caused in part
by tissue hypoxia.
Thus, the pC>2 levels used in our experiments can be considered to fall in the range
relevant to in vivo oxygen tensions. The pC>2 of the medium incubated in 0% oxygen
(3.3 kPa) lies in the lower region of some tissue pC>2 values but corresponds to that of
hypoxia in other tissues and the medium incubated in 2.5% oxygen (9 kPa) is close
to the pC>2 of arterial blood. Our results, showing that these levels of p02
significantly inhibit neutrophil apoptosis compared to cells cultured in 21% oxygen,
imply that examination of apoptosis under routine (21% O2) culture conditions
represents a relative hyperoxic challenge and may alter the susceptibility of cells to
apoptosis and does not accurately reflect the O2 environment in vivo. In addition,
pathological studies have suggested that neutrophils may remain viable for
considerably longer periods when recruited to an inflammatory focus (e.g. an
emphysema cavity) where there is local and often systemic hypoxia. The effect of
extreme tissue hypoxia on neutrophil survival that would delay their removal, could
potentially exacerbate the disease state and result in additional neutrophil-mediated
tissue destruction. Although neutrophils have been shown to phagocytose normally
under anaerobic conditions (Sbarra and Karnovsky, 1959) it might be expected that
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the respiratory burst, which is necessary for the effective killing of certain
microorganisms (Mandell, 1974), would also be inhibited under these conditions.
However, Gabig and co-workers (1979) have demonstrated that neutrophils have the
capacity to mount a nearly normal respiratory burst at oxygen tensions down to 1
kPa, suggesting that not only do neutrophils live longer under hypoxic conditions but
that they also remain fully functional.
We have also described the kinetics of hypoxia-mediated survival of neutrophils.
The ability of hypoxia to protect neutrophils from apoptosis after they had been
cultured in 21% O2 for time points up to, and including, 15 hours implies that
hypoxia can inhibit neutrophil apoptosis even in aged cells and, hence, is similar to
the apoptosis protection effects of other agents such as GM-CSF (S. Hannah,
personal communications). More importantly, we also found that when neutrophils
were returned to a normoxic environment after a lengthy hypoxic incubation they
lost their apoptotic potential for a considerable time period thereafter. While,
following shorter hypoxic incubations, neutrophils underwent apoptosis at rates
similar to those observed in control cells. In many other cell types re-oxygenation
after a hypoxic period induces cell death both by necrosis and apoptosis (Shimizu et
al., 1996; Van Der Laarse et al., 1979; Halsey et al., 1991; Iwata et ak, 1994; Vogt et
ak, 1998; Bossenmeyer et ak, 1998), however, the resistance of neutrophils to cell
death following re-oxygenation may be of relevance to the pathophysiology of
ischaemia-reperfusion injury. Ischaemia is a common clinical event in a number of
organs with potentially serious consequences. Evidence suggests that a major part of
tissue injury occurs upon reperfusion and the neutrophil has been heavily implicated
as contributing significantly to this damage (Welbourn et ak, 1991). A great deal of
the evidence for the role of neutrophils in reperfusion injury has come from cardiac
studies, however, this phenomenon has also been observed in other organs. For
example, in a rat model of hepatic ischaemia and reperfusion, pre-treatment with a
mAb to neutrophils resulted in an 86% decrease in the accumulation of these
leukocytes in the affected lobe. This was accompanied by a significant attenuation in
tissue necrosis, measured after 24 hours of reperfusion, from 80% in controls to 28%
in the treated groups (Jaeschke et ak, 1990). Similarly, in a model of renal ischaemia
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and reperfusion in rats, administration of an anti-neutrophil serum resulted in a
reduction in both creatinine levels and tubular necrosis (Klausner et al., 1989). Thus,
the relative resistance of neutrophils themselves to re-oxygenation-mediated cell
death may underlie their destructive potential in reperfused tissues.
Hypoxia has also been reported to modulate neutrophil receptor expression and, thus,
potentially alter cellular functions and responses to inflammatory cytokines.
Knowles and co-workers (1997) have reported that hypoxia increases whole blood
neutrophil phagocytosis in the presence of IL-8, TNFa and IL-1 p compared to
normoxic, control cells and, furthermore, that this enhanced phagocytosis was due to
increased expression of certain complement and/or FcyR receptors. Similarly,
Scanned and colleagues (1995) have reported increased expression of the leukocyte
adhesion molecules CD1 lb/CD 18 on hypoxic whole blood neutrophils and, in
addition, demonstrated an augmented LPS-induced upregulation of these molecules
following hypoxia. Contrary to these findings in whole blood, Simms and D'Amico
(1993) reported that hypoxia reduced isolated neutrophil FcyR III (CD16) and FcyR
II (CD32) expression, while having no effect on complement receptor type 1 (CD35)
and CD1 lb/CD18 expression. However, adherence of neutrophils in the presence of
the Arg-Gly-Asp-Ser (RGDS)-binding epitope of fibronectin was found to
significantly restore neutrophil FcyR II and FcyR III expression in the presence of
hypoxia. Neutrophils have also been reported to upregulate IL-1 P type 1 R, TNFaR
(p75) and IL-8R expression in response to hypoxia (Simms and D' Amico, 1996).
Interestingly, this response was abrogated when the neutrophils were bound to the
matrix proteins, fibronectin and laminin. The same study also found that, although
no change in receptor expression on unbound neutrophils was observed following
hypoxia/reoxygenation, this treatment caused cells adhered to laminin or fibronectin
to upregulate TNFa (p55 and p75) and IL-8 expression. It would thus appear that
hypoxia not only has the potential to affect expression of neutrophil cytokine
receptors and cell surface receptors that mediate cell adherence, bactericidal activity
and activation state but, in addition, that the effect ofmatrix proteins on these cell
surface molecules is also potentially regulated by oxygen tension.
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It is important to note that hypoxia and/or hypoxia-re-oxygenation have several other
potential pro-inflammatory effects. Albina and co-workers (1995) demonstrated that
macrophages grown in an anoxic environment have increased total L-arginine
metabolism, arginase activity and increased release of TNFa and IL-6, suggesting
that anoxia may also act as an inducer of macrophage activation. This proposal is
substantiated by other studies, which have demonstrated an increase in the
production and release of other inflammatory agents from these cells in response to
changes in pC>2. VanOtteren et al. (1995) showed that anoxia followed by re-
oxygenation resulted in the increased expression of both TNFa and macrophage
inflammatory protein-1 alpha (MlP-la) from LPS stimulated alveolar macrophages.
Naldini and co-workers (1997) showed that hypoxia increased IL-2, IL-4 and
interferon (IFN)-y production in human peripheral mononuclear cells, and Metinko et
al. (1992) demonstrated that anoxic pre-treatment ofmonocytes primed them for
augmented production of IL-8. Finally, hypoxia has been reported to increase LPS-
induced release of IL-1 and TNFa from alveolar macrophages (Hempel et al., 1996).
Many of these substances are chemotactic for and/or directly activate neutrophils.
For example, TNFa mediates inflammation by co-ordinating leukocyte migration via
the upregulation of endothelial cell and leukocyte adhesion molecules (Strieter et al.,
1989; Ulich et al., 1991; Pober and Cotran, 1991; Nawroth et al., 1986). In addition,
TNFa has been shown to activate multiple cell types including neutrophils,
lymphocytes and monocytes (Wewers et al., 1990; Shalaby et al., 1985; Klebanoff et
al., 1986). MlP-la was initially characterised as having significant neutrophil
activating and chemokinetic properties. While IL-8 interacts with its own specific
neutrophil receptor to induce motility (chemokinesis), directional migration
(chemotaxis), exocytosis of storage enzymes, NADPH oxidase priming and
activation and expression of the leukocyte integrin CD1 lb/CD 18 complex. Its
biological activity is maintained in the presence of significant changes in pH, and is
relatively resistant to proteolysis and denaturation as compared to other known
chemotactic factors (Matsushima and Oppenheim, 1989; Baggiolini et al., 1989;
Westwick et al.. 1989). The early and sustained generation and stability of IL-8
suggests that its production at sites of acute inflammation may result in prolonged
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biological activity, making it a pivotal cytokine in acute neutrophil-mediated disease
states.
Macrophages are not the only cells that have been shown to release pro¬
inflammatory agents in response to changes in pC>2 tension. Endothelial cells have
been reported to generate PAF (Milhoan et ah, 1992) and IL-8 (Pober and Cotran,
1991) following a hypoxic challenge. H2O2, a product of the endothelial xanthine
oxidase enzyme system (Welbourn et ah, 1991), is also upregulated following
hypoxia and re-oxygenation and this molecule is also capable of causing neutrophil
activation. Indeed, a stimulation of neutrophil phagocytosis and chemotaxis has been
observed when these cells were cultured with serum from tissue exposed to severe
ischaemia (Freischlag and Flanna, 1992). Hypoxia-treated endothelial cells have also
been shown to stimulate human neutrophils to produce superoxide anions and
leukotriene B4 (FTB4) (Arnould et ah, 1994). However, this activation by hypoxic
endothelial cells required close contact between both cell types, as conditioned
medium from hypoxic cells alone was not able to induce neutrophil activation.
A further and important pathophysiological effect of ischaemia and reperfusion is a
rapid and sustained elevation of neutrophil adhesion to vascular endothelium.
Rainger et al. (1995) found that adhesion of neutrophils to endothelial cells was time-
dependent with 30, 60 and 100 min of exposure causing graded increments in
neutrophil recruitment. In vitro studies of the effects of endothelial cell hypoxia and
reoxygenation have shown that the enhanced neutrophil adhesion is susceptible to
blockade by antibodies against CD 18, ICAM-1 and P-selectin (Arnould et ah, 1993;
Yoshida et ah, 1992). The report that hypoxia increases the expression of neutrophil
adhesion molecules CD1 lb/CD 18 (Scandell et ah, 1995) is in accordance with this,
however, production of PAF by endothelial cells has also been implicated in this
mechanism (Milhoan et al., 1992).
Thus it appears that hypoxia is capable of causing a plethora of cellular responses,
which favour neutrophil margination, recruitment and activation within tissues. The
ability of hypoxia to dramatically enhance the neutrophil's life span is a further
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factor that may enable us to explain the often severe tissue destruction associated
with inflammatory foci that are known to possess a low pC>2 and redox potential.
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CHAPTER 4
INTRACELLULAR SIGNALLING PATHWAYS IN THE INHIBITION OF
NEUTROPHIL APOPTOSIS BY HYPOXIA
4.1 Introduction
In the previous chapter we established and characterised the ability of hypoxia to
profoundly inhibit neutrophil apoptosis. This inhibitory effect of hypoxia on
neutrophil apoptosis is opposed to the pro-apoptotic effect of hypoxia in many other
cell types. For example, hypoxia induces apoptosis in cardiomyocytes (Tanaka et ah,
1994), the T-lymphoma cell line, WEH7.1 (Muschel et al., 1995), cultured neurons
(Rosenbaum et al., 1994), adenocarcinoma cells (Yao et al., 1995), macrophage-like
RAW 264.7 cells (Yun et al., 1997) and transformed rat fibroblasts (Graeber et al.,
1996). However, hypoxia has also been shown to inhibit several forms of stimulus-
induced cell death, namely TNFa-mediated cytolysis of L929 cells (Matthews et al.,
1987), dexamethasone-induced apoptosis in rat thymocytes (though prolonged
hypoxia still induces spontaneous apoptosis in this cell type) (Stefanelli et al., 1995)
and doxorubicin (an anthracycline cytotoxic antibiotic) cytotoxicity in Chinese
hamster ovary cells (Shen et al., 1987). The mechanisms underlying these effects are
not fully elucidated. However, in some cells TNFa acting at the TNFa-receptor
results in a rapid rise in the levels of intracellular reactive oxygen species (ROS)
(Larrick and Wright, 1990; Matthews et al., 1987) and in various cell types TNFa-
mediated apoptosis can be inhibited by antioxidants (Matsuda et al., 1991; Chang et
al., 1992). In addition, cellular sensitivity or resistance to TNFa is correlated with
decreased or increased levels of superoxide dismutase respectively (Hirose et al.,
1993). These findings led to the proposal that hypoxia may be inhibiting TNFa-
induced cytotoxicity via its negative effect on intracellular ROS levels. The
protective effects of antioxidants are not limited to TNFa cytotoxicity; N-acetyl
cysteine (NAC) blocks the induction of apoptosis in thymocytes by T-cell receptor
cross linking, and ionising radiation (McLaughlin et al., 1996); NAC, vitamin C and
trolox protect neurons against apoptosis induced by growth factor deprivation
(Mayer and Noble, 1994); and various antioxidants protect HL-60 cells from UV and
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drug induced apoptosis (Verhaegen et al., 1995). These results may imply that ROS
can activate or trigger apoptosis.
The inhibition of dexamethasone-induced apoptosis in rat thymocytes by hypoxia
can also be mimicked by antioxidants (McLaughlin et al., 1996). However, more
recent experiments have shown that ATP depletion can also inhibit apoptosis in this
system and that ATP is required for glucocorticoid binding (Stefanelli et al., 1997).
Thus, this group proposed that the inhibition of dexamethasone-induced apoptosis by
hypoxia is due to the adverse effect of hypoxia on intracellular ATP pools and not
ROS levels. A recent review has proposed the cellular ATP level as an important
determinant for cell death (Richter et al., 1996). It has been shown that, in growth
factor-dependant neural and haematopoetic cells, ATP levels decreased after growth
factor withdrawal (Mills et al., 1995; Whetton and Dexter, 1983). However, viability
and proliferation potential were maintained in the presence of an ATP-regenerating
system (Whetton and Dexter, 1983). In contrast, Chou and co-workers (1995)
demonstrated that reduction of intracellular ATP blocks actinomycin D-induced
apoptotic cell death. Likewise, Eguchi et al. (1997) showed that ATP depletion,
induced with an inhibitor ofmitochondrial ATPase, completely blocks Fas/APO-1
stimulated apoptosis.
The increased resistance of Chinese hamster ovary cells to doxorubicin by hypoxia
has been associated with the induction of the glucose-regulated protein (GRP) system
(Shen et al., 1987). Glucose deprivation is the most common stimulus used to induce
the GRP response, however, in addition to glucose deprivation this system can also
be induced by 2-deoxyglucose, the calcium ionophore A23187 and chronic hypoxia.
Shen et al. (1987) showed that all these stimuli concomitantly stimulated the GRP
response and led to cellular resistance to doxorubicin. It is notable that, in this
system, hypoxia proved the strongest inducer ofGRPs and provided the greatest
protection against doxorubicin. The GRP system represents a subset of a group of
stress proteins that includes the major heat shock proteins (HSPs). In the case of the
HSPs, it has been shown that the application ofHSP-inducing stress results in the
expression of a heat-resistance state referred to as thermotolerance. However, as
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well as playing a role in protecting cells from elevated temperatures, the HSPs,
particularly Hsp 70 and Hsp 27, have also been demonstrated to protect against
apoptosis induced by various stimuli, including serum withdrawal (Mailhos et ah,
1993), Fas/APO-1, staurosporine (Mehlen et al., 1996), doxorubicin (Oesterreich et
ah, 1993) and LPS (Wong et al., 1996). In addition, Hsp 70 has been postulated as a
factor that may limit cell damage during myocardial and cerebral ischaemia (Dillman
et al., 1986; Kawagoe et al., 1992). Hypoxia has been shown to induce Hsp 70
expression in cultured cells (Benjamin et al., 1990), although in macrophage like cell
lines the same stimulus caused a decrease in constitutive Hsp 70 (Hsc 70) levels, an
effect that was linked to hypoxia-induced apoptosis (Yun et al., 1997). These data
suggest that hypoxia may have different effects on HSP expression depending on the
cell type.
Another pathway that has a potential role in apoptosis and may be induced by
hypoxia is the p38 mitogen-activated protein (MAP) kinase pathway. The family of
p38 MAP kinases is a recently identified group of signalling molecules that mediate
environmental stress responses in various cell types. The p38 MAP kinase activity is
activated by dual phosphorylation on a Thr-Gly-Tyr motif in response to endotoxin,
cytokines, physical stress (such as hyperosmolarity), chemical stress (such as
hydrogen peroxide) (Han et al., 1993; Han et al., 1994; Raingeaud et al., 1995; Rouse
et al., 1994; Freshney et al., 1994; Lee et al., 1994) and, although less well
characterised, hypoxia (Seko et al., 1997). In neutrophils, p38 activity has been
demonstrated upon stimulation with certain inflammatory mediators (Nahas et al.,
1996) and appears to play a role in neutrophil activation (Schnyder et al., 1998; Zu et
al., 1998). In other cells, p38 MAP kinases have been implicated in gene regulation
(Tan et al., 1996; Wang and Ron, 1996), morphological alterations (Lin et al., 1997;
Lavoie et al., 1993) and have been suggested to play a role in the regulation of
apoptosis (Batistatou et al., 1993; Pittman et al., 1993; Kummer et al., 1997). For
example, p38 inhibitors inhibit glutamate-induced apoptosis in cerebellar granular
cells (Kawasaki et al., 1997), while activation of p38 was shown to protect against
anisomycin-induced cell death in cardiac myocytes (Zechner et al., 1998), suggesting
the effect of p38 MAP kinase on apoptosis may be cell type-dependent.
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Although the molecular and biochemical events underlying apoptosis remain to be
fully elucidated, there are several factors that appear to be common to most models
of apoptosis. Firstly, the bcl-2 oncogene (the mammalian homologue of the ced-9
gene in C. elegans) and other members of the bcl-2 family have been shown to
inhibit stimulus-induced cell death in a variety of cell types. Transgene-enforced
overexpression of Bcl-2 and Bcl-XL have demonstrated the capacity of these
proteins to confer apoptotic resistance to a number of different cells and tissues
including lymphocytes (McDonnell et ah, 1989; Strasser et ah, 1991), neurons
(Martinou et ah, 1994), hepatocytes (Lacronique et ah, 1996), prostrate endothelium
(Zhang et ah, 1997) and ovary follicles (Hsu et ah, 1996). Cell culture studies have
shown Bcl-2 and Bcl-XL to protect cells from a range of stimuli, including hypoxia
(Jacobson and Raff, 1995), ultraviolet irradiation (Zhai et ah, 1996), p53 (Schott et
ah, 1995), growth factor withdrawal (Farlie et ah, 1995), nitric oxide (Messmer et ah,
1996), hydrogen peroxide (Satoh et ah, 1996) and stimulation with Fas-L (Zhang et
ah, 1996). Secondly, dissipation of the mitochondrial transmembrane potential
(A\|/m), a characteristic ofmitochondrial dysfunction, appears to be a general feature
of apoptosis, irrespective of the cell type or apoptotic stimulus. In addition,
pharmacological or genetic manipulations that prevent apoptosis also abolish the
Av|/m disruption that usually precedes cell death (for review see Kroemer et ah, 1998).
Mitochondrial dysfunction and dissipation of the Avj/m are also associated with an
inhibition ofATP generation and mitochondrial calcium handling, an increased level
ofmitochondrial ROS generation and the release of apoptosis inducing factor-1
(AIF-1) and cytochrome c. Thus, although there is strong evidence that
mitochondria play a key role in regulating the apoptotic pathway, the precise
involvement of each of these factors is unclear.
Hypoxia is not the only factor capable of inhibiting neutrophil apoptosis. A wide
range of inflammatory mediators including IL-1 (3, TNFa, IL-6, G-CSF and GM-
CSF, the bacterial product LPS and the chemoattractant C5a have all been shown to
increase the life span of the neutrophil by attenuating apoptosis (Colotta et ah, 1992a;
Lee et ah, 1993). While the intracellular mechanisms underlying these effects are
poorly understood, there are data to support a role for tyrosine phosphorylation and
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intracellular acidification in GM-CSF/LPS and G-CSF-mediated inhibition of cell
death respectively (Yousefi et al., 1994; Sweeny et al., 1998, Gottlieb et al., 1995).
Prevention of neutrophil apoptosis by GM-CSF has also been associated with
induction ofRNA and protein synthesis and the RNA and protein synthesis
inhibitors, actinomycin D and cycloheximide have been shown to impede GM-CSF
mediated protection (Brach et al., 1992).
In this study we have investigated the signalling pathway(s) underlying the protective
effect of hypoxia on neutrophil apoptosis by examining:
(1) whether hypoxia acts through a similar mechanism to other agents known to
promote neutrophil survival,
(2) whether factors common to other models of apoptosis could be involved, and
(3) the role of other pathways, which have been reported in the literature to be
regulated by hypoxia and are capable of modulating apoptosis in other cell types.
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4.2 Results
4.2.1. Modulation of the GM-CSF survival effect in neutrophils by hypoxia
It is now well documented that several inflammatory cytokines are capable of
modulating the life span of the neutrophil. One such cytokine is GM-CSF, which has
been shown to inhibit neutrophil apoptosis (Lee et al., 1993). In view of this, the
possibility that the inhibitory effects of hypoxia and GM-CSF were mediated by a
common mechanism or that hypoxia stimulated GM-CSF production from either the
neutrophils themselves (Lindemann et al., 1989) or the small numbers of
'contaminating' monocytes (< 0.1%) present in the neutrophil preparations was
investigated. Neutrophils were incubated with GM-CSF (50 U/ml) for 20 hours in
atmospheres containing 21%, 2.5% or 0% oxygen. These experiments demonstrated
that the GM-CSF- and hypoxia-mediated survival of neutrophils were clearly
additive (figure 4.2.1), suggesting that the hypoxia and GM-CSF effects are discrete
and act via independent mechanisms.
4.2.2 Effect ofhypoxic culture on Bcl-2 expression in neutrophils
Studies on the nematode, C. elegans, have shown that individual cell survival is
signalled by the gene, ced-9 (Hengartner et al., 1992). The mammalian homologue
of the Ced-9 protein is Bcl-2 (Hengartner et al., 1994), which is capable of causing
survival of a number of cell lines and B-lymphocytes (Reed et al., 1987; Nunez et al.,
1990). The possibility that the protective effect of hypoxia was mediated by an
increase in Bcl-2 gene expression was examined by taking fixed, permeabilized cells
that had been previously incubated in atmospheres containing 21% or 0% oxygen
and measuring Bcl-2 levels in these cells using an anti-Bcl-2 mAb and flow
cytometry. MAC 387, which recognises an intracellular antigen in neutrophils, was
used to confirm efficient permeabilization of the neutrophils (relative mean
fluorescence > 50). Neither control nor hypoxia-treated neutrophils expressed Bcl-2
(table 4.2.2). Thus, it is unlikely that the enhanced survival of neutrophils under
hypoxic conditions was Bcl-2 related. The Bcl-2 protein was also not present in
neutrophils treated with other agents known to effect neutrophil apoptosis, namely
TNFa and GM-CSF, both alone or in conjunction with hypoxia (table 4.2.2). These






Figure 4.2.1 Modulation of the GM-CSF survival effect in neutrophils by
hypoxia. Neutrophils were incubated with GM-CSF (50 U/ml) for 20 hours in
atmospheres containing 21%, 2.5% or 0% oxygen. Control cells were incubated
under the same conditions but in the absence of cytokine. Apoptosis was assessed
morphologically on cytospins. The data are expressed as the mean ± SEM of n = 5
separate experiments, each performed in triplicate. Under each oxygen condition
tested, the addition ofGM-CSF caused a significant inhibition of apoptosis (P<0.05).
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6 hrs control 6 hrs + TNFa 20 hrs control 20 hrs + GM-CSF
21% Oxygen 1.08 ±0.12 1.11 ±0.12 1.09 ±0.12 1.01 ±0.01
0% Oxygen 1.17 ± 0.17 1.08 ±0.08 1.14 ± 0.14 1.01 ±0.24
Table 4.2.2 Bcl-2 production by neutrophils in response to 6 or 20 hours and/or
TNFa or GM-CSF treatment. Neutrophils were incubated in the presence or
absence of TNFa (12.5 ng/ml) for 6 hours or GM-CSF (50 U/ml) for 20 hours in
atmospheres containing 0% or 21% oxygen. The amount of Bcl-2 in the cells, once
permeabilized, was measured by flow cytometry as detailed in the methods section
and expressed as mean fluorescence relative to the negative control (MOPC21
antibody). In all cases, Bcl-2 could not be detected in the neutrophils. HL-60 cells,
which are known to express Bcl-2, were used as a positive control (relative mean
fluorescence = 4.43). MAC 387, which recognises an intracellular antigen in
neutrophils, was used to confirm the efficient permeabilization of the neutrophils
(relative mean fluorescence > 50).
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(Hockenbery et al., 1991). HL-60 cells which are known to produce Bcl-2 were used
as a positive control (relative mean fluorescence = 4.43 ±0.91) as opposed to
untreated neutrophils at time 0 (relative mean fluorescence = 1.07 ± 0.08).
4.2.3 Effect ofantioxidants on neutrophil apoptosis
To examine whether the effect of hypoxia was mediated solely by the inhibition of
ROS generation, the effect of exogenous addition of the anti-oxidant enzymes, SOD
and catalase, and methionine, an essential thiol containing amino acid, on neutrophil
apoptosis was investigated. Under normoxic (21% oxygen) conditions methionine (5
mM) and SOD (200 pg/ml) did not influence the rate of constitutive neutrophil
apoptosis at 20 hours (figure 4.2.3A), suggesting that hypochlorous and superoxide
radicals do not play a significant role in regulating neutrophil apoptosis. In contrast,
catalase (250 pg/ml), both alone and in combination with SOD, caused a significant
inhibition of neutrophil apoptosis at 20 hours (figure 4.2.3A). It is probable,
however, that this effect of catalase is non-specific and independent of its effect on
hydrogen peroxide levels since when neutrophils were incubated in the presence or
absence of 250 pg/ml catalase in atmospheres containing 21% or 0% oxygen for 20
hours the anti-apoptotic effect of catalase was still present in 0% oxygen (figure
4.2.3B).
4.2.4 Role ofp38 MAP kinase in hypoxic-mediated inhibition ofneutrophil
apoptosis
The potential role of the MAP kinase cascade in mediating the anti-apoptotic effect
of hypoxia on neutrophils was examined by incubating cells with SB 203580 (20
pM), a specific inhibitor of p38 kinase (Lee et al., 1994), under both hypoxic and
normoxic conditions. SB 203580 was originally discovered as an inhibitor of LPS-
induced cytokine (IL-1 and TNFa) synthesis in THP-1 monocytes (IC50 1 pM) (Lee
et al., 1994) and was subsequently shown to inhibit LPS-induced activation of
MAPKAP kinase-2, the physiological substrate for p38 kinase (IC50 0.6 pM).
SB203580 has also been shown to prevent the phosphorylation ofHsp 27 in response
to IL-1, cellular stress and LPS in KB and PC-12 cells (Cuenda et al., 1995) and
















Figure 4.2.3 Effect of antioxidants on neutrophil apoptosis. (A) Neutrophils
(5xl06/ml) were cultured under normoxic (21% oxygen) conditions for 6 or 20 hours
in the presence of 200 pg/ml SOD, 250 pg/ml catalase, 200 pg/ml SOD and 250
pg/ml catalase or 5 mM methionine. Control untreated neutrophils were also
prepared. (B) Neutrophils (5xl06/ml) were cultured for 6 or 20 hours in either
normoxic or hypoxic conditions in the presence or absence of 250 pg/ml catalase.
Apoptosis was assessed morphologically. Data represent mean ± SEM of n = 3




Figure 4.2.4 The role of p38 MAP kinase in hypoxia-mediated inhibition of
neutrophil apoptosis. Human neutrophils (5xl06/ml) were incubated in the presence
and absence of 20pM of the p38 MAP kinase inhibitor (SB 203580) in atmospheres
containing 21% or 0% oxygen. Data represent mean ± SEM of n = 3 separate
experiments, each performed in triplicate (*p<0.05).
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1997). The presence of p38 MAP kinase in neutrophils, and the ability of SB 203580
to inhibit this activity, was confirmed by assessing MAPKAP kinase-2 activity in
neutrophil lysates (Stokoe et al., 1993). These experiments, performed by Dr. A Paul
(University of Strathclyde), used neutrophils prepared in the Rayne lab and
demonstrated both basal and TNFa and sorbitol-stimulated MAPKAP kinase-2
activity (a specific and immediate target of p38 MAP kinase) (data not shown).
Incubation of neutrophils with SB 203580 (20 pM), while having no effect on the
extent of constitutive apoptosis at 20 hours, partially inhibited the anti-apoptotic
effect of hypoxia, although this effect was not significant (p<0.05) (figure 4.2.4).
These data suggest that p38 MAP kinase activation does not play a major role in
hypoxic-mediated inhibition of neutrophil apoptosis.
4.2.5 Effect ofglucose deprivation on neutrophil apoptosis
To address whether the protective effect of hypoxia in neutrophils involves depletion
of intracellular ATP pools, the ability of protracted glucose deprivation to mimic this
response was examined. Neutrophils were cultured in a glucose and sodium
pyruvate free medium, conditions which have been shown to rapidly decrease
intracellular ATP levels in MCF-7/ADR cells (Lee et al., 1997). Glucose has also
been implicated in inducing cell death through a free radical-mediated mechanism
(Donnini et al., 1996). Thus, to investigate whether glucose levels affect neutrophil
apoptosis, an additional high glucose condition (10 g/L, 50 mM glucose) was also
included in the experiment. Control cells were incubated in medium containing 4.5
g/L (25 mM) glucose. In these experiments all media (high glucose, control and
glucose-free) was supplemented with 10% dialysed (glucose-free) fetal calf serum
(FCS) in place of autologous serum. This substitution caused a reduction in the
control basal rate of apoptosis (autologous serum 42.4 ± 8.2 vs FCS 28.3 ± 8.55),
however the hypoxic inhibitory effect was uninfluenced. Neutrophils were then
incubated under normoxic or hypoxic conditions for 20 hours. To verify that the
glucose contents of these media did vary significantly, their glucose contents were
analysed using a Randox glucose test. This assay was performed by Clinical
Biochemistry (Edinburgh Royal Infirmary). The control medium was found to
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Figure 4.2.5 Effect of glucose deprivation on neutrophil apoptosis. Neutrophils
(5xl06/ml) were cultured under normoxic or hypoxic conditions for 20 hours in
either normal Iscove's MDM (4.5 g/L glucose) (control), Iscove's DMEM without
glucose or sodium pyruvate (w/o glucose) or Iscove's containing 10 g/L glucose
(high glucose). In all the conditions the Iscove's was supplemented with 10%
dialysed (glucose free) fetal calf serum. Apoptosis was assessed morphologically.
The data are expressed as the mean ± SEM of n = 4 separate experiments each
performed in triplicate.
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glucose medium >41 mM glucose. These measurements also confirm the absence of
detectable glucose in the dialysed FCS. The concentration of glucose in the culture
medium had no effect on the rate of neutrophil apoptosis under either 21% or 0%
oxygen (figure 4.2.5). Although not measured directly, these data suggest that
intracellular ATP levels do not affect neutrophil apoptosis and that the hypoxic
protective effect is not caused by depletion of intracellular ATP pools. In addition,
as the rate of neutrophil apoptosis did not increase under high glucose conditions,
these findings imply that the generation of free radicals by auto-oxidation of glucose,
likewise, is not a contributing factor to constitutive neutrophil apoptosis.
4.2.6 Effect ofheat shock on neutrophil apoptosis
In a number of studies upregulation of the heat shock proteins (HSPs), especially
Hsp 70 and Hsp 27, have been associated with an increased resistance to apoptotic
stimuli. For example, WEHI-s cells overexpressing Hsps 27 and 70 showed an
increased resistance to apoptosis inducing agents, such as actinomycin D and
etoposide (Samali and Cotter, 1996), and constitutive expression of Hsp 27 in murine
L929 cells blocked Fas/APO-1 mediated programmed cell death (Mehlen et al.,
1996). In view of these reports, and the fact that hypoxia has been reported to cause
activation of the heat shock transcription factor in mammalian cells (Benjamin et al.,
1990), the possible role ofHSPs in hypoxic inhibition of apoptosis was investigated.
Our initial protocol for induction ofHSPs involved incubating cells at either 42°C or
4°C for one hour, after which time they were returned to 37°C. Both these
treatments have previously been shown to induce Hsp 70 expression in human
neutrophils (Eid et al. 1987 and Cox et al., 1993). Control cells were kept at 37°C
throughout, while hypoxia-treated cells were incubated at 37°C in 0% oxygen. After
5 and 20 hours neutrophils were harvested and the rate of apoptosis assessed
morphologically. Neither the heat shock or cold shock treatments influenced the rate
of neutrophil apoptosis (figure 4.2.6A), although hypoxia did exert its normal
inhibitory effect in the same experiment.
In order to ensure that Hsp proteins were being induced, lysates from identically









Figure 4.2.6A Effect of heat shock on neutrophil apoptosis. Neutrophils
(5xl06/ml) were heat shocked or cold shocked by being placed at 42°C or 4°C
respectively for one hour before being returned to 37°C. Control cells were incubated
at 37°C in 21% oxygen, while hypoxic cells were incubated at 37°C in 0% oxygen.
After 5 and 20 hours cells were harvested, cytospins were prepared and apoptosis
assessed morphologically. Data represent mean ± SEM of n = 7 separate
experiments, each performed in triplicate (*p<0.05 compared with control values).
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Time 0 cells Control cells, 37"C Heat shocked cells, 42°C
1 2 3 4 5 6 7 8 9 10 11 12
86 kDa
51 kDa
Figure 4.2.6B Western blot showing Hsp 70 levels in human neutrophils.
Neutrophil lysates were prepared by either direct lysis in boiling sample buffer (odd
numbered lanes) or a TCA based lysis method (even numbered lanes) and separated
by 10% SDS-PAGE. Western blot was developed with an antibody to Hsp 70. After
isolation neutrophils were either lysed immediately (time 0, lanes 1 and 2) or
incubated in platelet poor plasma, PPP, (37°C, 45 min) before lysing (time 0, PPP,
lanes 3 and 4). Neutrophils with (lanes 7 and 8) or without (lanes 5 and 6) the PPP
incubation were then cultured for 4 hours at 37°C (control). Parallel cells were heat
shocked for 1 hour at 42°C before being returned to 37°C for 3 hours prior to lysing
(lanes 9 and 10 no PPP incubation; lanes 11 and 12 with PPP incubation). Identical
data was obtained in 2 additional experiments.
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Time Control Heat shock Hvnoxia
0 3.44
4 hours 2.91 2.63 2.4





Figure 4.2.6 C and D Flow immunocytometric analysis of Hsp 70 in human
neutrophils. (C) Neutrophils (5xl06/ml) were heat shocked by being placed at 42°C
for one hour before being returned to 37°C. Control cells were incubated at 37°C in
21% oxygen while hypoxic cells were incubated at 37°C in 0% oxygen. At the time
points stated the amount of Hsp 70 was measured as detailed in chapter 2 and is
expressed as mean fluorescence relative to the negative antibody (MOPC) control.
Equal amounts of Hsp 70 were detected under all conditions tested. MAC 387, which
recognises an intracellular antigen in neutrophils, was used to confirm the efficient
permeabilization of the neutrophils (relative mean fluorescence = 25 ± 8). (D)
Representative flow-cytometry (EPICS Profile II) histogram (cell count vs log
fluorescence) showing profile of neutrophils after labelling with MOPC antibody
(negative control, dashed outline) and Hsp 70 antibody (black outline).
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of lysis methods were employed as parallel Commassie blue stained gels
demonstrated inconsistent extraction, and in particular loss of high molecular weight
protein forms, when using standard lysis techniques. These problems occurred
despite inclusion of a broad spectrum of protease inhibitors and may reflect the major
protease content of these cells. Figure 4.2.6B shows a comparison of samples
prepared either by direct lysis into boiling laemmli sample buffer or by a TCA based
method (see chapter 2 for details). Samples were otherwise treated and analysed
identically. Of the various protocols tried, the TCA method produced the best
results, both on Western analysis and on Commassie blue stained gels. These data
show the presence of large amounts of Hsp 70 in neutrophils, even when lysed
immediately after they had been prepared from whole blood (figure 4.2.6B, lane 2),
suggesting that the isolation method itself (even when pre-warmed solutions were
used and dextran sedimentation performed at 37°C) may cause upregulation of this
protein. In an attempt to downregulate HSP expression before commencing the
experiment, neutrophils were incubated in pre-warmed platelet poor plasma (37°C,
45 min) (figure 4.2.6B, lane 4). However, even employing such a 'recovery period',
subsequent heat shocking failed to further upregulate Hsp 70 compared to control
cells at 4 hrs (figure 4.2.6B lanes 6, 8, 10 and 12). This finding is contrary to that
reported by Eid et al. (1987) who found upregulation of Hsp 70 in neutrophils at this
time point after an identical heat shock treatment. Incubating cells under hypoxic
conditions also failed to modulate Hsp 70 expression (data not shown). These
findings were substantiated by flow immunocytometric analysis (figures 4.2.6C and
D), where Hsp 70 was found to be still present at 20 hours in all conditions tested.
The presence of equal amounts ofHsp 70 in neutrophils independent of treatment,
suggests that this protein does not play a role in the modulation of either basal
neutrophil apoptosis or in the inhibition of apoptosis by hypoxia.
4.2.7 Effect ofmitochondrial inhibitors on the rate ofneutrophil apoptosis
To examine whether the inhibition of neutrophil apoptosis by hypoxia was due to an
effect of hypoxia on oxidative phosphorylation, the effect of mitochondrial inhibitors
on the rate of neutrophil apoptosis was investigated. Freshly isolated neutrophils
were treated with 0.1 pg/ml rotenone, 1 mM sodium azide or 1 mM potassium
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Figure 4.2.7 Effect of mitochondrial inhibitors on the rate of neutrophil
apoptosis. Neutrophils (5xl06/ml) were cultured under normoxic or hypoxic
conditions for 20 hours in the presence of 1 mM sodium azide, 1 mM potassium
cyanide and 0.1 pg/ml rotenone. Control, untreated neutrophils were also prepared.
Data represent mean ± SEM of triplicate incubations from a single representative
experiment of 2.
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cyanide and incubated in 21% or 0% oxygen for 20 hours. None of the
mitochondrial inhibitors mimicked or abrogated the action of hypoxia on neutrophil
apoptosis (figure 4.2.7). This lack of effect ofmitochondrial inhibitors implies that
the hypoxic inhibition of neutrophil apoptosis is specific for hypoxia and cannot be
induced by other cellular stresses associated with making the cells hypoxic, namely
the compromise of oxidative metabolism.
4.2.8 The protective effect ofhypoxia on neutrophil apoptosis is cycloheximide-
dependent
To investigate whether the inhibition of neutrophil apoptosis by hypoxia was protein
synthesis dependent, the effect of cycloheximide on this response was studied.
Neutrophils were treated with the protein synthesis inhibitor, cycloheximide (50 pM,
14 pg/ml), and incubated in atmospheres containing either 21% or 0% oxygen for 6
and 20 hours. A more detailed time course over a 24 hour period was also
performed. In agreement with previously published data (Whyte et al., 1997),
incubation of neutrophils with 50 pM cycloheximide significantly increased basal
apoptosis at all time points studied (figures 4.2.8A and B). These data imply that
continuous synthesis of some regulatory protein(s) may be necessary to prevent
neutrophils from undergoing apoptosis. Cycloheximide was also able to override the
protective effect of hypoxia, increasing the levels of apoptosis in hypoxic neutrophils
to those of normoxic, cycloheximide treated cells. Thus, it appears that the
protective effect of hypoxia on neutrophil apoptosis requires de novo protein
synthesis. Recently, it has been reported that the protective effect of dexamethasone
on neutrophil apoptosis can be overcome by a far lower concentration of
cycloheximide that has no effect on basal apoptosis (Cox and Austin, 1996). In view
of this, we investigated whether this was also the case with the hypoxic protective
effect. At doses of 1 pg/ml, a concentration that has been shown to interfere with,
but not abolish, protein synthesis in neutrophils (Cox et al., 1994), cycloheximide did
not alter basal levels of survival over 20 hours (figure 4.2.8C). However, the
increased rate of neutrophil survival observed under hypoxic conditions was
inhibited in a concentration-dependent fashion by co-treatment with cycloheximide



































Figure 4.2.8 The protective effect of hypoxia on neutrophil apoptosis is
cycloheximide-dependent. (A) Neutrophils (5xl06/ml) were cultured in the presence
or absence of cycloheximide (50 pM) in atmospheres containing either 21% or 0%
oxygen for 6 or 20 hrs. Apoptosis was assessed morphologically. Data represent
mean ± SEM of n = 6 separate experiments, each performed in triplicate (B)
Neutrophils were treated as in (A) and the rate of apoptosis assessed at intervals over
a 24 hour period. Data represent mean ± SEM of triplicate incubations from a single
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Figure 4.2.8C The hypoxic protective effect is more sensitive to CHX than basal
apoptosis. Neutrophils (5xl06/ml) were cultured in the presence or absence of
increasing concentrations of cycloheximide in atmospheres containing either 21% or
0% oxygen for 20 hrs. Apoptosis was assessed morphologically. Data represent mean
± SEM of n = 6 experiments using 3 separate donors (*p<0.05 compared with control
values).
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observed at a cycloheximide concentration of 10 pg/ml. These findings provide
strong evidence that protein synthesis is required for hypoxic inhibition of neutrophil




In these studies we have sought to identify the intracellular mechanism(s) underlying
the inhibition of neutrophil apoptosis by hypoxia.
Granulocyte macrophage-colony stimulating factor (GM-CSF) is an inflammatory
cytokine produced by activated lymphocytes, fibroblasts, endothelial cells
(Sallerfors, 1994; Munker et ah, 1986) monocytes (Yamaoka et ah, 1998),
macrophages (Cavaillon, 1994), and mesenchymal cells (Vandermolen et al., 1996)
following stimulation by cytokines (IL-1 and TNFa) or bacterial products.
Neutrophils themselves are also capable of synthesising this cytokine (Lindemann et
ah, 1989). As well as GM-CSF's ability to 'prime' the neutrophil for subsequent
enhanced responses to secretagogues such as fMLP (Guthrie et ah, 1984; Haslett et
ah, 1985), this cytokine is also able to inhibit neutrophil apoptosis in a concentration-
dependent manner (Colotta et ah, 1992a; Lee et ah, 1993).
Although enhanced survival of neutrophils by GM-CSF has shown to be RNA and
protein synthesis dependent (Brach et ah, 1992), the signal transduction mechanisms
underlying this effect are poorly understood. However, a role for tyrosine
phosphorylation has been proposed based on the observations that treatment of
neutrophils with GM-CSF was associated with increased tyrosine phosphorylation of
proteins and the inhibition of neutrophil apoptosis by GM-CSF could be overcome
by the tyrosine kinase inhibitor, genistein (Yousefi et al., 1994).
We postulated that GM-CSF and hypoxia could be promoting survival of neutrophils
through a common mechanism or that hypoxia might induce GM-CSF release from
the neutrophils and thereby inhibit apoptosis indirectly. To test this hypothesis, we
examined the combined effects of hypoxia and GM-CSF on neutrophil apoptosis.
Under all oxygen tensions tested, including 0%, we found GM-CSF further inhibited
neutrophil apoptosis. The fact that the hypoxic and GM-CSF effects were additive,
suggests that these anti-apoptotic stimuli exert their effects through independent
mechanisms.
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The best defined genetic pathway of cell death exists in the nematode,
Caenorhabditis elegans. Systemic genetic analyses have elucidated three genes, ced-
3, ced-4 and ced-9, that are important in the regulation of nematode cell death.
Mutations of ced-3 and ced-4 abolish all somatic cell deaths, which normally occur
during the development of C. elegans, suggesting that these genes encode effector
components of the pathway (Ellis and Horvitz, 1986). In contrast, ced-9 encodes a
negative regulator that functions to suppress inappropriate cellular suicide
(Hengartner et al., 1992). Mammalian homologues of Ced-9 have been identified
and include proteins belonging to the Bcl-2 family (Hengartner and Horvitz, 1994).
Bcl-2 can substitute functionally for Ced-9 in preventing nematode cell death, further
emphasising the highly conserved nature of the cell death pathway (Hengartner and
Horvitz, 1994). In mammalian cells Bcl-2 can also block apoptotic cell death
following a variety of stimuli. Bcl-2 conferred a death-sparing effect in a number of
haemopoietic cell lines following growth factor withdrawal (Vaux et al., 1988;
Hockenbery et al., 1990; Nunez et al., 1990). Similarly, Bcl-2 has also been shown
to protect primary neuronal cell cultures (Garcia et al., 1992) and rat adrenal derived
pheochromocytoma (PC-12) cells (Batistatou et al., 1993) from nerve growth factor
withdrawal-induced cell death. Finally, transgenic mice that redirected Bcl-2 to
cortical thymocytes markedly extended the role for Bcl-2 as an antidote to apoptosis;
thymocytes overexpressing Bcl-2 were resistant to glucocorticoid and y irradiation-
induced apoptosis as well as anti-T cell receptor-induced death (Sentman et al., 1991;
Strasser et al., 1991).
Initially a mechanism where Bcl-2 protects against programmed cell death by
inhibiting the generation or action of ROS was proposed (Hockenbery et al., 1993;
Kane et al., 1993; Veis et al., 1993; Buttke and Sandstrom, 1994). This theory was
based on the observations that Bcl-2 is predominantly localised to the mitochondria,
endoplasmic reticulum and nuclear membrane (Hockenbery et. al., 1990; Monaghan
et al., 1992; Jacobson et al., 1993), all important sites for ROS generation. In
addition, Bcl-2 was able to block y radiation-induced cell death (ionising radiation
produces hydroxyl radicals in aqueous solutions) (Sentman et al., 1991; Strasser et
al., 1991). Finally, overexpression of Bcl-2 has been reported to inhibit ROS
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generation directly (Kane et al., 1993) and block apoptosis caused by glutathione
depletion (Ellerby et al., 1996). However, evidence against this theory came from
experiments where Bcl-2 protected against apoptosis induced under anoxic
conditions where ROS generation is ablated (Shimizu et al., 1995; Jacobson and
Raff, 1995) and it has now been proposed that Bcl-2 acts at a mitochondrial level by
preventing the dissipation of the mitochondrial transmembrane potential (ATm) and
consequential release of protease activators (Kroemer et al., 1995; Yang et al., 1997).
In view of the ability of Bcl-2 to suppress apoptosis in a variety of cell types and
circumstances (Reed, 1994), we investigated the possibility that upregulation of Bcl-
2 was mediating the hypoxic inhibition of neutrophil apoptosis. However, we were
unable to detect Bcl-2 protein expression in either normoxic or hypoxic treated cells.
Treatment of cells with other agents known to modulate the rate ofneutrophil
apoptosis, namely GM-CSF and TNFa, were also unable to induce Bcl-2 expression.
These results are in accord with the observations that endogenous expression of Bcl-
2 is restricted to early myeloid cells in the bone marrow and is absent in mature
neutrophils (Hockenbery et al., 1991; Delia et al., 1992). It is notable, however, that
studies using transgenic mice that expressed Bcl-2 in mature neutrophils have shown
that Bcl-2, if present, does have the capacity to block apoptosis in this cell type
(Lagasse and Weissman, 1994).
Although these experiments rule out a role for Bcl-2 in the inhibition of neutrophil
apoptosis by hypoxia, it remains possible that other members of the Bcl-2 family
which have also been found to be death antagonists (e.g. Bc1-Xl, Bcl-w Bfl-1, Brag-
1, Mcl-1 and Al) could be involved.
Oxidative mechanisms have been widely implicated in playing a role in the induction
of apoptosis. Early evidence for this theory came from observations that many of the
chemical and physical treatments capable of inducing apoptosis are also known to
evoke oxidative stress. For example, both ionising and ultra-violet radiation are
capable of inducing apoptosis and both generate ROS such as H2O2 and OH*
(Halliwell and Guttereridge, 1990). Exposure to low concentrations of H2O2 induces
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apoptosis in a variety of cell types (Lennon et al., 1991), thereby establishing
oxidative stress as a direct mediator of apoptosis. Some agents that induce apoptosis
are not free radicals themselves but may elicit ROS formation. Doxorubicin,
cisplatin and a number of ether-linked lipids are anti-neoplastic agents which induce
both apoptosis and oxidative damage in sensitive cells (Benchekroun et al., 1993;
Stamler et al., 1992; Wagner et al., 1993; Takagi et al., 1974). In addition, anti¬
oxidants have been reported to provide protection against many different types of
apoptosis. N-acetyl-cysteine and N-t-butyl-phenylnitrone abolished Fas-induced
programmed cell death in T-Cells (Gulbins et al., 1996). Furthermore, the cellular
sensitivity or resistance to the cytotoxic effects of TNFa has been shown to correlate
with decreased or increased levels of superoxide dismutase respectively (Hirose et
al., 1993).
Neutrophils are phagocytotic cells and, when activated, are capable of generating and
releasing large amounts ofROS via the NADPH oxidase system. Since the
generation ofROS is entirely dependent on the availability of molecular oxygen
(Chance et al., 1979), an obvious explanation for the inhibition of neutrophil
apoptosis by hypoxia is that it is caused by a direct effect of hypoxia on the levels of
intracellular ROS. We investigated this hypothesis by examining whether exogenous
addition of SOD and catalase, which selectively metabolise O2" and H2O2
respectively, and methionine, an essential thiol-containing amino acid, would mimic
the hypoxic inhibition of neutrophil apoptosis. Methionine and SOD did not
influence the rate of neutrophil apoptosis, suggesting that hypocholorous and
superoxide radicals do not play a significant role in regulating neutrophil apoptosis.
This supports a previous study, which demonstrated that SOD was ineffective in
preventing cell death in human lung fetal fibroblasts (Kurita and Namiki, 1994). In
contrast, catalase, both alone and in combination with SOD, caused a significant
inhibition of neutrophil apoptosis at 20 hrs. It is probable, however, that this effect
of catalase is independent of its effect on hydrogen peroxide levels since a similar
non-specific anti-apoptotic effect of catalase has been demonstrated in WEFII 231
cells (Fang et al., 1995). In addition, catalase has now been identified as the anti-
apoptotic factor present in the conditioned medium of CCRF-CEM T-cell leukaemia
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cells (Sandstrom and Buttke, 1993). Further evidence to support this comes from the
experiment in which neutrophils were incubated in the presence or absence of
catalase in normoxic and anoxic atmospheres. Catalase was still able to inhibit
neutrophil apoptosis in 0% oxygen, again suggesting that its anti-apoptotic abilities
are independent of its effect on hydrogen peroxide levels. These data have now been
confirmed by a more recent study in which catalase, but not exogenous SOD or HO*
scavengers, reduced spontaneous apoptosis in ageing neutrophils. In this study
depletion of cellular glutathione levels likewise did not induce apoptosis (Rollet-
Labelle et al., 1997). Despite this, one group (Kettritz et al., 1996) has reported that
exogenous SOD can inhibit neutrophil apoptosis. This discrepancy may be
explained by the fact that the neutrophil isolation technique used in these
experiments is known to cause cell activation.
In contrast to the above data, two studies have reported the ability of antioxidants to
prevent phagocytosis-stimulated apoptosis in neutrophils. The thiols, GSH and
NAC, have been shown to be able to inhibit an increase in apoptosis associated with
neutrophil-mediated E. Coli ingestion, although not affecting basal apoptosis
(Watson et al., 1996). It is also notable that, in this system, catalase had no effect on
neutrophil apoptosis. In accord with this study, Coxon and co-workers (1996)
reported that phagocytosis of opsonized particles by neutrophils rapidly induced
apoptosis. Treatment of neutrophils with diphenylene iodonium (an NADPH oxidase
inhibitor), which effectively inhibited phagocytosis-induced superoxide generation,
while having no effect on phagocytosis itself, blocked phagocytosis-induced
apoptosis. Similarly, apoptosis following phagocytosis did not occur in neutrophils
from patients suffering from chronic granulomatous disease, which lack NADPH
oxidase.
Thus, it would appear that ROS do not play a pivotal role in spontaneous apoptosis in
cultured neutrophils, although ROS may be implicated in the induction of apoptosis
by certain stimuli e.g. E. Coli and opsonized particle ingestion (Watson et al., 1996;
Coxon et al., 1996) or Fas-L (Watson et al., 1997). These findings suggest that the
inhibition of neutrophil apoptosis by hypoxia is not caused by a direct effect of
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hypoxia on intracellular ROS levels and also argue against generation of ROS being
a universal mechanism underlying apoptosis in all cell types. Evidence supporting
this conclusion comes from experiments in which anoxic incubation failed to
attenuate stimulus-induced apoptosis. Hence, Jacobson and Raff (1995) found that
hypoxia did not attenuate staurosporine-induced apoptosis in a fibroblast cell line and
Muschel et al. (1995) found that hypoxia did not inhibit the induction of apoptosis in
T-lymphoma cell lines S49.1 and WEH7.1 by dexamethasone. In fact, hypoxia itself
induced apoptosis in the WEH7.1 cells, a response now observed in a number of cell
types including cultured neurons (Rosenbaum et al., 1994) and human
adenocarcinoma cells (Yao et al., 1995).
There has been a recent surge of interest in mitogen-activated protein kinase
(MAPK)-mediated signal transduction cascades, which are conserved eukaryotic
signalling pathways that convert receptor derived signals into a variety of cellular
functions (for reviews see Davis, 1993; Marshall, 1995; Hunter, 1995). MAPK
pathways have at their 'core' a three-component protein kinase cascade consisting of
a serine/threonine protein kinase (MAPKKK), which phosphorylates and activates a
dual-specificity protein kinase that, in turn, activates another serine/threonine protein
kinase (MAPK) (see figure 4.3.1). Currently three distinct mammalian MAPKs,
each with apparently unique signalling functions, have been identified. These
pathways serve to link signals from the cell surface to cytoplasmic and nuclear
events. The Ras/Raf/MEK/ERK pathway is one of these. In this pathway Raf
correlates to MAPKKK, MEK correlates to MAPKK and ERK-1 and ERK-2
correspond to MAPK. The second MAPK pathway in mammalian cells involves Ras
and mediates some of the signals, environmental stresses and pro-inflammatory
cytokines (Sanchez et ah, 1994), which result in the N-terminal phosphorylation of
Jun. It involves Ras, MEKK-1, a dual-specificity kinase (SEK1), and the MAPK Jun
Kinase (JNKs/SAPKs) (Hibi et al., 1993; Minden et ah, 1994; Yan et al., 1994).
The third group ofMAPKs are mammalian homologues of HOG1 found in yeast and
have been designated p38 MAP kinases on account of their molecular weight in
murine cells (Han et al., 1994). p21racl is one of the small GTP-binding proteins, and
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Figure 4.3.1 MAPK pathways in mammalian cells. (Modified from Marshall et
al., 1995). Both receptor tyrosine kinase and stress response pathways contain a
central core of a serine/threonine kinase, MAPKKK; a dual specificity kinase,
MAPKK; and a serine/threonine kinase, MAPK. Receptor tyrosine kinase signalling
occurs through Ras, and there is evidence that some stress responses, e.g. UV
radiation may also activate Ras (Hibi et al., 1993). The upstream components of the
p38 pathway are still uncertain. PAK-1, Rac and Cdc42 have been shown to activate
p38 MAPK (Zhang et al., 1995) although, they also activate JNK in the same system.
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belongs to the rho subfamily of ras-related proteins. A serine/threonine protein
kinase p65PAK (also called p21-activated kinase 1 [PAK1]) was identified as a target
for p21racl (Manser et al., 1994). p21racl has been shown to regulate p38 MAPK
through the downstream mediator PAK 1 (Zhang et al., 1995). In response to
environmental stresses, mitogens and pro-inflammatory cytokines, p38 MAPK is
activated, and in turn stimulates MAPK-activated protein (MAPKAP) kinase-2
(Rouse et al., 1994; Freshney et al., 1994), which has been shown to be activated in
neutrophils following stimulation with PMA or fMLP (Zu et al., 1996). The in vivo
substrates of MAPKAP kinase-2 include heat shock protein (Hsp) 27 and the
transcription factors CREB, AFT1 and 2 (Cuenda et al., 1995, Tan et al., 1996;
Raingeaud et al., 1995). The phosphorylation of Hsp 27 is thought to stimulate the
phosphorylation of actin and thus help repair the actin microfilament network that
becomes disrupted during cellular stress, thereby aiding cell survival (Lavioe et al.,
1995).
Studies of signalling mechanisms have revealed that the MAPKs may play important
roles in the pathways that regulate both cell growth and apoptosis. For example, the
removal of nerve growth factor from PC-12 cells leads to apoptosis (Batistatou et al.,
1993; Pittman et al., 1993), as well as the activation of JNK and p38 MAPK and the
inhibition ofERK (Xia et al., 1995; Park et al., 1996). Kawasaki et al. (1997)
recently proposed the involvement of p38 MAPK in glutamate induced
neurotoxicity: addition of glutamate, NMDA, Ca2+ or the Ca2+ ionophore A23187 to
cultures of rat cerebellar granule cells, all of which induce apoptosis in this system,
markedly increased p38 MAP kinase activity. The p38 MAPK inhibitor SB 203580
also inhibited glutamate-induced apoptosis by about 70%. In addition, inhibition of
p38 by insulin or the pyridinyl imidazole inhibitor, PD 169316, blocked apoptosis in
Rat-1 fibroblasts and PC-12 cells induced by trophic factor withdrawal (Kummer et
al., 1997).
Although studies looking at p38 MAPK activation in response to reduced oxygen
tensions are at present limited, both hypoxia and hypoxia/reoxygenation have been
shown to cause rapid activation ofPAK 1 and p38 MAPK, as well as
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phosphorylation of activating transcription factor (ATF)-2 in cardiac myocytes (Seko
et al., 1997). In addition, phosphorylated p38 MAPK levels increased in microglia
after global ischaemia (Walton et al., 1998) providing evidence that hypoxia can
cause activation of p38 MAPK, at least in some cell types. In view of such data and
the evidence that p38 MAPK may play a protective role in apoptosis, we investigated
the effect of SB 203580, a specific inhibitor of p38 kinase (Cuenda et al., 1995; Lee
et al., 1994), on the anti-apoptotic effect of hypoxia in human neutrophils.
As illustrated, 20pM SB 203580 caused a small, although not significant, reversal of
the hypoxia-mediated survival of neutrophils at 20 hrs, while having no effect on the
extent of apoptosis in control cells. A similar effect of SB 203580 has been observed
with respect to ameliorating the ability of LPS to delay neutrophil apoptosis (J.
Murray, ER Chilvers, personal communications). Hence, if hypoxia does induce p38
MAPK activation in neutrophils (and this was not assessed directly in these
experiments), this signal does not appear to be the major mediator of the anti-
apoptotic effect of hypoxia in this system. The activation of p38 MAPK under
conditions where apoptosis is stimulated (Kummer et al., 1997; Bastistatou et al.,
1993; Pittman et al., 1993; Xia et al., 1995; Park et al.; 1996 Kawasaki et al., 1997)
may represent an autoregulatory response by the cell to prevent cell death ensuing.
This hypothesis would be supported by the observations that TNFa stimulates p38
MAPK activity in neutrophils and that SB 203580 can potentiate TNFa-mediated
induction of apoptosis at 6 hours (J. Murray, unpublished data). Certainly, in cardiac
myocytes, activation of p38 MAPK results in protection of this cell type from
apoptosis induced by antisomyocin or overexpression of constitutively active
MEKK1 (Zechner et al., 1998) but such an effect would not seem to be as marked in
neutrophils under the conditions studied. It would be of interest to see whether
hypoxia can modulate other MAP kinase pathways in neutrophils and whether such
effects underlie hypoxia-mediated survival of human neutrophils.
The intracellular energy status of a cell is controlled by the balance between the rates
ofATP utilisation and formation, which depends upon the availability of substrates
such as oxygen, glucose and glutamine for ATP formation. Thus, incubation of cells
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under reduced oxygen conditions is likely to have a detrimental effect on
intracellular ATP levels. Several studies have found ATP to be necessary for cells to
undergo apoptosis. For example, it has been shown that ATP generation is required
for the execution of the final phase of apoptosis in human T-cells (Leist et ah, 1997)
and a study using isolated thymocyte nuclei found the presence ofATP to be
necessary for both the movement of chromatin to the nuclear periphery and apoptotic
body formation (Kass et al., 1996). However, it should be noted that this is not true
of all cell types, for example, in MCF-7/ADR cells depletion of intracellular ATP
was associated with the induction of apoptotic cell death (Lee et ah, 1997). It has
also been proposed that intracellular ATP levels are a determinant of the mode of cell
death, i.e. if cells are depleted ofATP they undergo necrotic cell death whereas if
ATP is available the cells die by apoptosis (Leist et ah, 1997; Eguchi et ah, 1997).
Thus, the possibility that hypoxia is inhibiting neutrophil apoptosis by depletion of
intracellular ATP stores was investigated. Culturing neutrophils in medium without
glucose or sodium pyruvate, conditions which have been shown to cause a rapid
decrease in intracellular ATP levels in MCF-7/ADR cells (Lee et al., 1997), had no
effect on the rate of apoptosis compared to control levels. These data imply either
that this protocol (despite being widely used to induce this effect) does not
significantly impact on ATP levels in neutrophils or that intracellular ATP levels are
not a crucial factor regulating constitutive neutrophil apoptosis. Furthermore, ATP
depletion does not appear to play a role in mediating the inhibition of neutrophil
apoptosis by hypoxia.
It is also important to note that glucose deprivation results in the induction of a set of
proteins referred to as glucose-regulated proteins (GRPs). The induction of the GRP
response has been linked to cellular resistance to chemotherapeutic agents (Shen et
al., 1987). In three breast cancer cell lines and two lymphoma lines the induction of
Grp 78 expression correlated with resistance to thapsigargin (an inhibitor of ER Ca2+
uptake)-induced apoptosis (McCormick et al., 1997). In addition to glucose
deprivation, this system can also be induced by 2-deoxyglucose, the calcium
ionophore A23184 and, most interestingly, anoxia. In fact, one proposal for why
cells within the hypoxic core of tumours are resistant to chemotherapeutic drugs is
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the ability of hypoxia to upregulate GRPs. Thus, the inability of glucose deprivation
to affect neutrophil apoptosis is of further interest as it also suggests that the GRP
response is not involved in the protective effect of hypoxia.
There is now convincing evidence that glucose, under physiological conditions, may
auto-oxidise generating free radicals (Wolff et ah, 1987; Hunt et ah, 1988). High
glucose conditions have been shown to induce apoptosis in a FRTL5 cell line, an
effect amplified by co-incubation with buthionine-sulfoximine (BSO), a transition
state inhibitor that blocks glutathione synthesis (Donnini et ah, 1996). In endothelial
cells, high glucose causes both increased apoptosis and necrosis, effects blocked by
the addition of the antioxidant SOD (Baumgartner-Parzer et ah, 1995). To
investigate whether the extent of neutrophil apoptosis seen under 'basal' control
conditions could be due, at least in part, to glucose-dependent oxidative stress (a
process that would be blocked by hypoxia), neutrophils were incubated in a high
glucose medium. Again, this condition had no effect on the rate of neutrophil
apoptosis, suggesting that free radical production by auto-oxidisation of glucose is
not a contributory factor in this system.
Cultured cells or whole organisms react to increased temperatures by synthesising a
small number ofhighly conserved proteins, termed heat shock proteins or HSPs.
This heat shock response has been found in every cell and organism examined to
date. Also universally, several of the proteins induced by heat are induced by a
variety of other stresses. Although the particular constellation of effective inducers
varies somewhat from organism to organism, in nearly all cells anoxia, ethanol and
certain heavy metal ions induce protein expression (for review see Lindquist and
Craig, 1988). The first proposed function for HSPs was thermotolerance, the ability
of cells pre-exposed to non-lethal temperatures to survive subsequent exposure to
temperatures lethal under normal conditions, and although there has long been
controversy about their specific role in thermotolerance, recent experiments indicate
that HSPs and in particular Hsp 70, indeed play an important role in this
phenomenon (Johnston and Kucey, 1988; Riabowol et al., 1988).
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The upregulation of HSPs has been associated with increased resistance of cells, not
just to lethal temperatures, but also to a broad range of cytotoxic stimuli and this
cytoprotective effect extends to protection against apoptosis as well as necrosis. For
example, heat shock treatment of tumour cell lines protected cells from apoptosis
induced by actinomycin-D, camptothecin and etoposide and this protection was
mimicked in cells transfected with Hsp 27 or Hsp 70 (Samali and Cotter, 1996).
Similarly, constitutive expression ofHsp 27 blocked Fas/APO-1-mediated cell death
in a murine fibrosarcoma cell line and expression of either human Hsp 27,
Drosophila Hsp 27 or the small stress protein human aB-crystallin protected these
cells from staurosporine (a protein kinase C inhibitor) induced apoptosis (Mehlen et
al., 1996). Wong et al. (1996) found that induction of the heat shock response in
endothelial cells attenuated the pro-apoptotic effect of LPS, an effect that could also
be achieved by transient overexpression ofHsp 70. Hsps 70 and 27 have also been
implicated in cellular resistance to chemotherapeutic drugs (Oesterreich et al., 1993;
Ciocca et al., 1992). This, and other evidence (Mosser et al., 1997; Mailhos et al.,
1993; Mosser and Martin, 1992; Yun et al., 1997), point to a role for the HSPs and
especially Hsps 27 and 70 in the protection of cells from apoptosis, however, their
mode of action remains unclear.
As previously noted, the HSPs can be induced by a range of stimuli including
hypoxia. The effect of hypoxia has been most widely studied on the regulation of
Hsp 70. This protein has been demonstrated to be induced by transient ischaemia in
rodent brain (Gonzalez et al., 1991; Kirino et al., 1991; Vass et al., 1988) and
differential expression ofHsp 70 and Hsc70 has been linked to the different
susceptibilities among brain cell populations to the transient ischaemia (Kawagoe et
al., 1992). Hsp 70 has also been proposed as a factor that may limit cell damage
during myocardial ischaemia (Dillman et al., 1986; Currie et al., 1988), a hypothesis
that prompted Benjamin et al. (1990) to investigate the biochemical events resulting
in activation ofHsp 70 gene transcription in cultured myogenic cells. This group
found that exposure of these cells to hypoxia stimulated DNA binding of heat shock
transcription factor (HSTF) through mechanisms independent of new protein
synthesis and suggested that hypoxia and heat shock induce expression by a similar,
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if not identical mechanism (for review of transcriptional control ofHSPs see
Linquist, 1986). It should be noted, however, that the kinetics of HSTF binding and
Hsp 70 gene expression differed depending on which of the two inducers were used;
heat shock induced these responses rapidly (< 20 min) while hypoxia took
considerably longer (2 hrs).
We proceeded to investigate the possibility that upregulation of HSPs could be
mediating the hypoxic-induced survival of neutrophils by examining the effect of
heat shock on neutrophil apoptosis. Heat shocking or cold shocking neutrophils,
treatments that have previously been shown to induce Hsp 70 expression in these
cells (Eid et ah, 1987; Cox et ah, 1993), had no effect on the rate of neutrophil
apoptosis, although hypoxia exerted its usual protective effect in the same
experiment. When we examined identically treated cells for expression ofHsp 70
using both Western blot analysis and flow immunocytochemistry we found that Hsp
70 was present in time 0 cells and also present in equal amounts in the control, heat
shock and hypoxically treated cells. These findings suggest that either neutrophils
constitutively express Hsp 70 or (more likely) that the isolation method used to
obtain purified neutrophils causes maximal activation of the heat shock response.
Other reports show little or no expression ofHsp 70 at 24 hr in control neutrophils
(Cox et al., 1994) and an upregulation ofHSPs in freshly prepared neutrophils in
response to heat shock (Eid et al., 1987). These findings are contrary to our own and
suggest that neutrophils do not constitutively express Hsp 70. In addition Cox et al.
(1993) showed that certain neutrophil isolation procedures cause upregulation of Hsp
70, thus it seems most likely that our results are due to the isolation method used.
However, we were unable to prevent the upregulation ofHsp 70 even when we
adapted the neutrophil isolation technique to that shown by Cox et al (1993) not to
activate the heat shock response. The reason for this discrepancy is unclear.
Incubation of neutrophils in platelet poor plasma (37°C, 45 min) immediately after
isolation also failed to reduce basal Hsp 70 expression. Although we failed to
manipulate Hsp 70 expression, the consistent presence of Hsp 70 in control, heat
shocked and hypoxic cells suggests this protein does not modulate neutrophil
apoptosis and is not responsible for the hypoxic-mediated survival effect in these
120
cells. These data agree with those of Cox et al. (1994) who found that, although
human bronchial epithelial cell conditioned medium (HBEC-CM) induced Hsp 70
expression in neutrophils and had an inhibitory effect on neutrophil apoptosis, the
active constituents ofHBEC-CM, G-CSF and GM-CSF, did not mimic this
upregulation, thus showing Hsp 70 expression was associated with, but not necessary
for, suppression of apoptosis.
These findings in neutrophils appear to be contrary to the many examples in the
literature reporting that Hsp 70 expression is associated with improved cell survival.
Perhaps this difference can be explained by the fact that all the other studies look at
apoptosis induced by various stimuli, whereas in the current study, we have
examined effects on spontaneous or constitutive apoptosis.
Mitochondria are considered a key site for the initial induction of the nuclear events
in apoptosis. The reasons for this are manifold. Firstly, alterations in mitochondria
structure and function have been characterised in several cell types presented with
apoptotic stimuli (Petit et al., 1995; Schulze-Osthoff et al., 1992). The protective
Bcl-2 protein is mainly located in the inner mitochondrial membrane (Korsmeyer et
al., 1995). Also, in a cell free system of apoptosis, isolated mitochondria can
contribute to the apoptotic disintegration of isolated nuclei (Newmeyer et al., 1994).
However the precise mechanisms by which mitochondria are involved and which
mitochondrial features, such as mitochondrial membrane potential, the electron
transport chain, ROS production, mitochondrial calcium handling, the cellular ATP
level and cytochrome c or AIF release, are essential for apoptosis are still not fully
elucidated. It is, therefore, perhaps not surprising that mitochondrial inhibitors (or
'chemical' hypoxia) have been shown to modulate apoptosis in multiple systems. In
many cultured cells mitochondrial toxins have been shown to induce apoptosis
(Dipasquale et al., 1991; Hartley et al., 1994; Mochizuki et al., 1994; Wolvetang et
al., 1994). However, certain mitochondrial inhibitors have also been shown to
inhibit apoptosis induced by specific stimuli, for example, complex I inhibitors have
been shown to inhibit apoptosis induced by ceramide in human myeloid leukaemia
cells (Quillet-Mary et al., 1997) and TNFa induced apoptosis in murine fibrosarcoma
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cell lines (Schulze-Osthoff et al., 1992). Notably, dexamethasone-induced apoptosis
in thymocytes can be inhibited both by hypoxia (Steffanelli et al., 1995) and by
mitochondrial inhibitors (Steffanelli et al 1997).
In order to see if hypoxia could be exerting its protective effect on neutrophil
apoptosis by acting on the mitochondria, we investigated the effect of a series of
mitochondrial inhibitors on neutrophil apoptosis. The complex I inhibitor, rotenone,
and the complex IV inhibitors, potassium cyanide and sodium azide, at
concentrations similar to those shown to modulate TNFa-induced apoptosis in
murine fibrosarcoma cell lines (Schulze-Osthoff et al., 1992), had no effect on
apoptosis in neutrophils incubated under normoxic or hypoxic conditions. Thus, it
appears that 'chemical' hypoxia does not mimic the survival effect of anoxic hypoxia
in human neutrophils, a finding that suggests the inhibition of neutrophil apoptosis
may be quite specific for hypoxia and does not reflect the broader metabolic
consequences ofmaking cells hypoxic. Neutrophils are not alone in their resistance
to mitochondrial inhibitors; rotenone has also been shown to have no effect on the
human lung carcinoma (A549) cell line (Hartley et al., 1994).
A fundamental question to answer when trying to elucidate any effector pathway is
to determine whether or not de novo protein synthesis is a requirement.
Traditionally, neutrophils have been considered to be pre-programmed end, or
terminally differentiated, cells capable of functioning with little or no protein
synthesis throughout their short life span (Bainton et al., 1971). This beliefwas
derived from observations that much of the nuclear chromatin ofmature neutrophils
is coarsely clumped, suggesting that a considerable portion of the genome is inactive
(Murphy, 1976). In addition, neutrophils lack evidence of a nucleolus and contain
very little endoplasmic reticulum or ribosomes. However, more recently neutrophils
have been shown to both synthesise mRNA transcripts and selectively synthesise a
large number of proteins (Jack and Fearon, 1988), allowing these cells to modulate
their responses to environmental factors. Additional evidence shows that new RNA
synthesis is required for the production of leukocyte pyrogen (Nordlund et al., 1970),
elastase (Hart, 1984) and plasminogen activator (Granelli-Piperno et al., 1977).
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Indeed, neutrophils are now known to produce a range of cytokines, including G- and
GM-CSF (Lindemann et ah, 1989), demonstrating that neutrophils do indeed possess
significant biosynthetic activity.
To investigate whether the survival effect of hypoxia on neutrophils requires de novo
protein synthesis, we examined the action of the protein synthesis inhibitor,
cycloheximide, on this effect. Using a concentration of 50 pM (14 pg/ml)
cycloheximide, a concentration previously shown by Whyte et al. (1997) to almost
completely inhibit protein synthesis in neutrophils, both control and hypoxically
treated neutrophils showed accelerated rates of apoptosis at all time points examined.
The observation that cycloheximide accelerates constitutive neutrophil apoptosis
agrees with previous data (Brach et al, 1992; Payne et ah; 1994; Whyte et ah, 1997)
and has led to the proposal that continuous synthesis of some regulatory (anti-
apoptotic) protein(s) may be necessary to prevent neutrophils undergoing
spontaneous apoptosis. Acceleration of apoptosis by protein synthesis inhibitors has
also been demonstrated in monocytic myeloid cells (Waring, 1990), the myeloid
leukaemic cell line (HL-60) (Martin et ah, 1990) and in the U-937 leukaemic cell
line (Kochi and Collier, 1993). However, this is certainly not true of all cell types.
In thymocytes, death via apoptosis, induced by multiple stimuli, can be delayed or
abrogated by RNA or protein synthesis inhibitors (Wyllie et ah, 1984; Cohen et ah,
1984; Sellins et ah, 1987; Kizaki et ah, 1989), as can apoptosis in hepatocytes
(Ledda-Columbano et ah, 1992) and neurons (Martin et ah, 1992). Thus, it would
appear that, in these cell types, molecules necessary for the execution of the death
program are synthesised de novo in response to the inducing stimulus, a finding more
in agreement with apoptosis being a cellular form of active rather than passive
suicide. It has been proposed that in cell types, which retain the capacity to
proliferate, RNA and protein synthesis inhibitors delay or prevent the development
of apoptosis, while cells such as neutrophils, which have lost the potential to
proliferate, do not depend on new protein synthesis to permit apoptosis and treatment
with these agents will typically accelerate basal rates of cell death (Cohen, 1991).
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The ability of cycloheximide to overcome completely the protective effect of
hypoxia in neutrophils, increasing levels of apoptosis in hypoxically treated
neutrophils to nearly those of cycloheximide treated control cells, is compatible with
the hypothesis that the hypoxic protective effect is protein synthesis dependent.
However, as cycloheximide at this concentration (50 pM; 14 pg/ml) itself exerts
such a powerful effect on basal apoptosis, it was also possible that the protective
effect of hypoxia was simply not strong enough to combat the pro-apoptotic effect of
cycloheximide. Thus, in order to further investigate the role of de novo protein
synthesis in the protection of neutrophil apoptosis by hypoxia the effect of lower
concentrations of cycloheximide on this phenomenon was examined. When cells
were treated with concentrations of 0.1, 1, and 10 pg/ml cycloheximide the enhanced
survival of neutrophils by hypoxia was overcome in a concentration-dependent
manner. Cycloheximide at lpg/ml, a dose that did not induce apoptosis in control
cells, effectively overcame the protective effect of hypoxia. Previous studies (Cox et
al., 1994) have shown this dose of cycloheximide is sufficient to markedly interfere
with, but not abolish, protein synthesis in neutrophils. These data provide strong
evidence that the prolonged survival of neutrophils by hypoxia is associated with
newly synthesised proteins that prevent programmed cell death. Clearly much more
work is required in order to elucidate the identity of these proteins.
Cycloheximide has also been shown to overcome dexamethasone (Cox et al., 1996),
GM-CSF (Brach et al., 1992), sodium butyrate (Stringer et al., 1996) and LPS
(Hachiya et al., 1995) induced survival of neutrophils, implicating a role for de novo
protein synthesis in all of these inhibitory effects. However, the survival proteins
involved have not been identified in any of these systems. Cox et al. (1994), found
increased expression ofMnSOD and Hsp 70, two proteins that have been associated
with enhanced survival in certain in vitro cell culture systems (Warner et al., 1991;
Peng et al., 1986; Angelidis et al., 1991; Kantanagwa et al., 1991), in response to
treatment of neutrophils with human bronchial epithelial cell conditioned medium
(HBEC-CM). However the major anti-apoptotic factors present in HBEC-CM,
namely G-CSF and GM-CSF, did not mimic the upregulation, implying that the
induction of these two stress proteins is not necessary for suppression of apoptosis.
124
Our data on Hsp 70 expression in neutrophils shown earlier in this chapter certainly
does not support a role for this protein in the protective effect of hypoxia in
neutrophils. Our previous data, and that of others (Hockenbery et ah, 1991) showing
a lack of expression of the oncoprotein Bcl-2 in neutrophils and the inability of
glucose deprivation to modulate neutrophil apoptosis also makes Bcl-2 and the GRPs
unlikely candidates for the role. However, there remain numerous putative proteins
that could be responsible for inhibiting neutrophil apoptosis, for example other
members of the Bcl-2 family, and the possibility that an, as yet, unknown protein is
involved is also feasible. Also it would be dangerous to assume that all these
inhibitory effects involve the same protein(s). Although it is not impossible that the
same anti-apoptotic proteins are involved, our data showing that the GM-CSF and
hypoxic protective effects are additive suggests, at least between these two protective
effects, that there are likely to be differences between the mechanisms involved.
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CHAPTER 5
INVOLVEMENT OF TRANSCRIPTION FACTORS IN THE HYPOXIC
INHIBITION OF NEUTROPHIL APOPTOSIS
5.1 Introduction
In the previous chapter we investigated the intracellular signalling pathways
underlying the hypoxic inhibition of neutrophil apoptosis. We found that this
pathway(s) was not sensitive to other cellular stresses, including glucose deprivation,
heat shock or chemical hypoxia. Antioxidants were also ineffective in mimicking the
inhibitory effect of hypoxia. However, this effect was sensitive to a protein synthesis
inhibitor, cycloheximide, indicating that de novo protein synthesis is required, or
involved, in mediating the anti-apoptotic effect of hypoxia in human neutrophils.
The archetypal model for gene regulation in response to an extracellular stimulus
involves ligand-receptor interaction followed by a series of downstream 'second-
messenger' events that target cytosolic transcriptional regulators and, hence, the
expression of appropriate genes. This commonly occurs via the induction or
repression of transcription, although additional mechanisms have been described,
including changes in mRNA stability or in the rate of translation. Most extracellular
ligands influence cell behaviour purely by interacting with a specific cellular receptor
and, hence, act solely as discrete and 'confined' messenger molecules. Such ligands
include polypeptide hormones, growth factors and a variety of smaller molecules
(such as catchecholamines, steroids and thyroid hormones). In contrast, oxygen
plays a central function in aerobic metabolism and, under normal conditions, this is
likely to preside over and dominate any additional role this molecule has in
signalling via a sensor-receptor mechanism. Thus, it seems likely that the
mechanism(s) available for oxygen sensing and signalling will deviate from these
well established systems.
One of the most studied mechanisms underlying oxygen sensing in mammalian cells
is that underlying hypoxia-induced upregulation of erythropoietin. Erythropoietin
126
(EPO) is a glycoprotein hormone required for the proliferation and differentiation of
erythroid cells (reviewed by Jelkmann, 1992). Upon hypoxic exposure, the kidney,
and to a lesser extent the liver, increase EPO synthesis by enhancing both
transcription of the EPO gene and EPO mRNA stability. Studies into the
mechanisms involved in EPO regulation were greatly enhanced by the discovery of
several human hepatoma cell lines, which are capable of producing EPO in a
hypoxia-dependent manner. We noted that the inhibition of neutrophil apoptosis by
hypoxia shared several characteristics with EPO production. For instance, the
induction of EPO mRNA and protein has also been reported to be insensitive to
mitochondrial inhibitors, certain antioxidants, heat shock and glucose deprivation,
but induction can be inhibited by the protein synthesis inhibitor, cycloheximide.
EPO production can also be stimulated by cobalt, nickel and manganese ions in a
concentration-dependent manner. These observations lead Goldberg and co-workers
(1988) to propose that the oxygen sensor involved in hypoxic regulation ofEPO
production was a haemoprotein, which was active in its deoxy state. While such a
protein system has yet to be identified, it is known that cobalt, nickel and manganese
can all substitute for the ferrous ion in the porphyrin of haem but have a much lower
affinity for oxygen. Goldberg et al., (1988) hypothesised that these metal ions would
lock the haem sensor in its (active) deoxy-state. Observations that carbon monoxide
(a haem inhibitor) and 4, 6-dioxoheptanoic acid (a haem synthesis inhibitor) were
able to inhibit hypoxia-induced EPO production further substantiated this theory.
Elowever, later observations that iron chelators were also potent inducers of EPO
mRNA expression were hard to accommodate using this model as haem iron is not
chelatable. Other proposals for how the cell may sense oxygen levels include the
involvement ofROS as signalling intermediates (Fandrey et al., 1994) and the
involvement of a flavoprotein oxidoreductase. This latter suggestion was based on
observations that iodonium compounds are powerful inhibitors of the hypoxic
induction of EPO gene expression (Gleadle et al., 1995b).
Although the molecular processes underlying the oxygen-sensing mechanism remain
unclear, the elements involved in the transcriptional control of EPO have been more
fully characterised. Through experiments involving the introduction of human EPO
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gene constructs into transgenic mice (Semenza et al., 1990; Semenza et al., 1991a)
and Hep3B cells (Semenza et al., 1991b; Semenza and Wang, 1992) an important
transcriptional regulatory element in the 3'-flanking region of the gene was
identified. A 50-nucleotide (nt) sequence from this region was shown to function as
a hypoxia-inducible enhancer of transcription in Hep3B cells and a trans-acting
factor that binds to this enhancer was found in nuclear extracts from Hep3B cells
exposed to hypoxia but not in control cells (Semenza and Wang, 1992). This DNA-
binding activity, termed hypoxia-inducible factor-1 (HIF-1), fulfilled the criteria for
a physiological regulator of EPO transcription. Other inducers of EPO expression
(e.g. C0CI2 and desferrioxamine) also induced HIF-1 binding, while inhibitors of
EPO expression, including cycloheximide, blocked induction ofHIF-1 activity.
Finally, mutations in the EPO 3' flanking region that eliminated HIF-1 binding also
eliminated enhancer function (Semenza, 1994). It is important to note that, while
EPO expression is cell type specific, induction of HIF-1 activity by hypoxia, cobalt
or desferrioxamine has been detected in many other mammalian cell lines (Wang and
Semenza, 1993b). Indeed, HIF-1 has been shown to mediate the hypoxic regulation
of vascular endothelial growth factor (VEGF), the primary regulator of angiogenesis
(Forsythe et al., 1996). HIF-1 has also been implicated in transcriptional activation
of the genes encoding iNOS and haem oxygenase 1 (Lee et al., 1997; Melillo et al.,
1995) and several glycolytic enzymes (Firth et al., 1994; Semenza et al., 1994),
suggesting that HIF-1 plays a very general role in mediating transcriptional responses
to hypoxia.
Glycerol gradient sedimentation, UV crosslinking, and methylation interference
studies have indicated that HIF-1 is a heterodimer consisting of a 120 kDa HIF-la
subunit and a 91-94 kDa HIF-1 (3 subunit and that both subunits contact DNA in the
major groove (Wang and Semenza, 1993a; Wang and Semenza, 1993c; Wang and
Semenza, 1995). These findings were confirmed by the analysis ofpurified HIF-1,
and subsequent protein microsequence analysis and cDNA cloning have now
revealed the molecular identity of these two subunits (Wang et al., 1995). Both HIF-
1 subunits are basic-helix-loop-helix proteins containing a PAS domain (bHLH-
PAS). PAS is an acronym derived from the first three proteins observed to contain
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this motif. These include the product of the period gene ofDrosophilia
melanogaster (Jackson et ah, 1986), the aryl hydrocarbon receptor nuclear
transporter (ARNT) gene of mammals (Burbach et ah, 1992) and the product of the
fruit fly single-minded gene (Nambu et ah, 1991). HIF-la was identified as a novel
bHLH-PAS protein while HIF-1 (3 is identical to ARNT, which appears to be a
common subunit for a family of bHLH-PAS proteins. Although there is still some
controversy about hypoxic regulation ofHIF-1 mRNA levels (Wang et ah, 1995;
Huang et ah, 1996), the general consensus is that HIF-1 function is regulated
primarily by HIF-la protein levels (see Semenza, 1998 and Ratcliffe et ah, 1998 for
recent reviews). HIF-1 P can be found in both the nucleus and the cytoplasm of cells
under normoxic conditions, although translocation of the protein to the nucleus
occurs only upon hypoxic stimulation, while HIF-la can only be detected at very
low levels in unstimulated cells. Western analysis ofwhole cell extracts has
demonstrated that hypoxic stimulation results in a rapid accumulation ofHIF-la,
with levels decaying rapidly (fi/2 < 5 min) when cells are returned to a normoxic
environment. The rapid increase in HIF-la levels in stimulated cells could involve
enhanced translation or enhanced stabilisation. Evidence for the latter mechanism
comes from treatment of hypoxic cells with cycloheximide, which has indicated that,
under hypoxic conditions, HIF-la is relatively stable and there is evidence that HIF-
la is rapidly degraded under normoxic conditions by the ubiquitin-protease system
(Salceda and Caro, 1997). Stabilisation ofHIF-la is also induced by cobalt, nickel,
manganese and iron chelators (Salceda and Caro, 1997), as would be predicted from
the ability of these compounds to induce HIF-1 activity. Jiang and co-workers
(1996) indicated that the C-terminal end ofHIF-la contained the putative
degradation domain. Further work by Pugh et al. (1997) has provided evidence
suggesting that amino acids 530-634 and within that fragment, amino acids 549-582,
are involved in the oxygen-regulated degradation of the protein. In addition to this,
an iron-binding site in fragment 529-658 has been reported and suggested as a
plausible mechanism for this oxygen-regulated degradation, excluding the need for a
separate oxygen sensor (Srinivas et al., 1998). Consistent with the theory that HIF-1
activity is controlled by HIF-1 a protein levels, forced overexpression of the a
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subunit in normoxic cells is itself sufficient to drive HIF-1-dependent reporter gene
expression. However, hypoxic stimulation of these cells further enhanced activity,
suggesting that hypoxia can also modify HIF-1 DNA-binding (Jiang et ah, 1996). In
agreement with this, further analysis ofC-terminal sequences from HIF-1 a showed
that amino acids lying immediately N-terminal to position 786 suppressed total
activity and conferred inducibility, an effect which appeared to be independent of the
level of expressed protein (Ratcliffe et al., 1998). Thus, the evidence to date
suggests that HIF-1 activity is regulated primarily by oxygen-dependent modulation
of the specific activity ofHIF-1 a activation domains in addition to an effect on HIF-
1 a protein levels.
Importantly, HIF-1 induction is observed in response to physiologically relevant O2
concentrations. A report by Jiang and co-workers (1996) demonstrated that HIF-1
DNA-binding activity and HIF-1 a protein expression increased exponentially as
cells were subjected to decreasing O2 concentrations, with a half maximal response
between 1.5 and 2% O2 and a maximal response at 0.5% O2. Such levels of oxygen
are comparable with those present in many tissues under conditions of normal or
compromised oxygen delivery (see Chapter 1, sections 1.3.2 - 4). Interestingly,
below 0.5% O2, rather than reaching a plateau, HIF-1 binding and protein levels
actually declined.
Although HIF-1 is probably unique in its specificity for hypoxia, at least in
mammalian cells, it is by no means the only transcription factor that has been
reported to be activated in response to hypoxia. Two other such transcription factors
are NF-kB (nuclear factor-xB) and AP-1 (activator protein-1). Unlike HIF-1, it has
been suggested that these transcription factors are induced by either (near-) anoxic
stress conditions (where the O2 concentration is below approximately 0.02%) or even
reoxygenation dependent processes (Wenger and Gassman, 1997). However, there
are other reports suggesting AP-1 may be induced by less strenuous hypoxia (5-10%
oxygen) (Millhorn et al., 1997; Norris and Millhorn, 1995).
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NF-kB exists in the cytoplasm of the majority of cells as a homo- or heterodimer
family of structurally related proteins (for reviews see Baldwin, 1996 and Ghosh et
ah, 1998). To date, five proteins belonging to the NF-kB family have been identified
in mammalian cells: p65, c-Rel, RelB, p50 and p52. NF-kB activity is regulated by a
class of inhibitory proteins called IkB; seven of these molecules have been identified
so far, the best characterised being IkBo, and bcBp. The IkB proteins bind to NF-kB
dimers keeping them sequestered in the cytosol. In response to an activating
stimulus, the IkB protein is phosphorylated on specific serine residues prior to
ubiquitination and subsequent proteosomal degradation, leaving NF-kB free to
translocate to the nucleus where it binds specific kB DNA sequences. This
mechanism allows for extremely rapid activation ofNF-kB making it ideally suited
for its pivotal role in many cellular responses to environmental stress. Indeed, NF-
kB can be activated by a manifold of stimuli known to cause cellular stress including
various cytokines, bacterial and viral products, ROS, UV light and y-irradiation.
More recently, hypoxia has been proposed as a further inducer ofNF-kB, however,
there is still some controversy associated with this. Notably, many of the inducers of
NF-kB activation are also known for their apoptotic effects and thus, perhaps
unsurprisingly, NF-kB has been implicated as playing a pivotal role in controlling
apoptosis. There is evidence that inhibition of the constitutive NF-kB activity in
WEHI 231 cells prevents apoptosis (Wu et al., 1996). In contrast, p65_/" mice die
during embryonic development through massive apoptosis of hepatocytes (Wang et
ah, 1996) suggesting an anti-apoptotic role for NF-kB. This role has been further
supported by data showing that cell lines, previously resistant to the cytotoxic effects
ofTNFa and other pro-apoptotic agents, became extremely sensitive when lacking
p65 or when expressing a dominant negative form of IkBoc (Beg and Baltimore,
1996; Wang et al 1996). Finally, a recent report has proposed an important
regulatory role for NF-kB in neutrophil apoptosis (Ward et al., 1999). Treatment of
neutrophils with gliotoxin, a potent inhibitor ofNF-kB, caused a marked
enhancement of both constitutive and TNFa-induced apoptosis, suggesting an anti-
apoptotic role for NF-kB in this cell type.
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Like NF-kB, the AP-1 transcription factor is a dimeric DNA-binding protein
consisting of homo- and heterodimer subunits (for recent reviews see Foletta et ah,
1998; Liebermann et al., 1998). These subunits are encoded by the proto-oncogenes
c-fos and c-jun and their related gene family members. The fos family consists of c-
fos, fra-1, fra-2, fosB and fosB2, while, to date, three jun family members have been
described (c-jun, junB and junD). Dimerization between Fos and Jun proteins occurs
via a structure referred to as a leucine zipper. The most stable dimers are those
formed between jun and fos family members, although Jun (but not Fos) proteins can
also homodimerize. AP-1 activity is regulated primarily by changes in DNA-binding
activity and abundance of the AP-1 protein. The levels of AP-1 protein are primarily
regulated by controlling transcription of their genes; however, more recent evidence
suggests that the abundance of both c-Jun and c-Fos can also be regulated by
modulation of their stability. In the case of c-Jun the phosphorylation of serines and
threonines at its amino-terminal activation domain by MAPK reduces the
ubiquitination of this protein and hence its degradation. In addition, AP-1 activity is
regulated by phosphorylation and is also sensitive to redox potential. In a variety of
cells, AP-1 activity can be enhanced by the administration of both organic
antioxidants as well as by thioredoxin, a protein with reducing capability, whereas
hydrogen peroxide and sulfhydryl-blocking reagents inhibit activation. Site-directed
mutagenesis has localised the critical redox sensitive sites to a single conserved
cysteine residue in the DNA binding domains of Fos and Jun. Replacement of these
cysteines by serine resulted in enhanced activity that is resistant to oxidants. It is
also noteworthy that this Cys—»Ser replacement is also present in the oncogenic v-
Jun. There is also much evidence indicating that the c-fos and c-jun family of genes
are inducible by hypoxia. Exposure of cardiac myocytes to severe hypoxia induced
mRNA expression of c-fos, c-jun, junD and junB. Likewise, when the brains of new
born rats were rendered acutely ischaemic, expression of c-fos and c-jun was induced
and in hypoxic Hep 3B cells expression of c-jun and junB was upregulated.
Consistent with these observations hypoxia has also been shown to induce AP-1
binding to its DNA sequence motif in several cell types including Hela, Hep-3B and
endothelial cells (Bandyopadhyay et al., 1995; Rupee and Baeuerle, 1995).
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Experiments showing that c-jun and c-fos expression was upregulated in cells treated
with pro-apoptotic stimuli prompted suggestions that AP-1 may play a role in
promoting apoptosis (Colotta et ah, 1992b). Further evidence supporting this theory
came from a study usingfos-lacZ transgenic mice, which found that there is
continuous expression of c-fos hours or days before cell death in numerous cell
populations which were undergoing terminal differentiation (Smeyne et al., 1993).
More recently JNK and c-Jun have been implicated in ceramide-induced apoptosis of
human myeloid and lymphoid tumour cell lines and growth factor withdrawal-
induced apoptosis in cultured neurons (Ham et al., 1995; Verheij et al., 1996).
Although the evidence that indicates that AP-1 and JNK are involved in some forms
of apoptosis is increasing, there are also a number of reports that suggest AP-1
proteins and JNK are not essential for cells to undergo apoptosis. For example,
programmed cell death can occur in embryos lacking either c-Fos or c-Jun or both c-
Fos and c-Jun (Roffler-Tarlov et al., 1996). In addition, splenic and thymic primary
cultures taken from c-fos deficient mice underwent apoptosis after treatment with
etoposide in identical manner to wild-type cultures (Gajate et al., 1996).
The aim of the work presented in this chapter was, firstly, to investigate the oxygen-
sensing mechanism underlying the anti-apoptotic effect of hypoxia and, secondly, to
examine the potential involvement of redox-sensitive transcription factors.
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5.2 Results
5.2.1 Effect ofdesferoxamine and cobaltous chloride on neutrophil apoptosis
One of the most studied mammalian oxygen sensing mechanisms is that which
controls the regulation of the transcription factor hypoxia inducible factor (HIF)-l.
This transcription factor was originally discovered due to its involvement in the
hypoxic mediation of erythropoietin synthesis but has subsequently been proposed to
be a part of a universal oxygen sensing mechanism. One of the characteristics of this
system is the ability of iron chelators and certain divalent metal ions, as well as
hypoxia, to cause activation ofHIF-1. Thus, to examine the hypothesis that HIF-1
may be involved in the inhibition of neutrophil apoptosis by hypoxia, we investigated
the effect of the iron chelator, desferrioxamine (DFO), and cobaltous chloride, two
agents that have been shown to cause activation ofHIF-1 in other cell types, on the
rate of neutrophil apoptosis. Neutrophils were incubated in the presence of 100 pM
DFO or 100 pM cobaltous chloride in atmospheres of either 21% or 0% oxygen for
20 hours. While neither of these agents had any effect on the rate of apoptosis
compared to untreated cells in 0% oxygen, in 21% oxygen DFO significantly
inhibited neutrophil apoptosis (p<0.05), although cobaltous chloride still had no
effect (figure 5.2.1). To ensure that the lack of effect of cobaltous chloride was not
because we were using an inappropriate concentration, a range of concentrations
from 1 pM to 10 mM was also tested. Concentrations of 1 mM and above proved
toxic to neutrophils and at no concentration did cobalt ions inhibit neutrophil
apoptosis (data not shown).
5.2.2 Iron chelators inhibit neutrophil apoptosis in a concentration-dependent
manner
To further investigate the observation that DFO inhibits neutrophil apoptosis (i.e.
mimics the effect of hypoxia), the influences of a range of concentrations (1 pM - 10
mM) ofDFO and a second iron chelator, CP94 (1 pM - 1 mM), was examined. Both
these iron chelators inhibited neutrophil apoptosis in a concentration-dependent
manner (figure 5.2.2A) and, at the maximally effective concentrations, were able to
inhibit apoptosis to a similar extent as hypoxia. In addition, the anti-apoptotic effect
of the iron chelators was only evident under hypoxic conditions at very high
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Figure 5.2.1 Effect of desferrioxamine and cobaltous chloride on neutrophil
apoptosis. Neutrophils (5 x 106/ml) were incubated with cobaltous chloride (100
(iM) or the iron chelator, desferrioxamine (100 pM), for 20 hours in atmospheres
containing 21% or 0% oxygen. Control, untreated cells were also prepared.
Apoptosis was assessed morphologically and data represent mean ± SD of triplicate
incubations from a single representative experiment of 2 (*p<0.05 compared with
control values).
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Figure 5.2.2A Iron chelators inhibit neutrophil apoptosis in a concentration-
dependent manner. Neutrophils (5 x 106/ml) were cultured under normoxic
conditions for 20 hours in the presence of increasing concentrations of
desferrioxamine (DFO, 1 p.M-10 mM) or CP94 (1 pM-1 mM). Control, untreated
neutrophils were also prepared. Apoptosis was assessed morphologically and
apoptosis expressed as percentage of the control values. Data represent mean ± SEM
of n = 3 (DFO) and n = 4 (CP94) separate experiments each performed in triplicate.
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concentrations (1 mM and above; data not shown), suggesting that hypoxia and the
iron chelators were acting through a common mechanism. It is notable that CP94
and DFO are structurally different, suggesting that this effect was due to their iron
chelating properties and not some common secondary action. This was demonstrated
2"b
experimentally by showing that a molar excess of iron (Fe ) could overcome the
protective (anti-apoptotic) effects of these iron chelators. Neutrophils were
incubated with 300 pM DFO or CP94 in the presence and absence of 3 mM ferrous
chloride (FeCfi). The protective effects of CP94 and DFO were completely
abrogated when FeCfi was present (figure 5.2.2B). These results suggest a role for
chelatable iron in the oxygen-sensing mechanism and may indicate the presence and
involvement of a ferro-protein sensor. In the context of other published work, these
data also support a putative role for the transcription factor HIF-1 in the inhibition of
neutrophil apoptosis by hypoxia.
5.2.3 Expression ofhypoxia induciblefactor (HIF)-l in human neutrophils
In view of the ability of agents known to induce HIF-1 activation in other cells to
mimic the effect of hypoxia on neutrophil apoptosis, we examined expression of
HIF-1 in human neutrophils. HIF-1 is a heterodimer consisting of the HIF-1 a and
HIF-1 p subunits. Both these subunits have been classified as basic helix-loop-helix
(bHLH)/PAS domain proteins and, while HIF-1 a is a novel protein, HIF-1 P was
found to be identical to the previously recognised aryl hydrocarbon nuclear
translocator, ARNT (Wang et al., 1995). In many studies (Huang et al., 1996;
Wenger et al., 1996a; Wood et al., 1996) HIF-la and HIF-ip mRNAs have been
found to be expressed in normoxic cells, indicating that HIF-1 activation may
involve both translational and post-translational mechanisms. As an initial approach,
we verified that neutrophils have the potential to express the HIF-1 protein by
demonstrating that neutrophils express HIF-la mRNA. This was achieved by
isolating RNA from freshly isolated, unstimulated neutrophils and performing an
RNA protection assay. This approach was also used to identify endothelial PAS
domain protein 1 (EPAS1), another PAS domain protein, which shares 48%
sequence homology with HIF-la (Tian et al., 1997). Although HIF-la mRNA was
shown to be present in both freshly isolated neutrophils and monocytes, EPAS1
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Figure 5.2.2B The protective effects of desferrioxamine and CP94 on neutrophil
apoptosis can be overcome by the addition of excess Fe2+ ions. Neutrophils were
incubated under normoxic conditions for 20 hours in the presence of: 300 pM CP94;
300 pM CP94 and 3 mM FeCl2; 300 pM DFO; and 300 pM DFO and 3 mM FeCl2.
Control untreated cells were also prepared and apoptosis was assessed
morphologically. Data represent mean ± SEM of n = 3 separate experiments, each
performed in triplicate (*p<0.05 compared with control values).
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Figure 5.2.3A RNase protection assay showing monocytes and neutrophils
constitutively express HIF-la mRNA but not EPAS1 mRNA. Human neutrophils
and monocytes were isolated from whole blood and total cellular RNA was prepared.
Ribonuclease protection of total RNA from monocytes (M) and neutrophils (N) was
performed for EPAS-1 and HIF-1a (40 pg each) with HeLa RNA utilised as a
positive control. RNA analysis was performed by Dr Michael Wiesener, Wellcome
Trust Centre for Human Genetics, Oxford. Data is a representative blot ofn = 2.
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mRNA was not found in either (figure 5.2.3A), indicating that both cell types have
the potential to upregulate HIF-1, but not EPAS1, in response to hypoxia.
The presence of HIF-1 (3 protein has been reported in both cytoplasm and nuclear
extracts from normoxic cells, while HIF-1a is only expressed at very low levels in
unstimulated cells (Wang et ah, 1995), suggesting that HIF-1 activity is regulated, at
least partially, by hypoxic-modulation of HIF-1 a protein levels. In view of this, we
examined whether neutrophils would upregulate HIF-1 a protein expression in
response to hypoxic-stimulation and iron chelator treatment. Human neutrophils
were incubated under normoxic conditions in the presence and absence ofDFO,
while parallel cells were made hypoxic by resuspension in medium that had been
pre-incubated in 0% oxygen conditions overnight. After 3 hours in these culture
conditions the cells were harvested and whole cell lysates prepared using a TRIZOL®
based lysis method (see section 2.2.6.2a for details). The lysates were then analysed
for HIF-1 a using western blotting. HIF-1 a was not present in the control cells but
was found in the hypoxic and DFO treated neutrophils (figure 5.2.3B), demonstrating
that neutrophils upregulate HIF-1 a protein in response to these stimuli.
Finally, in order to show that not only HIF-1 a protein can be induced in response to
hypoxic-stimulation, but also that HIF-1-DNA binding can occur under these
conditions, a DNA binding assay for HIF-1 was performed using neutrophil nuclear
extracts. Neutrophils were incubated under hypoxic and normoxic conditions and
after 3 hours cells were harvested and nuclear extracts prepared. These extracts were
incubated with a P-labelled double stranded oligonucleotide containing the HIF-1
binding site (see section 2.2.7.3 for details) and an electrophoretic mobility-shift
assay (EMSA) performed. Identically treated HeLa cells were used as a positive
control. Figure 5.2.3C shows a representative EMSA with protein complexes
binding the oligonucleotide and retarding the mobility of the probe. The HeLa
nuclear extracts demonstrate the normal binding pattern for HIF-1 (J. Gleadle,
personal communications) with both constitutive and inducible binding complexes
present. However, in comparison, the neutrophil extracts exhibit a very different
binding pattern with no obvious inducible band. The reason for these differences is,
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Figure 5.2.3B Western blot showing HIF-la protein expression in human
neutrophils. Neutrophil lysates were prepared by a Trizol® based lysis method and
separated by 10% SDS-PAGE. Western blot was developed with an antibody to HIF-
la. After isolation neutrophils were incubated in either a normoxic atmosphere (21%
oxygen) or a hypoxic environment (0% oxygen) or incubated in the presence of
desferrioxamine (DFO, 1 mM) for 3 hours before cell lysis. Whole cell lysate from
hypoxia treated HeLa cells was used as a positive control. Western blot analysis was
performed by Dr Michael Wiesener, Wellcome Trust Centre for Human Genetics,
Oxford. Data is a representative blot from n = 2.
HeLa 21% 0% + DFO
220 kDa — 1
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Figure 5.2.3C Electrophoretic mobility-shift assay using nuclear protein
extracts from neutrophils and an oligonucleotide containing a HIF-1 binding
site. Nuclear extracts were prepared from neutrophils and HeLa cells that had been
exposed to either normoxia (21% oxygen) or hypoxia (0% oxygen) for 3 hours. A 5'
end-labelled oligonucleotide containing a HIF-1 DNA-binding site was used as the
probe. The position of the inducible complexes (i) and constitutive complexes (c) in
the HeLa samples are indicated, however, these bands are not evident in the
neutrophil samples. The multiple lane repeats for the neutrophils represent samples
from 2 separate experiments. The data is a representative experiment of n = 3.
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at present, unclear. The neutrophil bands were reduced significantly when unlabelled
wildtype probe was added to the binding reaction, although there was no change
when excess probe containing a mutated binding site was added (data not shown),
suggesting that these bands reflect, at least partially, specific binding to the HIF-1
binding site. Thus, although we have been able to show the presence ofHIF-1 a
mRNA in neutrophils and an increase in HIF-1 a protein levels in response to
hypoxia, we were unable to correlate this to an increase in HIF-1 binding activity to a
recognised HIF-1 DNA binding site.
5.2.4 NF-kB binding activity in nuclearprotein extracts from human neutrophils
In view of reports implicating a role for NF-kB in regulating apoptosis and data from
several groups suggesting that NF-kB DNA-binding may be induced by hypoxia, we
investigated the activity of this transcription factor in hypoxic neutrophils.
Neutrophils (107/ml) were resuspended in medium that had been pre-incubated in
either 0% oxygen or 21% oxygen conditions overnight, thus ensuring that cells were
fully hypoxic from time 0, with parallel cells cultured in the presence of DFO (1
mM). At a range of time points up to 6 hrs, neutrophils were harvested into ice cold
PBS and nuclear fractions isolated (see section 2.2.8.1 for details). The nuclear
extracts were incubated with P-labelled double stranded oligonucleotide containing
the NF-kB binding site and binding activity assessed by EMSA. As shown in figure
5.2.4A, when neutrophil nuclear extracts were used, the NF-kB EMSAs indicated the
presence of 3 discrete bands. The fastest (C) and slowest (A) migrating NF-kB DNA
binding activities were strongly expressed as opposed to the middle complex (B),
which was very weakly expressed. Other workers in the group (C.Ward, personal
communications) have demonstrated, by including an excess of cold probe in the
binding reaction, that only bands B and C represent specific NF-kB binding (Ward et
al., 1999). In addition, known activators ofNF-kB, LPS and TNFa, are able to
upregulate band B while having no effect on band C, which is also expressed in
freshly isolated neutrophils, leading to the proposal that band C represents a form of
constitutively active NF-kB while band B is an inducible form (Ward et al., 1999).
In all experiments none of the conditions detailed above caused an upregulation of
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Figure 5.2.4A The effect of hypoxia and desferrioxamine on NF-kB binding in
nuclear extracts from human neutrophils. Electrophoretic mobility-shift assay
using nuclear protein extracts from neutrophils exposed to either, normoxia (21%
oxygen), hypoxia (0% oxygen) or incubated in the presence of 1 mM
desferrioxamine (DFO) for the stated times. A 5' end-labelled oligonucleotide
containing an NF-kB DNA-binding site was used as the probe. The position of the
three DNA-binding complexes A, B and C are indicated (see text for details). HeLa
cell nuclear extract was used as a positive control; there was no shift in probe
mobility in the absence of nuclear protein extract (lane 2; -ve). This gel is a
representative example of 6 others.
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Figure 5.2.4B Upregulation of inducible NF-kB binding by LPS in human
neutrophils. Electrophoretic mobility-shift assay using nuclear protein extracts from
neutrophils exposed to either, normoxia (21% oxygen), hypoxia (0% oxygen) or
incubated in the presence of desferrioxamine (DFO, 1 mM) or lipopolysaccharide
(LPS, 1 pg/ml) for the stated times. A 5' end-labelled oligonucleotide containing an
NF-kB DNA-binding site was used as the probe. The position of the three DNA-
binding complexes A, B and C are indicated. HeLa cell nuclear extract was used as a
positive control; there was no shift in probe mobility in the absence of nuclear
protein extract (lane 2; -ve). This gel is representative of n = 2 separate experiments.
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band B. However, in certain experiments hypoxia caused an increase in the density
of band C, which was most evident at earlier time points. This effect appeared to be
donor specific as it was not observed in all experiments. To ensure the lack of
upregulation of band B was not due to experimental technique, identical experiments
were performed including a fourth condition in which neutrophils were co-incubated
with LPS (1 pg/ml) for 30 min or 6 hours. Figure 5.2.4B shows a representative
EMSA demonstrating an obvious upregulation of band B in the LPS treated cells, an
effect which was not observed with hypoxia or DFO treatment.
5.2.5 AP-1 binding activity in nuclearprotein extracts from human neutrophils
Activation of the transcription factor, AP-1, has also been demonstrated in response
to hypoxia. In view of this, the effect of hypoxia on AP-1 binding was investigated
in human neutrophils. Neutrophil nuclear proteins from cells treated as described in
section 5.2.4 were co-incubated with P-labelled double stranded oligonucleotide
containing the AP-1 binding site and binding activity assessed by EMSA. Figure
5.2.5A shows a representative EMSA from one such experiment. AP-1 binding was
present in all conditions at every time point tested; there was no difference in the
intensity of the bands, as assessed by densitometry, with any of the treatments or
between time points (figure 5.2.5B). AP-1 binding was also found in freshly isolated
cells and could not be upregulated by using LPS (1 pg/ml) (data not shown). The
binding activity was shown to be specific for the AP-1 site using an excess of
unlabelled probe containing the AP-1 binding site but was not affected by inclusion
of unlabelled probe containing the NF-kB site (figure 5.2.5C). These data suggest
that constitutive AP-1 binding is found in human neutrophils and this is not
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30 min 1 hour 3 hours 5 hours 6 hours
Normoxia 34.3 ±8.5 30.1 ±9.8 31.5 ±7.6 31.7 ±7.6 31.4 ±6.2
Hypoxia 36.9+10.4 28.7 ±9.5 30.3 ±6.3 36.1 ±5.2 27.8 ±4.8
+ DFO 29.5 ±9.8 28.5 ±9.5 24.8 ± 8.3 36 ±7.3 26.5 ±5.0
C
+ cold + cold
-ve 21% 0% NF-kB AP-1
Figure 5.2.5 The effect of hypoxia and desferoxamine on AP-1 binding in
nuclear extracts from human neutrophils. A Electrophoretic mobility-shift assay
using nuclear protein extracts from neutrophils exposed to either normoxia (21%
oxygen), hypoxia (0% oxygen) or incubated in the presence of 1 mM
desferoxamine (DFO) for the stated times. A 5' end-labelled oligonucleotide
containing an AP-1 DNA-binding site was used as the probe. HeLa cell nuclear
extract was used as a positive control; there was no shift in probe mobility in the
absence of nuclear protein extract (-ve). This gel is representative of n = 6 separate
experiments. B AP-1 band density was also analysed using densitometry and mean
values from 6 experiments were obtained for all conditions. No statistical difference
was found between conditions (p < 0.05). Data are expressed as mean ± SEM. C
Electrophoretic mobility shift assay using neutrophil nuclear extracts. AP-1 binding
is evident in nuclear extracts from cells incubated in both 21% and 0% oxygen while
there was no shift in probe mobility in the absence of nuclear protein extract (-ve).
The addition of excess cold NF-kB probe to the binding reaction had no effect on
binding to the AP-1 probe, however, addition of cold AP-1 probe displaced binding
to the labelled probe suggesting that bands represent specific AP-1 binding.
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5.3 Discussion
In the above experiments we have sought to characterise the oxygen-sensing
mechanism underlying the hypoxic-mediated survival of neutrophils and have
examined the potential involvement of several redox-sensitive transcription factors in
this phenomenon.
The molecular mechanism underlying oxygen sensing in mammalian cells has been
investigated primarily in two systems: erythropoietin (EPO)-producing hepatoma-
derived cell lines (Goldberg et ah, 1988; Porter and Goldberg, 1993) and type 1
carotid body cells (Acker, 1994; Acker and Xue, 1995). We noted that the
upregulation of EPO mRNA in response to hypoxic stimulation and the hypoxic
inhibition of neutrophil apoptosis share similar characteristics, namely that both
events are not mimicked by mitochondrial inhibitors, glucose deprivation or heat
shock and both are sensitive to the addition of cycloheximide. In view of this, the
possibility that the effect of hypoxia on these physiological processes shares a
common mechanism was investigated. Early experiments with intact animals
(Goldwasser et al., 1958) as well as perfused kidneys (Fisher and Langston, 1968)
demonstrated that the production of EPO could also be stimulated by cobaltous
chloride treatment. Moreover, when human hepatoma cells (Hep3B or HepG2) were
incubated for 24 hours in the presence ofC0CI2, there was a concentration-dependent
enhancement of EPO mRNA expression (Fandrey and Bunn, 1993). Manganese and
nickel have also been shown to cause a concentration-dependent increase in EPO
production, albeit at higher ion concentrations than cobalt, although other divalent
cations (zinc, iron and cadium) were not able to stimulate EPO-production (Goldberg
et al., 1988). In addition to these metal ions, iron chelators have been demonstrated
as potent stimulators ofEPO mRNA production (Wang and Semenza, 1993a). Thus,
as a preliminary experiment to test the hypothesis that a similar mechanism may be
involved in the inhibition of neutrophil apoptosis by hypoxia, neutrophils were
incubated with C0CI2 and an iron chelator, DFO. Surprisingly, C0CI2 had no effect
on neutrophil apoptosis, however, DFO promoted neutrophil survival in a
concentration-dependent manner. The same effect was obtained with CP94, which is
a member of the hydroxypyridinone group of iron chelators and, although their
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primary action is also the chelation of iron, these compounds are structurally quite
different from DFO (Dobbin et ah, 1993). At higher concentrations these
compounds inhibited apoptosis to a similar extent to hypoxia. Depending on iron
availability, these chelating agents may act to chelate extracellular iron and transfer it
into cells or they may enter the cell and bind iron intracellularly. However, as
reported for EPO (Wang and Semenza, 1993a), the addition of a molar excess of
ferrous chloride to the medium prevented the action of both iron chelators,
suggesting that they are operating by the latter mechanism. Both of the iron
chelators used show a very strong preference for iron over other metal ions (Porter et
ah, 1989; Hider et ah, 1994), and the common action of the different compounds thus
suggests that their ability to inhibit neutrophil apoptosis is most probably achieved
by the chelation of iron.
One putative explanation for the ability of iron chelators to mimic the protective
effect of hypoxia on neutrophil apoptosis is that this effect may involve a ferro-
protein oxygen sensor, which is active only in its deoxy-form. In this model iron
chelators would exert their effect by locking this sensor in its deoxy, active state.
Haem iron is not chelatable (Rounalt et ah, 1985), thus eliminating haem containing
proteins as possible oxygen-sensing candidates, however, examples exist among non-
haem ferroprotein sensors of labile iron atoms being susceptible to chelation
(Klausner et al., 1993; Spiro et ah, 1989).
A second possibility is that the effect of iron chelators on the free iron pool could
effect the generation of ROS. Iron acts as the catalyst in the Haberweiss reaction:
O2 + H2O2 —^ O2 + OH + HO*
Thus chelation of iron would block the catalysis of H2O2 resulting in reduced
hydroxyl-radical concentrations. Changes in ROS levels could be involved in
signalling or have a direct effect on apoptosis, however, our data (Chapter 4)
showing that the antioxidants, superoxide dismutase and methionine, failed to mimic
the effect of hypoxia on neutrophil apoptosis argues against this as a putative
mechanism.
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We also cannot discount a potential effect of iron chelators on non-haem iron
containing enzymes. Two such enzymes, which have also been implicated in
modulating apoptosis, are the lipoxygenases and ribonucleotide reductase (Tang et
al., 1996; Anderson et al., 1994; Huang and Plunkett, 1995). Lipoxygenases catalyse
the site-specific oxygenation of polyunsaturated fatty acids to produce
hydroperoxides. In human neutrophils the principle lipoxygenase is 5-LPO (Ford-
Hutchkinson et al., 1994), which catalyses the first two steps in the conversion of its
substrate (arachidonic acid) to leukotriene A4. Leukotriene A4 is the precursor of the
potent pro-inflammatory molecule leukotriene B4. Indeed, hydroxypyridone iron
chelators have been shown to inhibit leukotriene release from neutrophils by this
mechanism (Abeysinghe et al., 1996). A second iron chelator sensitive enzyme is
human ribonucleotide reductase. This enzyme catalyses the conversion of
ribonucleotides to deoxyribonucleotides and, hence, iron chelators are inhibitors of
DNA synthesis (Alcain et al., 1997). However, it seems unlikely that the iron
chelators could be inhibiting neutrophil apoptosis via an effect on these enzymes.
LTB4 has been shown to inhibit neutrophil apoptosis in a concentration-dependent
manner (Hebert et al., 1996), thus inhibiting 5-LPO might be expected to have a pro-
apoptotic effect but it is difficult to explain an anti-apoptotic effect using this
mechanism. In addition, DFO is too large and hydrophilic to access the active site of
5-LPO and thus does not inhibit this enzyme (Cooper and Porter, 1997). Both the
hydroxypyridones and DFO have been shown to inhibit ribonucleotide reductase in
neutrophils (Cooper and Porter, 1997), however, inhibitors of this enzyme have been
shown to have anti-proliferation effects in dividing cells and in other cells appear to
induce rather than inhibit apoptosis (Wright et al., 1996; Cory et al., 1985).
The ability of iron chelators to promote neutrophil survival to a similar extent to
hypoxia is consistent with the hypothesis that a similar oxygen-sensing mechanism to
that mediating the hypoxic regulation of EPO is involved. However, the lack of
effect of C0CI2 on the rate of neutrophil apoptosis led us to question this theory.
Various models of oxygen sensing have been proposed to accommodate the effects
ofmetal ions and chelators on EPO production. Goldberg et al. (1988) hypothesised
that the oxygen sensor in this system is a haem protein and that cobalt substitutes for
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the iron atom in the haem moiety. Because these metals have a low affinity for
oxygen, they would lock the sensor in the deoxy conformation. They provided
experimental evidence for this proposal by showing that induction of EPO by
hypoxia could be blocked by carbon monoxide (CO) and by haem-synthesis
inhibitors. In contrast to its effects in hypoxic cells, CO did not inhibit the induction
of EPO by cobalt. This result is fully consistent with the inability of cobalt
substituted haem to bind CO. If this proposal is correct, and operates in a similar
way in other cell types, it is difficult to explain the lack of effect of cobalt on
neutrophil apoptosis in any other way than by proposing a different oxygen sensing
mechanism to the one utilised by EPO. However, to date, no such ferro-protein
oxygen sensing molecule has been identified in mammalian cells. Furthermore the
role of iron chelators as potent stimulators of EPO production is difficult to explain
using this model. Similarly, the inhibitory effect of haem synthesis inhibitors and
CO have not been found in all cells (Eckardt et ah, 1993; Graven et ah, 1998). The
inconsistencies in this proposal has led to additional suggestions. Other models of
oxygen sensing have been based on the role of oxygen as an electron acceptor in a
variety ofnon-mitochondrial redox systems involving electron transport. For
instance, the involvement of a hypoxia-sensitive, but cyanide-insensitive,
cytochrome b in an electron transport chain similar to that involved in the NADPH
oxidase respiratory burst has been proposed (Gorlach et ah, 1993; Gorlach et ah,
1994). In this system O2 has been proposed to be reduced to ROS such as superoxide
anions, H2O2 and hydroxyl radicals and that one or more of these molecules may be
responsible for hypoxia-induced signal transduction (Ehleben et ah, 1997; Fandrey et
ah, 1997; Ratcliffe et ah, 1997). However, it is notable that the cloned neutrophil
NADPH oxidase has been eliminated as an essential component of the hypoxia
signal transduction pathway (Wenger et ah, 1996b). Indeed, iron chelators have also
been shown not to effect the respiratory burst in neutrophils (Abeysinghe et ah,
1996). Involvement of an NADPH-oxidase like molecule was supported by the
observation that diphenylene iodium (DPI), which inhibits NADPH oxidase by
reacting with its flavin cofactor, blocked the induction of EPO expression in hypoxic
cells (Gleadle et ah, 1995b). A second important observation in this study was that,
while DPI inhibited hypoxic induction ofEPO, it was not able to block cobalt or
151
desferoxamine stimulated induction, giving the first indication that these stimuli
work via different mechanisms or at different points in a common pathway. In
addition, whereas exposure ofHEPG2 cells to either hypoxia or C0CI2 induced
absorption-spectrophotometric changes that suggested effects on an NADPH
oxidase-like cytochrome b55g, DFO had no such effect, implying a different mode of
action (Ehleben et ah, 1997). These experimental findings suggest that the three
known inducers of EPO expression each act via a different molecular pathway.
Thus, it appears plausible that the inability of cobalt to inhibit neutrophil apoptosis
does not rule out a role for a similar oxygen-sensing mechanism to that involved in
the hypoxic regulation of EPO.
Although the precise mechanism underlying oxygen 'sensing' remains unclear,
studies on the transcriptional control of EPO have been more fruitful. Cis-acting
DNA sequences required for transcriptional activation in response to hypoxia were
identified in the EPO 3' flanking region and a trans-acting factor that binds to the
enhancer, hypoxia-inducible factor-1 (HIF-1), fulfilled criteria for a physiological
regulator of EPO transcription (Semenza, 1994). EPO expression is cell type
specific but induction ofHIF-1 activity by hypoxia, C0CI2 and DFO has been
detected in many mammalian cell lines and the EPO enhancer is able to direct
hypoxia-inducible transcription of reporter genes transfected into non-EPO-
producing cells (Wang and Semenza, 1993b; Maxwell et ah, 1993). More recently,
HIF-1 has also been shown to be involved in the hypoxic regulation of several other
genes, including glycolytic enzymes, certain growth factors and haem oxygenase 1
(for review see Wood and Ratcliffe, 1997). Thus, HIF-1 appears to play a very
general role in mediating transcriptional responses to hypoxia. As noted, HIF-1 has
been shown to be a heterodimer consisting of the HIF-1a and HIF-1 P subunits
(Wang and Semeza, 1995) and both subunits are basic-helix-loop-helix proteins
containing a PAS domain (bHLH-PAS) (Wang et ah, 1995). HIF-1 P was found to be
identical to ARNT, while HIF-1 a represented a novel bHLH-PAS protein (Wang et
ah, 1995). mRNAs for HIF-la and HIF-ip have been found in all cells and tissues
examined to date (Wenger et ah, 1996a; Wiener et ah, 1996) and, in keeping with
this, we found HIF-la mRNA to be expressed in both human neutrophils and
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monocytes. We also examined neutrophils for endothelial PAS domain protein 1
(EPAS1) mRNA expression. EPAS1 is a recently discovered member of the bHLH-
PAS protein family. It shares a 48% sequence homology with ElIF-la and, like HIF-
la, can form heterodimers with ARNT and activate transcription from a HIF-1
binding site (Tian et ah, 1997). EPAS1 mRNA is also widely expressed in many
tissue types, although protein expression is mainly restricted to endothelial cells.
However, we were unable to detect EPAS1 mRNA in neutrophils. These results are
consistent with those of Tian and co-workers (1997) who found HIF-1a but not
EPAS1 mRNA expressed in leukocytes.
HIF-1 activity is largely controlled by HIF-1a protein levels and we found that HIF-
1 a protein levels were upregulated in neutrophils upon stimulation with hypoxia and
DFO suggesting (but not proving) that HIF-1 activity is also increased under these
conditions. However, we were unable to show this experimentally. When a DNA-
binding assay was performed using nuclear extracts from both normoxic and hypoxic
neutrophils an unusual binding pattern was observed, with no visible inducible band,
which bore little relation to the 'standard' HIF-1 binding pattern seen with HeLa cell
nuclear extracts. The reason for this is unclear and further work is required to
elucidate whether this represents an experimental artefact or a true representation of
HIF-1 binding in neutrophils.
Recent experimental evidence has implicated a role for HIF-1 in hypoxia-induced
apoptosis (Carmeliet et ah, 1998). Hypoxia was able to induce apoptosis in wild-
type (HIF-la+/+) C4.5 cells but not in HIF-la-deficient Kal3 Chinese hamster ovary
(CHO) cells. Furthermore, a HIF-la dependent induction of p53 and p21 and
suppression of Bcl-2 was observed. It will be of considerable interest to investigate a
possible association between the induction ofHIF-la by hypoxia in neutrophils and
the inhibition of neutrophil apoptosis. However, at present these studies are
hampered by the lack of a cell permeable and specific HIF-1 inhibitor and the
inability to readily transfect neutrophils.
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A second transcription factor, which, like HIF-1, has been proposed to play a role in
the control of apoptosis is NF-kB. NF-kB consists of homo- or heterodimers of the
Rel protein family, p50/NF-icBl, p52/NF-KB2, p65/RelA, RelB and c-Rel. Evidence
suggesting that NF-kB may act to protect cells against apoptosis came from studies
in which cell lines previously resistant to pro-apoptotic stimuli (TNFa, ionising
radiation and chemotherapeutic drugs) became very sensitive to these agents when
lacking p65 or when expressing a dominant negative form of IkBcc (Beg and
Baltimore, 1996; Wang et al 1996). Furthermore, experiments using gliotoxin, a
potent inhibitor ofNK-kB, and DNA-binding assays have implicated this
transcription factor in mediating the late (>12 hrs) anti-apoptotic effect ofTNFa in
neutrophils (Ward et ah, 1999). Unlike HIF-1, NF-kB activity is upregulated by a
large range of physiological stimuli, including cytokines (TNFa and IL-1), LPS,
phorbol esters, mitomycin C, calcium ionophore, lectins, ultraviolet light and ROS
(Anderson et al., 1994; Schreck et ah, 1991). Koong and co-workers (1994) have
also proposed that hypoxia can cause NF-kB activation by a mechanism involving
tyrosine phosphorylation ofMBa. We thus investigated the response ofNF-kB to
hypoxia in human neutrophils. As detailed above, nuclear extracts from neutrophils
were found to contain 3 separate DNA-binding activities. The slowly migrating
complex A is unlikely to represent specific NF-kB binding as it was not sensitive to
the addition of excess unlabelled probe. However, the two other complexes (B and
C) were judged to represent specific binding activities. The slower-migrating
complex (B) has been designated as an inducible form ofNF-kB as it is only very
weakly expressed in control cells and is upregulated by known NF-kB inducing
agents, while complex C appears to represent a constitutively expressed form of this
transcription factor. We found no upregulation of complex B in response to either
hypoxia or DFO although, as previously reported, LPS was able to induce activation
(McDonald et al., 1997). The inability ofDFO to effect inducible NF-kB binding is
consistent with reports that iron chelators are inhibitors ofNF-kB activation (Schreck
et al., 1992). In contrast, we found a donor specific enhancement of the binding
activity complex C by hypoxia. Due to the inability of DFO to produce this effect,
and the inconsistency of these results when using neutrophils from different donors,
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it appears unlikely that this NF-kB binding complex is involved in the anti-apoptotic
effect of hypoxia although further studies will be required to prove this conclusively.
There is still some debate concerning the ability of hypoxia to activate NF-kB.
Although degradation of IkBoc and transcriptional activation of reporter constructs
containing icB-binding sites has been reported in Jurkat T-cells following hypoxia
(Koong et ah, 1994), other studies using HeLa cells suggest that NF-kB is only
upregulated following reoxygenation (Rupee and Baeuerle, 1995). The latter finding
is more in keeping with the large body of evidence indicating that NF-kB is activated
under pro-oxidant conditions and that antioxidants inhibit NF-kB (for review see
Piette et al., 1997). Indeed, rapid activation ofNF-kB during reoxygenation may
explain the above neutrophil data: although we took care to harvest neutrophils into
ice cold PBS immediately following removal from hypoxic conditions, activation of
NF-kB by reoxygenation has been reported to be extremely rapid reaching maximal
levels in less that 15 minutes.
A third transcription factor that is sensitive to intracellular redox levels is AP-1. Like
the previously mentioned transcription factors, AP-1 is a dimeric protein. Its subunits
consist of the products of the proto-oncogenes c-jun and c-fos and their related
family members. Although AP-1 activity is largely induced at a transcriptional level
by de novo synthesis of these subunits, c-Jun stability can also be enhanced by
phosphorylation of serine and threonine residues by MAPK. In addition,
phosphorylation can also increase AP-1 binding activity. Initial observations that
AP-1 can be stimulated by anti-oxidants and inhibited by oxidants, suggested that
AP-1 can be regulated by the redox state of the cell. Site-directed mutagenesis
identified a conserved cysteine residue in the basic DNA-binding motif of both Fos
and Jun; under non-reducing conditions an inter-molecular disulphide bridge is
formed between the cysteine residues of each basic motifwithin a dimer, which
prevents DNA binding (Bannister et al., 1991). It has been demonstrated that the
reduction of AP-1 under physiological conditions is mediated by a ubiquitous nuclear
protein called Ref-1 rather than by low-molecular weight redox compounds
(Xanthoudakis and Curran, 1992). Ref-1 is itself subject to redox control. Its
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activity can be augmented by thioredoxin, suggesting that AP-1 may be regulated by
a redox cascade (Abate et al., 1990). In view of these findings, it is perhaps not
surprising that hypoxia has also been reported to induce AP-1 binding
(Bandyopadhyay et ah, 1995; Rupee and Baeuerle, 1995).
Contrary to these data, we were unable to detect an enhancement of AP-1 binding in
response to hypoxia in human neutrophils. In HeLa cells, Rupee and co-workers
(1995) found that hypoxia induced a biphasic activation of AP-1 with upregulation
first noticeable at 15 minutes and peaking at 40 minutes and a second increase in
activity seen at 5 hours. Although we investigated similar time points and used a
nearly identical level of hypoxia, there was no evidence that hypoxia influenced AP-
1 binding in neutrophils. The ability ofDFO to lower intracellular ROS levels is
well documented and, thus, this agent may be expected to reduce the redox potential
of cells, however, as with hypoxia, DFO did not affect AP-1 binding in neutrophils.
Hypoxic induction ofAP-1 appears to be cell type-dependent to the extent that, while
AP-1 binding was increased 4-6 fold over basal levels in HeLa cells, it was elevated
much more modestly in endothelial and Hep-3B cells (Bandyopadhyay et al., 1995).
While activation ofAP-1 binding in response to LPS has been reported in neutrophils
(Sugita et al., 1998), we were unable to mimic this effect in our system. However,
the AP-1 response to LPS appears to be very concentration-sensitive and it is
possible that the single concentration of LPS (1 pg/ml) used was too high. An
additional difference is that Sugita and co-workers incubated cells in the absence of
serum, while our system includes 10% autologous serum. Hence, we cannot exclude
the possibility that serum is responsible for the high basal levels ofAP-1 binding
observed in our experiments and that this precluded us observing any further
stimulation with LPS or, indeed, hypoxia. We also found this constitutive AP-1
binding in freshly isolated (to) cells but, as neutrophils come into contact with
platelet poor plasma during several steps in the isolation process, it is again feasible
that AP-1 binding activity is induced during cell preparation. While it would be of
interest to repeat these experiments in the absence of serum, the inability of both
hypoxia and desferrioxamine to modulate AP-1 binding under culture conditions in
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which these agents are able to profoundly inhibit neutrophil apoptosis suggests that
AP-1 binding is not a key step in this process.
It is also notable that, although AP-1 binding has been reported following hypoxia,
this effect has not always been sufficient to activate AP-1 inducible genes,
suggesting that some other factor is also required (Bandyopadhyay et al., 1995).
Indeed transcriptional activation of vascular-endothelial growth factor (VEGF) by
hypoxia in C6 glioma cells requires binding of both AP-1 and HIF-1 (Damert et al.,
1997). Hence, AP-1 activation may play an important 'permissive' role in allowing
HIF-1 mediated gene regulation.
Several reports have implicated a role for certain AP-1 subunits in apoptosis. For
example, an increase in c-jun or c-fos expression was noted in cells that were
induced to undergo apoptosis following exposure to various stresses (Colotta et al.,
1992b) and it has been proposed that c-Jun is necessary for both growth factor
withdrawal induced apoptosis in cultured neurons (Ham et al., 1995) and ceramide-
induced apoptosis in human tumour cell lines (Verheij et al., 1996). However, again
these observations implicate a pro-apoptotic role for AP-1. Furthermore, although
AP-1 may be involved in apoptosis induced by specific stimuli in certain cell types,
there is now substantial evidence against a universal role for AP-1 in apoptosis. c-
fos primary cells isolated from c-fos null mice are able to undergo normal
apoptosis (Gajate et al., 1996) and neither c-Fos or c-Jun are essential for normal in
vivo development (Roffler-Tarlov et al., 1996).
To conclude, these data suggest that the oxygen-sensor involved in the inhibition of
neutrophil apoptosis by hypoxia may be a ferro-protein and that the oxygen-sensing
mechanism is similar to that involved in the hypoxic-induction of EPO mRNA in
other cell types. Consistent with this proposal, we have demonstrated that
neutrophils are capable of upregulating HIF-1a protein in response to the anti-
apoptotic stimuli, hypoxia and DFO. Thus, it is possible that HIF-1 may be involved
in the upregulation of gene(s) which serve an anti-apoptotic function in neutrophils.
However, further work will be required to substantiate this hypothesis. Our data also
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suggest that the transcription factors AP-1 and NF-kB do not play an important role
in the inhibition of neutrophil apoptosis by hypoxia.
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CHAPTER 6
THE ROLE OF OXIDATIVE PATHWAYS IN TUMOUR NECROSIS
FACTOR-a-STIMULATED APOPTOSIS IN HUMAN NEUTROPHILS
6.1 Introduction
Tumour necrosis factor-a (TNFoc) is a cytokine that was originally described as a
peptide capable of inducing necrosis of tumours in experimental animal models
(Carswell et al., 1975). Consistent with this finding, TNFa has also been shown to
be cytotoxic to certain cell types in vitro (Niitsu et al., 1988; Watanabe et al., 1988;
Helson et al., 1975) and, depending on the cell type, can induce either necrosis or
apoptosis. The role of TNFa as a powerful priming agent in neutrophils is also well
documented (Klebanoff et al., 1986; Shalaby et al., 1985; Atkinson et al., 1988), and
like other pro-inflammatory agents, TNFa was initially reported to have the capacity
to delay neutrophil apoptosis (Colotta et al., 1992a). However, recent reports have
demonstrated that TNFa induces apoptosis in neutrophils at early time points (2-12
hours) in culture (Takeda et al., 1993; Murray et al., 1996), a finding which sets
TNFa apart from other neutrophil priming agents, such as LPS, G-CSF and GM-
CSF.
Two distinct receptor subtypes for TNFa, with molecular masses of 55 kD
(TNFRI/TNFR55) and 75 kD (TNFRII/TNFR75), have now been identified
(Hohmann et al., 1990; Brockhaus et al., 1990) and human and mouse cDNAs
corresponding to both receptor subtypes have been isolated and characterised
(Loetscher et al., 1990; Schall et al., 1990; Smith et al., 1990; Lewis et al., 1991;
Goodwin et al., 1991). These receptors are members of a superfamily of receptors
referred to as the NGF/TNF receptor family. This family is characterised by
functional trimerization and the presence of one to six cysteine-rich repeats of
approximately 40 amino acids in the extracellular domain, which provide the ligand
binding motif. The extracellular domains of the two human TNFRs are 28%
identical but, of note, have no more homology to each other than to other members of
the NGF/TNF receptor superfamily. Likewise, there is no significant homology
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between the intracellular domains of the two TNFRs, indicating that these receptors
almost certainly serve discrete functions and employ different mechanisms of action
(Lewis et al., 1991).
TNFR55 contains a classical intracellular death-domain sequence (Tartaglia et al.,
1993), and has been reported to be the sole mediator of the TNFa-triggered death
signal in most non-haematopoietic cell types. Despite this, the TNFR75, which lacks
such a death domain sequence, has been proposed to play a key role in mediating
TNFa-induced cytotoxicity in murine CD8+ peripheral T-cells (Zheng et al., 1995),
and recently a requirement for both TNFRs in TNFa-mediated induction of
neutrophil apoptosis has been reported (Murray et al., 1997).
Despite the characterisation of the TNFRs, the intracellular mechanisms regulating
TNFa cytotoxicity are not fully understood. Studies demonstrating that TNFa
results in a rapid rise in the levels of intracellular reactive oxygen species (ROS)
(Larrick et al., 1990; Matthews et al., 1987) led to proposals that TNFa may mediate
its cytotoxic effects in certain cell types through a free-radical based mechanism.
Consistent with this, in some model systems TNFa-mediated apoptosis can be
inhibited by the anti-oxidants, thioredoxin (Matsuda et al., 1991) and N-
acetylcysteine (Chang et al., 1992). The mitochondria, a prime source ofROS, have
also been implicated in playing a role in TNFa induced cell killing. Alterations in
mitochondrial ultrastructure have been observed following treatment with TNFa and
TNFa cytotoxicity can be affected by treatment of cells with mitochondrial inhibitors
(Schulze-Osthoff et al., 1992). Furthermore, it has been reported that cellular
sensitivity or resistance to TNFa correlates with decreased or increased levels of
mitochondrial superoxide dismutase respectively (Hirose et al., 1993).
The aim of the work presented in this chapter was to investigate the potential
involvement, and role, ofROS in TNFa-induced apoptosis in human neutrophils. If
ROS are involved in the pro-apoptotic process then TNFa-stimulated apoptosis
ought to be reduced by (a) anaerobic conditions (if oxygen-based radicals are
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involved) (b) free-radical scavengers and (c) inhibitors of pathways which generate
free radicals. Thus, experiments were designed to investigate the effect of these
conditions/agents on TNFa-induced neutrophil apoptosis.
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6.2 Results
6.2.1 Characterisation of TNFa-stimulated apoptosis in neutrophils
Studies performed by Dr. J. Murray in the lab demonstrated that co-incubation of
human neutrophils with TNFa caused a significant inhibition of neutrophil apoptosis
when assessed after 20 hours in culture (figure 6.2.1A), an effect common to many
other neutrophil priming agents. However, consistent with the observation that
TNFa is cytotoxic to many other cell types, this cytokine was shown to cause a
significant increase in morphological apoptosis at earlier time points (up to 12
hours), when the constitutive rate of apoptosis was still low (figure 6.2.1 A). Figure
6.2.IB shows a more detailed time course of TNFa-induced apoptosis. The early
pro-apoptotic effect ofTNFa was rapid (observed in all experiments by 2 hr), time-
dependent, and maximal in terms of the ratio of apoptotic to non-apoptotic cells at 6
hours. To explore the concentration-dependence of TNFa-stimulated apoptosis at 6
hours, neutrophils were incubated in the presence of increasing concentrations of
TNFa (0-100 ng/ml). Figure 6.2.1C shows that the TNFa effect is nearly maximal
by 10 ng/ml with an EC50 value of 2.8 ng/ml. In view of these data, in all subsequent
experiments the effect of TNFa was examined after a 6 hour incubation period using
а, just maximal, TNFa concentration of 25 ng/ml.
6.2.2 Effect ofhypoxia on TNFa-stimulated apoptosis
In certain cell lines the cytotoxic effect of TNFa has been abrogated using
antioxidants and mitochondrial inhibitors and this has led to the hypothesis that
TNFa mediates its cytotoxic effect via an increase in intracellular ROS levels. To
investigate whether this could be the case in neutrophils, we examined the effect of
anoxia on the pro-apoptotic effect ofTNFa in this cell type. Neutrophils were
cultured in the presence or absence ofTNFa under normoxic (21% oxygen) or
'anoxic' conditions using medium that had been fully deoxygenated before use. The
pro-apoptotic effect of TNFa was greatly reduced under anoxic conditions (figure
б.2.2A), implicating an essential role for molecular oxygen in the cytocidal effect of
TNFa. In a second set of experiments, neutrophils were cultured under anoxic
conditions but using medium thar had not been deoxygenated prior to TNFa
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Figure 6.2.1A Time course for the effect of TNFa on apoptosis in neutrophils.
Human neutrophils (5 x 106/ml) were incubated in Iscove's MDM supplemented
with 10% autologous serum in the presence or absence of TNFa (25 ng/ml). At the
time points indicated, the cells were harvested and assessed for the morphological
features of apoptosis. Data represent mean ± SEM of 6 determinations from 2
independent experiments (*p<0.05 compared with control values) (experimental data
provided by Dr. J Murray).
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Figure 6.2.IB TNFa induces neutrophil apoptosis at early time points.
Human neutrophils (5 x 106/ml) were cultured in serum-supplemented Iscove's
MDM in the absence or presence of 25 ng/ml TNFa. Neutrophils were harvested
hourly for 8 hours and apoptosis assessed morphologically. Data represent mean ±
SEM of 3 separate experiments, each performed in triplicate (experimental data
provided by Dr. J. Murray).
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Figure 6.2.1C Concentration-response curve for TNFa-induced apoptosis.
Human neutrophils were incubated at 5 x 106/ml with increasing concentrations of
TNFa (0-100 ng/ml). After 6 hours, neutrophils were harvested and apoptosis
assessed morphologically. Data represent mean ± SEM from 3 separate experiments,







Figure 6.2.2A Hypoxia inhibits TNFa-stimulated apoptosis in neutrophils.
Neutrophils (5 x 106/ml) were resuspended in medium that had been incubated
overnight in either 0% or 21% oxygen. Cells were then cultured in the presence or
absence of TNFa (25 ng/ml). After 6 hours, neutrophils were harvested and
apoptosis assessed morphologically. Data represent mean ± SEM from 5 separate





Figure 6.2.2B Requirement for culture medium to be fully deoxygenated in
order to inhibit TNFa-stimulated apoptosis. Neutrophils (5 x 106/ml) were
cultured in the presence or absence of TNFa in medium that had not been initially
deoxygenated. Cells were then incubated in atmospheres containing 21, 2.5 or 0%
oxygen for 6 hours. At this time, neutrophils were harvested and apoptosis assessed
morphologically. Data represent mean ± SEM from 5 separate experiments, each
performed in triplicate.
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stimulation. By serial monitoring of the medium pC>2 we were able to demonstrate
that, under these conditions, the medium did not fully equilibrate with the anoxic
atmosphere until at least 30 minutes into the incubation period (data not shown). In
these experiments TNFa-induced neutrophil apoptosis occurred at a rate not
significantly different (p < 0.05) from that seen under normoxic conditions (figure
6.2.2B), indicating that the (oxygen-dependent) commitment of cells to undergo
apoptosis in response to TNFa is likely to be extremely rapid, occurring within 30
minutes of exposure to this cytokine.
6.2.3 Effect ofhypoxia on TNFa receptor expression
The pro-apoptotic effect ofTNFa in neutrophils requires the presence of both the
p50 and p75 TNFa receptor subtypes (Murray et ah, 1997). To ensure that hypoxia
was not inhibiting TNFa-induced apoptosis by influencing TNFR expression, we
quantified, using flow cytometric analysis, TNFR55 and TNFR75 expression in
neutrophils incubated in the presence and absence ofTNRa under normoxic and
'anoxic' conditions (using medium which had been fully deoxygenated before
addition ofTNFa or normoxic, control, medium). These experiments (figure 6.2.3),
although preliminary, demonstrated no major difference in the extent of TNFR55 and
TNFR75 loss observed during a 30 min incubation in flexiwell plates between
normoxic or anoxic medium. The addition of TNFa did not increase the extent of
either TNFR55 or TNFR75 loss under these conditions, but again no differences
were observed in TNFR expression between hypoxic and normoxic conditions.
6.2.4 Effect ofantioxidants on TNFa-stimulated apoptosis
To further investigate the role of oxygen in the pro-apoptotic effect of TNFa, the
effect of antioxidants on this phenomenon was examined. In view of the previous
experiments showing that the first half hour of TNFa exposure is critical in
determining the fate of the cells, neutrophils were pre-incubated with antioxidants for
30 minutes before being exposed to TNFa. The effects of a wide range of
antioxidants were examined, namely: N-acetyl-L-cysteine (NAC, 5 and 10 mM);
dimethylsulfoxide (DMSO, 400 mM); reduced glutathione (5mM); taurine (100
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A
Time 0 21% control 21% + TNF 0% control 0% + TNF
TNFR55 3.27 ±0.01 1.69 ±0.06 1.58 ± 0.13 2.04 ±0.12 1.62 ±0.15
TNFR75 3.42 ± 0.42 1.66 ±0.02 1.67 ±0.18 1.81 ±0.09 1.72 ±0.23
21 % oxygen control 21 % oxygen + TNF
Figure 6.2.3 Effect of hypoxia on TNFR55 and TNFR75 expression in
neutrophils. Human neutrophils (5 x 106/ml) were resuspended in either anoxic (0%
oxygen) or normoxic (21% oxygen) medium prior to incubation in the presence or
absence of TNFa for 30 minutes. At this time point neutrophils were harvested and
incubated at 4°C for 30 min with a saturating concentration of mouse anti-human
TNFR55, TNFR75 or CD2 (negative control) mAbs and subsequently with FITC-
conjugated goat anti-mouse immunoglobin (30 min). TNFR expression was then
quantified using flow cytometry. TNFR expression was also assessed on freshly
isolated cells. (A) Data are expressed as mean fluorescence relative to the negative
control and is the mean ± SEM of 3 separate experiments. (B) Representative flow-
cytometry (EPICS Profile II) histograms (cell count vs log fluorescence) showing the
profile of treated neutrophils after labelling with TNFR55 antibody (black outline)


















Figure 6.2.4 Antioxidants do not inhibit TNFa-stimulated apoptosis.
Neutrophils (5 x 106/ml) were pre-incubated for 30 min in the presence of the
antioxidants: N-acetyl-L-cysteine (NAC, 5 and 10 mM); dimethylsulfoxide (DMSO,
400 mM); reduced glutatione (5mM); taurine (100 mM); trolox (10 mM); mannitol
(200 mM); 3-amino-l,2,4,-triazole (3AT, 12.5 mM); superoxide dismutase (SOD,
200 pg/ml); catalase (CAT, 250 pg/ml); and both superoxide dismutase (200 pg/ml)
and catalase (250 pg/ml). While control cells were pre-incubated in culture medium
alone. Treated cells were then cultured in the presence or absence of 25 ng/ml TNFa
for 6 hours in 21% oxygen. Control cells were incubated in the presence or absence
of TNFa under both normoxic (21%) and hypoxic (0%) conditions. Data represents
mean ± SEM of 4 separate experiments each performed in triplicate (*p<0.05
compared with 21% + TNFa values).
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mM); trolox (10 mM); mannitol (200 mM); superoxide dismutase (SOD, 200 pg/ml);
catalase (CAT, 250 pg/ml); and both superoxide dismutase (200 pg/ml) and catalase
(250 pg/ml). In addition, the effect of the catalase inhibitor, 3-amino-l,2,4,-triazole
(3AT, 12.5 mM), was investigated.
No significant inhibitory effect on the induction of apoptosis by TNFa was observed
with any of the agents tested (Figure 6.2.4). However, SOD both alone and in
conjunction with catalase, significantly enhanced TNFa-induced apoptosis without
affecting the constitutive rate of apoptosis.
6.2.5 Effect ofhydrogen peroxide on TNFa-stimulated apoptosis
SOD catalyses the reaction: 2H+ + 2 O2" —» H2O2 + 2O2". Thus, to investigate the
possibility that SOD was enhancing the pro-apoptotic effect of TNFa by increasing
intracellular hydrogen peroxide levels, we examined the direct effect of exogenously
applied H2O2 on neutrophil apoptosis. Neutrophils were co-incubated with TNFa
and increasing concentrations of H2O2. An initial set of experiments using a wide
range of H2O2 concentrations (0.05 - 10 mM) suggested that a concentration of H2O2
that might enhance the levels of TNFa-stimulated apoptosis, without affecting basal
apoptosis lay between 1 - 5 mM (figure 6.2.5A). Thus, a second set of experiments
examined the effect of 1 - 5 mM H2O2 on TNFa stimulated apoptosis (Figure
6.2.5B). Only 5 mM H2O2 significantly increased basal apoptosis, while
concentrations of 3 mM H2O2 and above significantly enhanced TNFa-stimulated
apoptosis. These data suggest that TNFa-induced apoptosis can be augmented by,
and is more sensitive to, H2O2 than basal apoptosis.
6.2.6 Effect ofmitochondrial inhibitors and iron chelators on TNFa-stimulated
apoptosis
An important cellular source ofROS are the mitochondria and, in order to investigate
the putative involvement of these organelles in TNFa-stimulated apoptosis, a range
ofmitochondrial inhibitors were utilised. Neutrophils were pre-incubated with the
mitochondrial inhibitors: rotenone (0.1 pg/ml), a complex I inhibitor;
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Figure 6.2.5 The effect of hydrogen peroxide on TNFa stimulated apoptosis.
Neutrophils (5 x 106/ml) were incubated with a range of concentrations of hydrogen
peroxide (0.05 - 10 mM) (A) or a narrow range between 1-5 mM (B) in the presence
or absence of TNFa for 6 hours. At this time, neutrophils were harvested and
apoptosis assessed morphologically. Data represents mean ± SEM from n = 4
separate experiments, each performed in triplicate (*p<0.05 compared with + TNFa
values measured in the absence in the absence of H2O2 and # p<0.05 compared with
















































Figure 6.2.6A The effect of mitochondrial inhibitors on TNFa-stimulated
apoptosis. Neutrophils (5 x 106/ml) were pre-incubated with the mitochondrial
inhibitors: rotenone (0.1 pg/ml); thenoyltrifluoroacetone (TTFA, 250 pM); antimycin
A (50 pM); sodium azide (1 mM) and the uncoupler dinitrophenol (1 mM) for 30
minutes before being cultured in the presence or absence of 25 ng/ml TNFa for 6
hours. Parallel control cells were also prepared. At this time point, neutrophils were
harvested and apoptosis assessed morphologically. Data represent mean ± SEM from
n = 4 separate experiments each performed in triplicate (*p<0.05 compared with
values obtained with cells incubated with TNFa alone).
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thenoyltrifluoroacetone (TTFA, 250 pM), a complex II inhibitor; antimycin A (50
pM), a complex III inhibitor; sodium azide (1 mM), a complex IV inhibitor; and the
uncoupler dinitrophenol (1 mM) for 30 minutes before being incubated in the
presence or absence of TNFa. While none of these agents effected basal apoptosis,
both TTFA and antimycin A significantly inhibited the induction of apoptosis by
TNFa. A similar effect was also seen with dinitrophenol. In contrast, sodium azide
significantly enhanced TNFa-induced apoptosis compared with control values, while
no affect was seen with rotenone (figure 6.2.6A).
The ROS produced by the mitochondria are changed into the more reactive OH*
molecule via the iron dependent Fenton reaction. Thus, to investigate the hypothesis
that TNFa induces apoptosis by enhancing ROS release from the mitochondria, the
effect of iron chelators on TNFa-stimulated apoptosis was examined. As in previous
experiments, neutrophils were pre-incubated with the iron chelators desferrioxamine
(DFO) and CP94 for 30 minutes before being exposed to TNFa. No effect was
observed with either 1 or 10 mM DFO or 1 mM CP94 and, although 10 mM CP94
did partially inhibit TNFa-induced apoptosis, this concentration also increased basal
apoptosis, suggesting a toxic effect (figure 6.2.6B).
6.2.7 Role ofCPP32 in TNFa-stimulated apoptosis
Release of cytochrome c from the mitochondria has also been implicated as an
important step in precipitating apoptosis in other cell types. There is strong evidence
to indicate that cytochrome c is an important co-factor in the auto-proteolysis
required for the cleavage of ICE protease, caspase 9. Caspase 9 is then able to
process, thus activating, CPP32 (caspase 3). Activation of this enzyme has been
shown to be alone sufficient to induce apoptosis. In view of this, we investigated the
effect of the specific CPP32 inhibitor, Z-DEVD-FMK, on TNFa-stimulated
apoptosis in neutrophils. Z-DEVD-FMK (100 pM) significantly reduced the
cytocidal effect of TNFa, although not to the same extent as anoxia (figure 6.2.7). A
higher concentration of this inhibitor (200 pM) was unable to further abrogate the


















































Figure 6.2.6B The effect of iron chelators on TNFa stimulated-apoptosis.
Neutrophils (5 x 106/ml) were pre-incubated with the iron chelators desferrioxamine
(DFO, 1 and 10 mM) and CP94 (1 and 10 mM) for 30 minutes before being cultured
in the presence or absence of TNFa for 6 hours. Parallel control cells were also
prepared. At this time point, neutrophils were harvested and apoptosis assessed
morphologically. Data represent mean ± SEM of n = 4 separate experiments, each






Figure 6.2.7 The effect of a CPP32 inhibitor on TNFa-stimulated apoptosis.
Neutrophils (5 x 106/ml) were incubated with the CPP32 inhibitor, Z-DEVD-FMK,
(DEVD, 100 pM) in the presence and absence of TNFa (25 ng/ml). Parallel control
cells were also prepared. After 6 hours, neutrophils were harvested and apoptosis
assessed morphologically. Data represent mean ± SEM from n = 8 separate
experiments each performed in triplicate (*p<0.05 compared with cells incubated
with TNFa alone).
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caspase inhibitor, Z-VAD-FMK, had a more potent effect, reducing TNFa-induced
apoptosis to control levels (C. Ward, personal communications).
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6.3 Discussion
In our initial experiments we confirmed the previous observations of our group
(Murray et al., 1997), which found that TNFa has an apparently unique bimodal
effect on the rate of neutrophil apoptosis in vitro, with the capacity to induce early
apoptosis (<12 hours) in addition to decreasing the extent of apoptosis at a much
later time point (20 hours). We also demonstrated that the pro-apoptotic effect of
TNFa is concentration-dependent with an EC50 value of 2.8 ng/ml.
Although many mechanisms have been proposed to explain how TNFa may mediate
its cytotoxic effect, there is no one theory which appears to hold true for all cell
types. In addition, different pathways may be employed to induce apoptosis and
necrosis. One hypothesis suggests that an increase in intracellular ROS levels may
play a critical role in TNFa-induced cytotoxicity and the experiments described in
this chapter were designed to investigate whether this could be the case in
neutrophils. Preliminary work found that if neutrophils were made anoxic prior to
TNFa exposure, the pro-apoptotic effect of TNF-a was greatly reduced. These data
suggest that the pro-apoptotic effect ofTNFa in neutrophils may involve oxidative
pathways and are consistent with the observations of Matthews and colleagues
(1987), who found that TNFa-mediated cytolysis of L929 cells was inhibited by
anaerobic conditions. However, when neutrophils were exposed to TNFa in medium
that was not fully anoxic until 30 minutes into the incubation period, TNFa was still
able to induce apoptosis. These data suggest that oxygen is required at a very early
stage and that the commitment of these cells to undergo apoptosis is extremely rapid,
occurring within 30 minutes ofTNFa exposure.
Reports showing an adverse effect of hypoxia on the expression of certain receptor
types in neutrophils (Simms and D'Amico, 1993) prompted us to investigate
TNFR55 and TNFR75 expression in neutrophils incubated under anoxic conditions.
The time-dependent decrease in both TNFR55 and TNFR75 observed during
neutrophil culture is consistent with the demonstration of adherence-induced TNFR
shedding by Lantz et al (1994); however, we found no difference in the rate of
receptor shedding observed between neutrophils incubated under normoxic and
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anoxic conditions, either in the presence or absence of TNFa. These findings are in
agreement with those of Scanned et al. (1995), who, despite observing an
upregulation of TNFR expression in response to chemical hypoxia (induced with
sodium cyanide), found no difference between TNFR expression in control cells and
neutrophils treated with physical hypoxia. Thus, the inhibition of TNFa-stimulated
apoptosis in neutrophils cannot be explained by a direct effect of hypoxia on TNFR
expression.
To investigate further the role ofROS in TNFa-induced apoptosis, neutrophils were
pre-treated with a wide range of compounds possessing antioxidant properties before
being exposed to TNFa. Both mannitol, which quenches hydroxyl radicals, and
DMSO, a free radical scavenger, exhibited some inhibitory effects, although when
grouped, these effects were not significant. NAC is a well established thiol
antioxidant, which after cellular uptake, deacylation and conversion to glutathione,
functions both as an intracellular redox buffer and, in conjunction with glutathione
peroxidase, as a ROS scavenger (Droge et al., 1992; Roederer et al., 1992). NAC has
been shown, using a similar experimental protocol, to block TNFa-induced
cytotoxicity in several cell types, including L929 fibroblasts and oligodendrocytes
(Mayer and Noble, 1994). 10 mM NAC has previously been shown to completely
inhibit PMA-stimulated superoxide anion and hydrogen peroxide production in
neutrophils, as well as protecting these cells from PMA-induced cytotoxicity (Takei
et al., 1996). However, in our system NAC, at both 5 and 10 mM, failed to protect
against TNFa induced apoptosis and, consistent with this result, no effect was
observed with reduced glutathione. The vitamin E analogue, trolox, and anti¬
oxidant, taurine, also failed to abrogate TNFa-induced killing. It remains possible,
however, that the lack of effect of antioxidants may be due to an inability of these
compounds to penetrate to the site ofROS generation. We have already
demonstrated the commitment to undergo TNFa-induced apoptosis is extremely
rapid, and, although neutrophils were pre-incubated with the antioxidants for 30
minutes before exposure to TNFa, this pre-incubation time may not have been
adequate. However, due to the extent of spontaneous TNFR shedding that occurs in
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neutrophils cultured under such conditions (Murray et ah, 1997), it was not possible
to extend this incubation time.
The antioxidant enzymes, superoxide dismutase (SOD) and catalase, catalyse the
reactions 2H+ + 2O2" —> H2O2 +O2 and 2H2O2 —» H2O + O2 respectively. A role for
endogenous mitochondrial (Mn) SOD in TNFa-mediated cytotoxicity has been
demonstrated by Wong et al (1989) studying a human embryonic kidney cell line. In
this system, overexpression ofMn SOD resulted in improved survival after TNFa
treatment for 24 hours. TNFa can itself upregulate Mn SOD mRNA, as shown in a
murine adipogenic cell line and in a pulmonary adenocarcinoma cell line (Warner et
al., 1991). Previous data suggest that neutrophils do not upregulate Mn-SOD in
response to TNFa stimulation and, in addition, that exogenous superoxide dismutase
does not affect apoptosis induced by TNFa (Kettritz et al., 1997). Contrary to these
findings, we found that exogenous SOD markedly enhanced TNFa-stimulated
apoptosis. The discrepancy between our findings and those of Kettritz and co¬
workers (1997) may be because of differences in methodology; we used a higher
concentration of SOD and included a pre-incubation step in our experiments.
As discussed above, SOD promotes the formation of H2O2 from superoxide anions.
Thus, although the synergistic killing effect of SOD and TNFa was unexpected, we
postulated that it might be explained ifH2O2 was the critical ROS involved in the
TNFa effect. In order to investigate this possibility, the effect of FI2O2 on basal and
TNFa induced neutrophil apoptosis was examined. The ability of H2O2 to induce
apoptosis in certain cell types is well documented (Lennon et al., 1991) and
concentrations as low as 0.1 mM have previously been shown to enhance basal
apoptosis in neutrophils (Hannah et al., 1995). As an initial experiment, we
investigated the effect of a broad range of H2O2 concentrations (0.05 - 10 mM) on
both TNFa-induced and basal apoptosis. At concentrations of 1 mM and below, no
effect on either TNFa-induced or constitutive apoptosis was observed, while
apoptosis under both conditions was induced by 5 and 10 mM H2O2. The greater
resistance of neutrophils to H2O2 treatment observed in our experiments compared
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with those of Hannah and co-workers (1995) can probably be explained by the
increased amount of serum present in our cell culture medium (10% as opposed to
2%). However, when the effect of 1 - 5 mM H2O2 was examined, we found that
although H2O2 increased both basal and TNFa-induced apoptosis in a concentration-
dependent manner, TNFa-stimulated cell killing was more sensitive to H2O2 than
basal apoptosis. Indeed, 3 and 4 mM H2O2 were able to enhance TNFa-induced
apoptosis without significantly affecting control levels. These data may suggest a
role for H2O2 in TNFa-stimulated apoptosis in neutrophils. However, the
concentrations required to enhance TNFa-induced killing are undoubtedly supra-
physiological, although the 10% serum present in the culture medium may have had
a neutralising effect on the H2O2. Furthermore, the inability of catalase (an H2O2
scavenger) to protect against TNFa killing and the lack of effect of the catalase
inhibitor (3-AT), which would be expected to enhance H2O2 levels, again argues
against a role for this ROS in TNFa-stimulated neutrophil apoptosis.
Investigations on TNFa cytolysis of L929 tumour cells demonstrated that cells
treated with TNFa showed gross abnormalities in their mitochondrial structure. It
was reported that these organelles looked swollen and had fewer cristae compared to
mitochondria from control cells (Schulze-Osthoff et al., 1992). In addition,
mitochondrial inhibitors have been able to effect TNFa-induced cytotoxicity in
several cell types, thus, implicating a role for the mitochondria in TNFa-mediated
cell killing. Coupled with this, it has long been recognised that the mitochondria are
an important source of ROS under certain conditions. According to Boveris and
Chance (1973) about 1-2% of the oxygen consumed in state 4 (resting respiration) is
utilised by the formation of ROS. In the presence of various drugs (i.e.
mitochondrial inhibitors and quinoid compounds) mitochondrial generation of ROS
can increase several fold.
Two sites in the mitochondrial respiratory chain have been identified as sources
responsible for the formation of ROS. One is dependent on the auto-oxidation of the
flavin mononucleotide from the NADH-dehydrogenase (complex I), whereas the
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Figure 6.3.1 Production of superoxide radicals by the mitochondrial
respiratory chain. Succinate and NADH are oxidized by succinate dhydrogenase
and NADH dehydrogenase respectively. The two electrons (e") are then passes on to
ubiquinone (UQ). From UQ, e" pass through different cytochromes (cyt). Finally,
reduced cytochrome c is re-oxidised by the multi-enzyme complex cytochrome
oxidase. For every four e" taken in by this complex, one oxygen molecule becomes
fully reduced to two molecules ofwater. 1 to 5% of oxygen leaks from this pathway,
mainly at the UQ site, and undergoes stepwise univalent reduction. The one e"
reduction of molecular oxygen generates the superoxide radical ((V*). This can
subsequently be reduced to hydrogen peroxide (H2O2), most commonly in a
dismutation reaction catalysed by superoxide dismutase (SOD). H2O2 can be directly
detoxified to water by a catalase or peroxidase-catalysed reduction. Alternatively
H2O2 can be reduced, usually in an iron-catalyzed reaction, to the hydroxyl radical
(OH*), which can react with almost every type of organic substrate (S) in living cells.
The site of action of the mitochondrial inhibitors and iron chelators used in the
experiments described in the text are also indicated.
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ubisemiquinone (complex III), which is an intermediate of the Q-cycle reaction
(Turrens and Boveris, 1980; Turrens et ah, 1985). Mitochondrial substrates and
inhibitors have been described as effective modulators ofROS and the production of
oxygen radicals at the ubiquinone site is diminished by complex I and II inhibitors
(Cino and Del Maestro, 1989; Konstantinov et ah, 1987; Cadenas and Boveris,
1980). On the other hand, formation of ROS increases several fold in the presence of
the complex III inhibitor, antimycin A, proposing ubisemiquinone as the main
reductant site of oxygen (Boveris et ah, 1976). Thus, if TNFa activates ROS
production at the ubisemiquinone site in mitochondria to induce apoptosis, we would
expect the complex I and II inhibitors rotenone and TTFA, to inhibit TNFa-induced
apoptosis and the complex III inhibitor, antimycin A, to cause enhancement. Such
an effect has indeed been reported to be the case in both L929 and WEHI mouse
fibrosarcoma cells (Schulze-Osthoff et al., 1992). However, we found the complex I
inhibitor, rotenone, had no effect on TNFa-induced apoptosis in neutrophils (a
finding in agreement with that of Matthews et al (1987) who found this inhibitor did
not effect TNFa cytolysis of L929 cells). Both TTFA (complex II) and antimycin A
(complex III) significantly reduced the TNFa pro-apoptotic effect, however, the
respiratory chain uncoupler, dinitrophenol, displayed a similar anti-apoptotic effect,
implying that the TNFa effect may simply be ATP-dependent. In contrast, the
complex IV inhibitor, sodium azide, markedly enhanced the pro-apoptotic effect of
TNFa.
The first oxygen reduction product generated in the mitochondria, under both
physiological and pathological conditions, appears to be the superoxide radical,
which is converted to H2O2 (Loschen et al., 1974). Dismutation of O2" and,
subsequently, H2O2 results in the production ofmore toxic ROS, namely the
hydroxyl radical and singlet oxygen. Conversion of superoxide and hydrogen
peroxide to these harmful oxygen intermediates is catalysed by transition metals such
as iron ions in the Fenton reaction and the (metal catalysed) Haber-Weiss reaction
(Freeman and Crapo, 1982; Halliwell and Gutteridge, 1990). Thus again, ifTNFa is
causing upregulation ofROS generation from the mitochondria, and this process was
coupled to the induction of apoptosis, then iron chelators could be expected to
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abrogate TNFa killing. We therefore investigated the effect of two cell permeable
iron chelators, DFO and CP94, on the TNFa pro-apoptotic effect. Neither
concentration of DFO tested affected TNFa-induced apoptosis and, although the
higher concentration of CP94 (10 mM) did partially inhibit, it also induced basal
apoptosis suggesting that this concentration was toxic in neutrophils.
Together, these data do not support the hypothesis that the early induction of
apoptosis by TNFa reflects an effect of this cytokine, either at the ubiquinone site or
through enhanced free radical production, but does implicate the mitochondria in
having some mediatory role in the induction of apoptosis by TNFa. Our data,
showing that complex II and III inhibitors abrogate the TNFa effect, while a
complex IV inhibitor enhances TNFa-induced apoptosis, suggest that such a
regulatory step may lie between complexes III and IV. This suggestion is supported
by the knowledge that cytochrome c functions as the mediator between these two
complexes and, notably, that cytosolic cytochrome c has been shown in many
circumstances to be necessary for the initiation of the apoptotic program in other cell
types (Yang et al., 1997).
Cytochrome c is encoded by a nuclear gene and translated by cytosolic ribosomes as
apopcytochrome c (Gonzales and Neupert, 1990). Apopcytochrome c is
subsequently translocated to the mitochondria where a haem group is attached
covalently to form holocytochrome c (Gonzales and Neupert, 1990).
Holocytochrome c can be released from the mitochondria into the cytoplasm and this
event has been shown to be required for full activation of CPP32 (caspase 3), a
member of the family of interleukin-l|3-converting enzyme (ICE)/ced-3 cysteine
proteases (Liu et al., 1996; Yang et al., 1997). ICE is a cysteine protease, identified
as a mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3
(Yuan et al., 1993). All known caspases occur as zymogens and become activated
after proteolytical processing (Henkart, 1996). The ICE family of proteases (or
caspases) are thought to be potential positive regulators of apoptosis since apoptosis
is induced by overexpression of these protease genes and is inhibited by ICE/ced-3
protease-specific inhibitors (for review see Zhivotovsky et ah, 1996).
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Recent reports have implicated a potential role for CPP32 and the mitochondria in
TNFa cytotoxicity. Activation of CPP32 like proteases has been implicated in
TNFa-induced hepatic parenchymal cell apoptosis (Jaeschke et ah, 1998). Dong and
co-workers (1998) demonstrated that, in a human monocytic leukaemia U937
subclone resistant to TNFa-induced apoptosis, CPP32 activation in response to this
cytokine was not observed, unlike the TNFa-sensitive parental cell line. In addition,
the parental cell line also demonstrated a change in mitochondrial AvFm after TNFa
treatment, an effect not observed in the TNFa-resistant cells, suggesting that the
mutant cell line may have a functional defect in apoptosis signalling between the
TNFR55 and the mitochondria. Similarly, experiments using mitochondrial
respiratory chain-deficient clones of a leukaemic cell line demonstrated resistance to
TNFa-induced apoptosis and CPP32 activation. However, these cells were sensitive
to staurosporine-induced apoptosis, an effect which could be inhibited by a CPP32
inhibitor, suggesting that, while certain agents can activate CPP32 directly, TNFa
requires the mitochondria to mediate this activation (Higuchi et al., 1997). Caspase
inhibitors were also able to completely abrogate TNFa-induced apoptosis in TNFa-
sensitive HeLa cells and KYM cells (Vercammen et al., 1998). However, it is
important to note that the same inhibitors also sensitise L929 cells to TNFa-induced
necrosis, an effect that is more clearly dependent on enhanced ROS production.
Such data provide additional evidence to support the view that TNFa-induced
necrosis and apoptosis may be mediated via independent mechanisms. Finally,
expression of CPP32 was found to be reduced in TNFa-resistant inflammatory lung
neutrophils when compared to TNFa-sensitive peripheral blood neutrophils,
however, it should be noted that TNFR expression was also significantly less in the
inflammatory lung neutrophils (Watson et al, 1997).
We thus investigated a potential role for CPP32 in TNFa-induced apoptosis in
neutrophils by utilising the specific inhibitor of this enzyme, Z-DEVD-FMK. We
found this inhibitor was able to significantly attenuate TNFa-stimulated killing,
although this effect was not as pronounced as that of hypoxia. However, a more
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general caspase inhibitor (Z-VAD-FMK) was able to completely inhibit TNFa-
induced apoptosis (C. Ward, personal communications). These results imply a role
for CPP32, amongst other caspases, in TNFa-stimulated apoptosis in neutrophils.
Clearly, the events occurring upstream of CPP32 activation, including a potential
role of the mitochondria, and the down-stream substrates of this enzyme still require
further investigation.
Recently the role that cytochrome c plays in CPP32 activation has been clarified.
The cytoplasmic partner of cytochrome c in its pro-apoptotic capacity has been
identified as Apaf-1 (apoptosis activating factor-1) (Zou et al., 1997; Li et al., 1997).
This protein was found to be homologous to the nematode protein Ced-4, a factor
that is also capable of activating pro-caspase 3. The above authors have now
demonstrated that the addition ofApaf-1, cytosolic cytochrome c (previously Apaf-
2) and dATP to pro-caspase 9 (previously Apaf-3) results in the activation of caspase
9 which can then cause cleavage of pro-caspase 3 (CPP32) to its active form.
A second pathway that has been reported to cause CPP32 activation involves
stimulation of receptors from the TNF/NGF receptor superfamily. Recent reports
demonstrate that, following TNFR55 activation, two proteins, TNF-receptor
associated death-domain-containing protein (TRADD) and Fas-associated death-
domain-containing protein (FADD) are complexed to the intracellular domain of the
TNFR55 at the region involved in receptor-induced cell death (death domain) (Hsu et
al., 1995; Chinnaiyan et al., 1996). The TRADD-FADD complex recruits another
protein called FLICE/MACH (caspase 8) by means of the interaction of their
respective death-effector domains. This protein complex is referred to as the death
binding signal complex (DISC). Upon binding to the receptor cluster, caspase 8
becomes activated by auto-proteolysis and thereby is able to cleave and activate
downstream effector caspases (Muzio et al., 1996).
Despite in vitro evidence that caspase 8 can process and thus activate other caspases
including CPP32 (Fernandes-Alnemri et al., 1996; Muzio et al., 1997), more recent
evidence suggests that caspase 8 may not always act through a direct caspase-caspase
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cascade. Using a Xenopus cell-free system, Kuwana and co-workers (1998)
observed that, in the absence ofmitochondria, caspase 8 was only able to produce a
partial apoptotic phenotype in nuclei added to the extracts. However, when
mitochondria were present full nuclear apoptosis occurred, the critical step being the
release of cytochrome c from mitochondria into the cytosol. Further evidence
supporting the existence of a direct and an indirect pathway involving caspase 8
comes from a study by Scaffidi et al. (1998) who investigated the role of caspase 8 in
Fas-mediated apoptosis. In a similar fashion to TNFR55, cross-linking of the Fas
receptor by engagement of the Fas-ligand results in the formation of a DISC that, in
the case of Fas, consists of the adapter proteins FADD/MORT-1 and caspase 8.
Scaffidi and colleagues identified two cell types, which each activate apoptosis
through one of two different Fas signalling pathways. In the so-called Fas type 1
cells, receptor activation was followed by the recruitment of a relatively large
amount of caspase 8 to the DISC. The activated caspase 8 initiated the apoptotic
pathway by processing downstream effector caspases into their active counterparts as
well as causing mitochondrial damage that also initiated a proteolytic cascade. In the
so-called Fas type II cells, less caspase 8 was recruited to the DISC in response to
receptor cross-linking and the activated caspase 8 induced apoptosis predominantly
by causing mitochondrial damage. Recently, two groups have reported that a critical
step lying between caspase 8 activation and mitochondrial damage is the cleavage of
BID, a BH3 domain containing pro-apoptotic Bcl-2 family member (Li et al., 1998;
Luo et al., 1998). Full length BID is located in the cytosol, however, following
cleavage by caspase 8 into its truncated (and active) form (tBID), it translocates to
the mitochondria. Once located on these organelles, tBID induces cytochrome c
release and thus can initiate a pro-apoptotic cascade.
Although signal pathways resulting in CPP32 activation are rapidly emerging, the
physiological substrate(s) and/or apoptotic 'effector' mechanism of this enzyme are,
as yet, unknown. One well characterised potential substrate ofCPP32 is the DNA
repair enzyme poly(ADP-ribose) polymerase (PARP). However, the observation that
mice lacking the PARP gene are still capable of efficient DNA repair (Wang et al.,
1995) makes it difficult to consider cleavage ofPARP as an important early event in
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the apoptotic process. Furthermore, this is supported by a report suggesting that
PARP is not found in neutrophils (Sanghavi et ah, 1998).
Putative recognition sequences for caspase 3-related proteins are also present in the
amino-acid sequences ofNF-kB p65 (RelA) and NF-kB p50 (Nicholson et al., 1995;
Nolan et al., 1991; Ghosh et al., 1990). Indeed, repression ofNF-kB activity by
proteolytic cleavage of these subunits in Jurkat T cells could be prevented by
inhibitors of caspase 3 like proteases (Ravi et al., 1998). Gelsolin, an actin filament-
capping protein, has also been identified as a substrate for CPP32 and caspase
cleaved gelsolin has been shown to sever actin filaments (Kothakota et al., 1997).
Interestingly, neutrophils contain high levels of gelsolin and treatment of these cells
with TNFa and cycloheximide has been shown to result in an augmented rate of
gelsolin cleavage. Furthermore neutrophils isolated from gelsolin"7" mice
demonstrate a delay in morphological aspects of apoptosis in response to various
apoptotic stimuli including co-incubation with TNFa and cycloheximide (Kothakota
et al., 1997).
To conclude, we have presented data that implicate a role for both the mitochondria
and the caspase family of proteases, in particular CPP32, in TNFa-stimulated
apoptosis in neutrophils, findings that are supported by other reports in the literature.
However, further investigations are required to link these two steps. Taking into
account recent findings in other systems, we propose the following hypothesis:
TNFa acts via its cell surface receptors to activate the caspase protease cascade both
directly, via proteolysis of FLICE, and indirectly by exerting a detrimental effect on
the mitochondrial respiratory chain (MRC) (perhaps through BID). Our data would
predict that this latter event causes release of cytochrome c into the cytoplasm, which
would then act as a necessary co-factor for the cleavage of pro-caspase 9, thus
leading to an augmented activation of the effector caspases, including CPP32. In this
model hypoxia could exert a protective effect on the MRC either by reducing damage
caused by ROS or by preventing loss of the mitochondrial ATm, thus preventing the
release of cytochrome c.
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Figure 6.3.2 Proposed mechanism underlying TNFa-induced apoptosis in
human neutrophils. Simplified diagram showing one putative mode of action of
TNFa. In this model TNFa binds to the TNFRs. Following TNFR activation TNF-
receptor associated death-domain-containing protein (TRADD) and Fas-associated
death-domain-containing protein (FADD) are complexed to the TNFR55. This
receptor complex then recruits FLICE (MACH/caspase8), a protein complex termed
the death binding signal complex (DISC). Subsequently, FLICE is activated by
autoproteolysis and in turn cleaves and activates both effector caspases, including
CPP32 (caspase 3), and BID. The truncated (active form) of BID (tBID) then
translocates to the mitochondria where it causes cytochrome c release into the
cytosol. Cytosolic cytochrome c would act as a necessary co-factor in caspase 9
activation thus augmenting activation of CPP32. The mechanism by which CPP32
induces apoptosis is, as yet, unclear. However putative substrates include the actin
filament cleaving protein, gelsolin, poly (ADP-ribose) polymerase (PARP) and the




Neutrophil apoptosis has been proposed as a major mechanism underlying the
removal of redundant neutrophils from an inflammatory focus. Although the
intracellular processes underlying neutrophil apoptosis are not yet fully defined, the
ability ofmany pro-inflammatory agents to modulate this event in vitro is well
documented. For example, LPS, GM-CSF, G-CSF and the interleukins 1, 6 and 8 all
delay neutrophil apoptosis, while TNFa is able to induce apoptosis in these cells.
Several of these agents also act to prime the functional responsiveness of neutrophils.
Thus, it appears that the balance of inflammatory mediators present at an inflamed
site may hold the potential to either up or downregulate neutrophil function and
longevity. We were interested to examine the possibility that other changes in the
neutrophil's environment could also affect the functional life span of these cells.
Clinically, the effect of hypoxia on neutrophil apoptosis is particularly relevant.
Neutrophils are implicated in the pathogenesis ofmany inflammatory diseases, such
as, emphysema, acute respiratory distress syndrome, idiopathic pulmonary fibrosis,
glomerulonephritis and reperfusion injury following myocardial infarction. In these
conditions, the accumulation of neutrophils is associated with destruction of tissue or
deposition of scar tissue, which can lead to catastrophic loss of organ function. In
the majority of these diseases, the sites of inflammation, and hence neutrophil
accumulation, will be relatively hypoxic. This is because of reduced blood flow to
the site of inflammation or, in the case of pulmonary disease, reduced gas exchange
due to lung damage. Furthermore, tissue hypoxia following haemorrhage and trauma
is thought to be a possible initiating factor of the generalised inflammatory response
seen after shock. Thus, the aim of the work presented in this thesis was to examine
the effect of hypoxia on neutrophil apoptosis.
We have shown that, while hypoxia had no effect at early time points (< 6 hr) when
the constitutive rate of apoptosis is still low, at later times (> 10 hrs) hypoxia was
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able to markedly inhibit neutrophil apoptosis. The anti-apoptotic effect of hypoxia in
neutrophils was confirmed by annexin V binding and propidium iodide staining and
was shown to be concentration-dependent. Furthermore, while neutrophils had to be
hypoxic from time 0 in order for hypoxia to achieve its full protective action, a
delayed hypoxic challenge was still able to provide some inhibitory effect, even at a
late stage in the apoptotic 'program'. The effect of re-oxygenation on neutrophil
apoptosis was also examined. When hypoxic neutrophils (3 - 18 hr) were returned to
a normoxic environment they underwent apoptosis at the same rate as control cells.
However, if the hypoxic incubation time was more prolonged (20 hr), the re-
oxygenated neutrophils became resistant to spontaneous apoptosis for a considerable
time period after they were returned to a normoxic environment.
We were unable to mimic the inhibitory effect of hypoxia on neutrophil apoptosis
using anti-oxidants, suggesting that the effect of hypoxia was not mediated solely by
the inhibition of ROS generation. The rate of neutrophil apoptosis was also not
sensitive to changes in glucose concentration or heat shock treatment, indicating that
the enhanced survival of neutrophils under reduced oxygen conditions is specific for
hypoxia, and is not sensitive to other cellular stresses such as cellular ATP depletion.
These results also argue against a role for the GRP and HSP families of stress
proteins in the inhibition of neutrophil apoptosis by hypoxia. Experiments indicating
that neutrophils consitutively expressed Hsp 70 under the culture conditions studied
and, moreover, that neither heat shock or hypoxic treatments caused further
upregulation of this protein in neutrophils, also indicate that HSP expression is not an
important factor in the inhibition of neutrophil apoptosis by hypoxia. The inhibitory
effect ofhypoxia on neutrophil apoptosis was additive to the anti-apoptotic action of
the cytokine, GM-CSF, implying these effects are discrete and act via independent
mechanisms. Furthermore, neither of these protective effects was associated with
expression of the proto-oncogene Bcl-2. p38 MAP kinase has been reported to be
activated upon hypoxic stimulation and has been implicated in some forms of
apoptosis. However, the anti-apoptotic effect of hypoxia was not significantly
affected by a p38 MAP kinase inhibitor, suggesting that this kinase does not play a
major role in the signalling pathway underlying hypoxic inhibition of neutrophil
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apoptosis. Treatment of neutrophils with mitochondrial inhibitors also failed to
mimic the anti-apoptotic effect of hypoxia. Thus, it would seem that the hypoxic
inhibition of neutrophil apoptosis is specific for hypoxia, and cannot be induced by
other cellular stresses associated with making the cells hypoxic, namely the
compromise of oxidative metabolism. However, the hypoxic-mediated inhibition of
neutrophil apoptosis was found to be sensitive to the protein synthesis inhibitor,
cycloheximide, even at very low concentrations that did not influence the rate of
constitutive apoptosis. These observations strongly implicate de novo protein
synthesis as a requirement for the inhibition of neutrophil apoptosis by hypoxia and
imply that hypoxia may be inducing upregulation of a survival protein(s).
In order to investigate the oxygen-sensing mechanism involved in the anti-apoptotic
effect of hypoxia, neutrophils were incubated in the presence of the iron chelators,
DFO and CP94. Both iron chelators mimicked the effect of hypoxia in a
concentration-dependent manner. Moreover, the inhibitory effects of CP94 and DFO
could be overcome by the addition of a molar excess of FeCl2, indicating these
compounds were acting via the chelation of intracellular iron. Thus, chelatable iron
may be closely involved in the oxygen-sensing mechanism underlying the hypoxic
inhibition of neutrophil apoptosis and leads to the proposal that the control
mechanism may involve the interaction of oxygen with a ferro-protein sensor. These
data also suggested that the inhibition of neutrophil apoptosis by hypoxia can be
induced by stimuli similar to those that are known to induce activation of the
transcription factor HIF-1. For instance, other groups have shown that HIF-1 cannot
be induced by mitochondrial inhibitors, heat shock or glucose deprivation but is
activated when cells are made hypoxic or treated with iron chelators. HIF-1 activity
is also induced in many cell types by cobalt ions, however, incubation of neutrophils
with cobaltous chloride had no effect on the rate of apoptosis, indicating that the
oxygen-sensing mechanisms underlying these effects may not be identical.
HIF-1 is a heterodimer consisting of the HIF-la and HIF-1 P subunits, with HIF-1
activity being largely regulated by hypoxic-modulation ofHIF-la protein levels. In
order to investigate a potential role for HIF-1 in the hypoxic inhibition of neutrophil
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apoptosis, HIF-la mRNA and protein expression was examined. HIF-la mRNA
was found to be present in untreated neutrophils, while HIF-la protein was
expressed in hypoxic or DFO stimulated cells but was not present in control
neutrophils, suggesting that HIF-1 activity is also increased under these conditions.
However, in preliminary studies we were unable to demonstrate this experimentally
using a DNA-binding assay for HIF-1.
We also examined the putative activation of two other redox-sensitive transcription
factors in hypoxic and DFO-stimulated neutrophils. A constitutive form ofNF-kB
binding was found to be upregulated in response to hypoxia; however, this effect was
extremely donor specific and the iron chelator, DFO, did not cause a similar
enhancement. AP-1 DNA binding activity was found to be present constitutively in
neutrophils, and treatment of cells with hypoxia or DFO failed to further modulate
binding of this transcription factor. These data indicate that neither NF-kB nor AP-1
play an important role in the inhibition of neutrophil apoptosis by hypoxia.
Finally, the role of oxidant pathways in TNFa-stimulated apoptosis in neutrophils
was investigated. Incubation of neutrophils under anoxic conditions resulted in a
major abrogation of the pro-apoptotic effect of TNFa, implicating an oxygen-
dependent step in TNFa-mediated apoptosis. TNFR55 and TNFR75 expression in
neutrophils was not affected by incubation under anoxic conditions compared to
control cells, suggesting that hypoxia was not inhibiting TNFa-induced apoptosis by
influencing TNFR expression. Co-incubation of neutrophils with mitochondrial
inhibitors and TNFa demonstrated that pharmacological inhibition of the respiratory
chain at complexes II and III attenuated the pro-apoptotic effect ofTNFa, while
inhibition of complex IV enhanced the efficacy of TNFa. In contrast, antioxidants
and iron chelators did not affect the ability ofTNFa to induce neutrophil apoptosis,
implying that the mitochondria, but not ROS, may play a role in the enhancement of
neutrophil apoptosis by TNFa. Inhibition of the pro-apoptotic enzyme CPP32
(caspase 3) also protected neutrophils from TNFa-induced apoptosis suggesting, that
activation of this enzyme may be an important effector step in this process.
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The discovery that neutrophil apoptosis can be markedly inhibited by hypoxia
indicates that neutrophils may remain alive and viable for considerably longer
periods when recruited to an inflammatory focus (e.g. an empyema cavity), which
often exists in a state of low oxygen tension. The ability of extreme tissue hypoxia to
prolong neutrophil longevity and, thus delay neutrophil clearance, could potentially
exacerbate the disease state and result in additional neutrophil-mediated tissue
damage. Since the neutrophil is becoming increasingly associated with a number of
pathological states, such as rheumatoid arthritis and glomerulonephritis, the
recognition that the oxygen tension of the inflammatory site may potentiate the
destructive capacity of the neutrophil (by increasing neutrophil longevity) suggests
that increasing tissue oxygenation may aid in the treatment of such conditions.
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